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Abstract
The US 11 protein herpes simplex virus type-1 is a small, highly basic phosphoprotein, 
which localises to the nucleoli of infected cells. Although this non-essential protein has a 
number of activities attributed to it, its actual role during infection is unknown. The two 
major functions that have been associated with US 11 are the antagonism of host-mediated 
translational shut-off and the ability to bind RNA, the latter of which is the focus of this 
thesis.
To date, US 11 has been shown to bind five RNAs; the antisense transcript of the US 11 5' 
UTR, a truncated transcript of the UL34 gene, termed A34, the Rev-response element of 
human immunodeficiency virus type-1, the Rex-response element of human T-cell 
lymphotrophic virus type-1 and rRNA derived from the 60S ribosome subunit. The 
function of the RNA-binding activity of US 11 during infection is as yet unclear. The RNAs 
bound by US 11 appear, at least superficially to possess little in common, both in terms of 
their sequence and the biological influence of US11 on them. US11 may potentially interact 
with other RNAs in infected cells and the aim of this work was to attempt to test this 
hypothesis.
Firstly, methods in which US 11-RNA complexes could be isolated from infected cell 
lysates were examined. Using a GST-US11 fusion protein to pull out interacting RNAs 
from lysates it proved possible to isolate the known binder, A34 RNA. Secondly, a reverse 
transcription-polymerase chain reaction (RT-PCR) method was developed to allow the 
amplification of sequences pulled out with GST-US11. This lead to the identification of a 
585nt sequence that was present in three HSV-1 3' co-terminal genes, UL12, UL13 and
I
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UL14, which encode alkaline nuclease, a protein kinase and a nuclear protein of unknown 
function, respectively.
The interaction between this RNA, termed 12/14 RNA, and US11 was examined in vitro. 
The binding was found to be sequence-specific and mediated by the C-terminal domain of 
US11. US 11 bound 12/14 RNA in a multimeric fashion, for which the N-terminal domain 
was not required. The affinity of the C-terminal domain of US11 for 12/14 RNA is less that 
that for A34 RNA, indicating that these RNAs may be bound in a slightly different fashion. 
The binding site for US11 was mapped to a 232nt region which encompasses 108nt of the 
UL12 5' UTR, 225nt of the 3' ORF and 7nt of the 3' UTR of UL13 and lies within the 3' 
UTR of UL14. The interaction between this shorter RNA and US11 was examined and the 
binding found to be dependent on secondary structure.
The influence of US 11 on the expression of UL12, UL13 and UL14 was examined in 
infected cells. In the absence of US 11 the levels of UL12 and UL14 remain unchanged, but 
the expression of UL13 is elevated at early times post-infection. It therefore appears that 
US 11 can down-regulate the expression of the UL13 protein kinase at early times during 
infection.
II
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Chapter 1
1.0 Introduction
Introduction
1.1 The Herpesviridae
The Herpesviridae are a family of enveloped viruses with a double stranded, linear 
DNA genome that infect a wide range of vertebrates and at least one invertebrate 
(Comps & Cochennec, 1993; Roizman & Sears, 1993). Over 112 herpesviruses have 
been isolated to date. This family of highly successful viruses varies considerably in 
size, structure, pathology and biology and are highly host specific, although more than 
one herpesvirus can infect an individual organism. Herpesviruses share a set of 'core' 
genes in particular those involved in nucleotide metabolism, DNA replication, capsid 
structure and virion maturation, indicating that they share a common progenitor. The 
'non-core' genes are more specific to the virus subfamilies and include genes involved in 
latency, immune evasion and pathogenesis.
A trait common to all herpesviruses is the ability to assume a non-replicative, latent 
state and persist within the host after primary infection (Whitley, 1996). This enables 
the virus to evade immune clearance and reactivation from latency can lead to recurrent 
rounds of disease.
1.1.1 Classification
The Herpesviridae can be divided in to three subclasses, Alpha- (a), Beta- (p ) , and 
Gammaherpesvirinea (y), based on their biological properties (Roizman et at, 1981) and 
more recently with sequencing of many herpesviruses, the genetic content, which in 
general, agrees with the original classification. Alphaherpesviruses have a wide host
1
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range in cell culture, spread rapidly, have a short growth cycle, destroy the host cell and 
can establish a latent infection in sensory ganglia. Betaherpesviruses have a narrow host 
range, a slow growth cycle and slow viral spread in tissue culture and establish a latent 
infection in secretory glands and lymphoreticular cells. Gammaherpesviruses infect 
lymphocytes in vivo. In tissue culture they generally grow in lymphoblastoid cell lines, 
but some can also grow in epithelial and fibroblastoid cell lines (Roizman & Sears,
1996).
1.1.2 Morphology
The classification of viruses to the Herpesviridae family is primarily based on virion 
morphology (Dargan, 1986; Rixon, 1993). Virions are composed of four distinct 
structures: the DNA core, the capsid, the tegument and the envelope (Fig. 1.1). The 
DNA core consists of the linear virus genome packaged at high density without any 
proteinacious components, occupying the entire capsid volume. The capsid of HSV-1 is 
approximately 125nm in diameter and is composed of 162 capsomers, of which 150 are 
hexamers (hexons), 12 pentamers (pentons), and 320 triplexes (Wildy et al., 1960; 
Schrag et a l , 1989; Zhou et a l, 1994) (Fig. 1.2). The tegument, an amorphous 
proteinaciuos layer, lies between the nucleocapsid and the envelope. The tegument is 
made up of at least 18 proteins, the functions of which are diverse and include viral 
gene transactivation, uncoating, modifying the intracellular environment and regulatory 
proteins. The envelope, derived from the host cell membranes, is studded with viral 
glycoproteins (Wildy & Watson, 1963).
2
HSV Virion
tegum ent
capsid
envelope
Viral DNA
Fig. 1.1: Schematic representation of the HSV-1 virion.
Reproduced from Clements & Brown, 1997.
Fig. 1.2: Reconstruction of HSV-1 B capsid. Reproduced from Zhou et al., 
1995.
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1.1.3 Human Herpesviruses
There are eight herpesviruses known to infect humans (Table 1.1). They cause a wide 
variety of disease states ranging from minor lesions to viral encephalitis (Whitley & 
Schlitt, 1991). As is the case with all herpesviruses, after primary infection a life long 
latent infection is established from which the virus can reactivate. Herpesvirus infection 
in immunocompromised individuals is of particular medical significance (Cotte et al., 
1993).
1.2 HSV-1
1.2.1 Clinical features of HSV-1
The clinical manifestation of HSV-1 is predominantly associated with oral lesions (cold 
sores) that last 4-7 days. However, 30-50% of genital herpes lesions are caused by 
HSV-1 (Kinghom, 1993). Rarely, HSV-1 infection can lead to more serious diseases 
such as rhinitis, Herpetic whitlow, primary herpes dermatitis, eczema, herpeticulum, 
keratoconjunctivitis and encephalitis (Whitley, 1996).
1.2.2 Genomic arrangement of HSV-1
The genome of HSV-1 is 152kb in size and encodes over 80 polypeptides (McGeoch et 
al., 1985, 1986, 1988). It consists of two covalently linked unique regions, the unique 
long (Ul) and unique short (Us) (Fig. 1.3). The Ul region is 107.9kb long and encodes
3
Herpesvirus Class Associated illness
Herpes simplex virus
type-1
(HSV-1)
a Causes 80-95% of oral lesions (cold sores). 30- 
50% of genital lesions are caused by HSV-1. 
Rarely: conjunctivitis, Herpetic whitlow, keratitis, 
and encephalitis
Herpes simplex virus
type-2
(HSV-2)
a Causes 5-20% of oral lesions (cold sores). 50-70% 
of genital lesions are caused by HSV-2. Rarely: 
conjunctivitis, Herpetic whitlow, keratitis, and 
encephalitis. Maternally transmitted neonatal 
infections are generally life threatening.
Varicella zoster virus 
(VZV)
a Primary infection: chicken pox (rash) appears 14- 
15 days post-infection, accompanied by fever. 
Reactivation: shingles; lesions appear at the 
relevant dermatone often accompanied by extreme 
pain which can last for months after lesions have 
healed.
Epstein Barr virus 
(EBV)
y Primary infection in children is often 
asymptomatic. Primary infection in older children 
and adults associated with infectious 
mononucleosis (glandular fever). Associated with 
Burkitt's lymphoma and nasophamgeal carcinoma.
Human cytomegalo­
virus 
(HCMV)
P Primary infection: enlargement and fusion of 
macrophages. Often asymptomatic though can be 
fatal especially in new boms. Infection is 
problematic in immunocompromised individuals 
where symptoms include gastro-enteritis and 
retinitis.
Human herpesvirus 6 
(HHV-6)
P Infant rash, exanthem subitum.
Human herpesvirus 7 
(HHV-7)
P Febrile illness.
Kaposi's sarcoma 
associated herpesvirus 
(KSHV)
y Associated with Kaposi's sarcoma, a vasculated 
nodular skin lesion.
Table 1.1: Human herpesviruses.
The eight herpesviruses known to infect humans, classification and the diseases 
associated with them.
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at least 59 genes. The Us region is 13kb and encodes approximately 13 genes. The 
unique sequences are flanked by inverted repeats, R l (9kb) and Rs (6.5kb) (McGeoch et 
a l , 1988). The Rl and Rs are not related in sequence apart from the a sequence (400bp) 
located at the genome termini. One copy of the a sequence is located at the S terminus, 
whereas the L can terminate with more than one copy. The a sequence is also present at 
the L-S junction as an inverted repeat and again can be present at more than one copy 
(Wagner & Summers, 1978).
1.2.3 The lytic cycle
The lytic cycle is the process whereby the virus enters a cell, replicates and releases 
progeny virions into the surrounding medium (Roizman & Sears, 1996). In essence the 
lytic cycle consists of virus attachment, entry, gene transcription, DNA replication, 
capsid assembly, virion maturation and egress, resulting in the death of the host cell 
(Fig. 1.4).
1.2.3.1 Attachment and adsorption
The attachment of the HSV-1 virion to the host cell membrane is mediated by the 
interaction between the viral glycoproteins and cell surface receptors. HSV-1 virions 
have been shown to bind highly sulphated glycosamine glycans such as heparin 
sulphate and dextran sulphate via gC (and probably gB), mannose-6-phosphate 
receptors and the complement receptor C3b (Spear, 1993; Shieh & Spear, 1994). Fusion 
of the virion membrane with the cellular membrane is a pH-independent process that 
requires gB, gD, gH and gL (Spear, 1993).
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A number of cell surface receptors are involved in initiating fusion, tumour necrosis 
factor-like molecule (or herpesvirus entry mediator (HveA)) interacts with gD 
(Montgomery et a l, 1996). Poliovirus receptor-related protein (HveC) is thought to be a 
major mediator of entry via an interaction with gD in mucosal and neuronal infection 
(Gertaghty et a l, 1998). The abundance of virion-cell surface interactions indicates that 
HSV-1 is likely to utilize more than one attachment/entry pathway.
1.2.3.2 Nucleocytoplasmic transport
The nucleocapsid traverses the cytoplasm, shedding tegument components, transported 
via the microtubule network and a dynein-like motor (Penfold et a l, 1994; Sodeik et a l, 
1997). The DNA is delivered to the nuclear pore complex (NPC). Empty capsids can be 
visualised closely associated with NPCs (Batterson et a l, 1983).
1.2.3.3 Gene expression
HSV-1 genes are transcribed by the host cell DNA-dependent RNA polymerase II 
(RNAP II) (Costanzo et a l, 1977). Viral mRNAs are post-transcriptionally modified 
(capping, cap methylation and polyadenylation) by existing cellular pathways. 
However, as only five of the HSV-1 genes contain introns, splicing is not generally 
required. HSV-1 genes are transcribed in a temporal cascade, with the induction of one 
class directly or indirectly leading to the induction of the next (Honess & Roizman, 
1974; Honess & Roizman, 1975; Clements et a l, 1977). Three kinetic classes can be 
identified, the immediate early (IE) or a  genes, the early (E) or p genes, and the late (L) 
or y genes.
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i. Immediate Early gene transcription
The expression of immediate early genes occurs without de novo viral protein synthesis. 
The virion-borne transactivator, a-TIF (VP 16), binds to TAATGARAT sequences 
upstream of IE promoters, complexing with the host transcription factors Oct-1 and 
HCF and recruiting the RNAP II holoenzyme (Contanzo et a l, 1977; Batterson & 
Roizman, 1983; O'Hare et al 1988; O'Hare, 1993). Four of the five IE gene products, 
ICP27, ICP22, ICP4 and ICPO are responsible for the regulation and expression of the E 
and L genes (reviewed by Hayward, 1993; Subak-Sharp & Dargan, 1998). The fifth, 
ICP47, inhibits the presentation of antigenic peptides by MHC I molecules (Jugovic et 
a l, 1998).
ii. Early gene expression
In general, E genes encode proteins involved in nucleotide metabolism and DNA 
replication. The promoter regions of E genes are composed of a TATA box, a cap site 
and upstream sequences required for the binding sites for cellular factors such as SP1 
(Jones & Tijan, 1985). No upstream sequences specific for viral proteins have been 
detected, though IE gene products may be involved in the stabilization of cellular 
transcription factor binding or aid their recruitment.
6
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iii. Late gene expression
Late genes can be subdivided into two categories, leaky late or yi genes and true late or 
j 2 genes. Leaky late genes are expressed at low levels prior to DNA replication whereas, 
the expression of true late genes is dependent on DNA replication (Honess & Watson, 
1977). In general, late promoters consist of a TATA box and cap site (Johnson & 
Everett, 1986b; Homa et a l , 1988). In some, notably the true late genes encoding gC 
and US11, a downstream activator sequence (DAS), located 20-40bp downstream of the 
TATA box is required for expression (Shapira et al., 1987; Kibler, et al., 1991; 
Guzowski etal., 1994).
Two models for the requirement of DNA expression for late gene expression have been 
proposed. The first suggests factors that repress transcription are bound to the promoters 
of late genes and are displaced by the passage of the replication fork. The second 
hypothesis states that late genes possess weak promoters, and the amplification of the 
DNA template is required to produce significant levels of expression.
1.2.3.4 Rendering the host cell permissive to support the viral life cycle
HSV-1 infection leads to the redirection of cellular factors and metabolism to the 
massive task of producing large amounts of infectious virions. Upon infection, HSV-1 
down-regulates host cell DNA synthesis, translation and splicing, in favour of the 
production of its own macromolecules. Numerous cellular components and pathways 
are modified during HSV-1 infection, and two of these events are discussed here.
7
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The first phase of this assault is initiated by the virion host shut-off (vhs) protein which 
is delivered in the tegument, vhs, which displays a limited homology with the fen-1 
nuclease family, causes the destabilization and degradation of mRNA (Kwong et a l, 
1988).
The IE gene product ICP27 causes the redistribution of splicing factors and the 
inhibition of splicing (Hardwicke & Sandri-Goldin, 1994; Phelan et a l, 1996; Bryant et 
a l, 2001). Most cellular genes contain introns, compared with only five genes of HSV- 
1. The activity of ICP27, therefore, results in the nuclear retention of cellular genes.
1.2.3.5 HSV-1 DNA replication
Expression of the E gene products leads to the onset of DNA replication. HSV-1 
encodes seven genes directly involved in DNA replication and several accessory 
enzymes required for nucleotide metabolism (reviewed by Lehman & Boehmer, 1999). 
Viral DNA is thought to be replicated initially by theta replication, followed by rolling 
circle replication to produced concatameric DNA molecules (Roizman & Sears, 1996). 
Replication begins with the binding of one of the three origins of replication (Ori) by 
the UL9 Ori binding protein (Olivo et a l, 1988). This leads to the recruitment of the 
helicase/primase complex (UL5, UL8, and UL52), to form a replication bubble and the 
binding of DNA polymerase (UL30 and UL42) (Crute et a l, 1989). The replication fork 
proceeds with the continuous synthesis of DNA on one strand and the discontinuous 
synthesis on the other, and is maintained by the single strand specific DNA binding 
protein, UL29 (Knopf, 2000).
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1.2.3.6 Capsid assembly
With the onset of DNA replication and late gene expression, all the components 
necessary for the production of mature virions are in place. Capsid assembly begins in 
the cytoplasm and is completed within the nuclear compartment. VP5 interacts with pre- 
VP22a and VP26, and VP19C interacts with VP23 in the cytoplasm (Homa & Brown,
1997). It is thought that the nuclear localisation signals contained in pre-VP22a and 
VP19C mediate the nuclear import of these structural complexes. The spherical pro- 
capsid is assembled via protein-protein interactions between the viral structural and 
scaffold proteins (Newcomb et a l , 2001). The viral DNA is packaged and cleaved into 
genome length units directed by signals in the terminal a sequence (Stow et al., 1983). 
VP22a is expelled and simultaneously the capsid undergoes a structural transition to an 
icosahedral shape (Rixon, 1993).
Three forms of capsid are found inside infected cells, A-, B- and C- capsids which can 
be resolved via sucrose density gradient ultracentrifugation (Gibson & Roizman, 1972). 
C-capsids contain viral DNA and are able to form mature infectious virions. B-capsids, 
the precursor of C-capsids, do not contain DNA. The core of B-capsids is occupied by 
VP22a and can package viral DNA leading to the extrusion of VP22a. A-capsids, 
however, do not contain DNA or VP22a and are thought to be the result of abortive 
packaging attempts. A-capsids cannot form infectious particles.
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1.2.3.7 Virion maturation and viral egress
The capsid buds through the inner nuclear membrane and into the perinuclear space, 
acquiring an envelope (Granzow et a l , 2001). The next stage in virion 
maturation/egress is a matter of some debate. The most recent evidence suggests that 
de-envelopment occurs as the capsid buds through the outer nuclear membrane, 
followed by re-envelopment in a post-Golgi compartment (Browne et a l , 1996; Skepper 
et a l, 2001). The virion is thought to exit the cell via the secretory pathway (Rixon, 
1993).
1.2.4 HSV-1 Latency
All herpesviruses can assume a biologically silent state in specific cell types. After 
initial virus amplification at a primary oral mucosal site of infection, HSV-1 enters 
sensory neurones innervating that site and are transported via retrograde axonal 
transport to the trigemminal and dorsal root ganglia (Kristensson et a l, 1986; recently 
reviewed by Preston, 2000) (Fig. 1.5). Here the virus assumes a latent state as an 
episome (Mellerick & Fraser, 1987).
During latency the only transcriptionally active region of the genome is a 10.4kb 
fragment within the Rl/Rs component, giving rise to the latency associated transcripts 
(LATs) (Spivack & Fraser, 1988; Stevens et a l, 1988). Although not required for the 
establishment and maintenance of latency, they may be involved in the reactivation 
process (Sedarati et a l, 1989; Javier et a l, 1988). Reactivation from latency is poorly
10
0)
CJ CO
03 ft<U
>
JM
I n
<  PQ
Chapter 1 Introduction
understood. It can be triggered by external stress or stimuli, such as UV-irradiation and 
hormonal irregularities (Hill, 1985).
1.3 The US11 protein of HSV-1
The US 11 protein of HSV-1 is a small basic phosphoprotein that localizes to the 
nucleolus of infected cells. The US11 gene is conserved only in HSV-1 and HSV-2. 
US 11 is non-essential for virus growth in vitro and in vivo and the function of US 11 
during the HSV-1 lytic cycle is unclear. The major properties associated with US 11 are 
RNA-binding and the antagonism of the interferon-induced, double-stranded RNA- 
dependent protein kinase (PKR) pathway.
1.3.1 US11: a non-essential gene
The US11 gene is located in the Us region of HSV-1 the genome (Marsden et a l , 1978; 
Honess et a l , 1980). Deletion of US 11 itself does not appear to have an impact on the 
growth, establishment of latency, or reactivation of the virus in vivo or in vitro models 
(Longnecker & Roizman, 1986; Brown & Harland, 1987; Longnecker & Roizman, 
1987; Meignier et al.\ 1988; Nishiyama et a l 1993).
1.3.2 The US11 gene and evolution
The US 11 gene is a true late gene, its expression being dependent on DNA replication 
(Johnson et a l , 1986; Johnson & Everett, 1986a & b). US11 mRNA is transcribed from 
the leftward strand of the genome and its mRNA is 3' co-terminal with US 12 and US 10,
11
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sharing a common polyadenylation signal (Fig. 1.6). US 11 is a 161 amino acid protein 
encoded by a 483bp ORF, lying between nucleotide positions 145246 and 144763 
(Rixon & McGeoch, 1984, 1985; McGeoch et al., 1986). The US11 TATA box and 
transcriptional start sites lie within the ORF of US 12. Its first Met-ATG lies within the 
3' UTR of US 12 and its stop codon within the ORF of US 10. The TATA box, 
transcriptional start site and first Met-ATG of US 10 lies within the ORF of US11. The 
overlap between the ORF of US 10 and that of US 11 spans 249bp, 83 amino acids. 
US 10 and US11 are transcribed in different reading frames and therefore do not share a 
common amino acid sequence (Rixon & Clements, 1982; Rixon & McGeoch, 1984 & 
1985).
Within the US 11 and US 10 ORFs lies a three and one-third 18bp tandemly reiterated 
repeat sequence, TCTCCCGGGAGACCGGGG, encoding a 6 amino acid repeat motif 
of SPREPR in US 11 and LPGSPG in US 10. The number of copies of this tandem 
reiteration varies between virus strains and is thought to account for the intrastrain 
difference in the size of the US 11 protein and restriction fragments encompassing this 
region (Lonsdale et al., 1979; Rixon & McGeoch, 1984; Umene & Yoshida, 1989).
US 11 can be divided into two domains, the N-terminal (amino acid 1-83) and the C- 
terminal domain (amino acid 84-161). The C-terminal domain of US 11 consists almost 
entirely (amino acid 84-156) of 24 repeated tripeptide units, XPR, where X represents 
any amino acid (Fig. 1.7). The 6 amino acid repeat encoded by the 18bp reiterated DNA 
sequence lies within this region, encoding 7 of the XPR repeats. The tripeptide repeat 
motif extends either side of the reiterations and all possible codons for P and R are 
utilized, therefore there is no equivalent extended repeat in US 10 outside of that 
encoded by the tandem reiteration. Rixon & McGeoch (1984) suggested that the 
polypeptides are under selective pressure as opposed to the DNA sequence as the
12
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14406
14415
14423
14431
14439
14447
14452
14463
14471
14479
14487
14495
14503
14511
14519
14527
14535
14543
mRNA cleavage Poly(A) signal
atggcggttt tctatgccga catcggtttt ctcccccgca ataagacacg atgcgata*aa atctgtttgt aaaatttatt aagggtacaa
US10 stop codon
attgccctag cacaggggtg gggttagggc cgggtcccca cacccaaacg caccaaacag atgcaggcag tgggtcgagt
acagccccgc gtacgaacac gtcgatgcgt gtgtcagaca gcaccagaaa gcacaggcca tcaacaggtc gtgcatgtgt
cggtgggttt ggacgcgggg ggccatggtg gtgataaagt taatggccgc cgtccgccag ggccacaggg gcgacgtctc
ttggttggcc cggagccact gggtgtggac cagccgcgcg tggcggccca acatggcccc tgtagccggg ggcgggggat
cgcgcacgtt tgcagcgcac atgcgagaca cctcgaccac ggttcgaaag aaggcccggt ggtccgcggg caacatcacc
aggtgcgcaa gcgcccgggc gtccagaggg tagagccctg agtcatccga ggttggctca tcgcccgggt cttgccgcaa
gtgcgtgtgg gttgggcttc cggtgggcgg gacgcgaacc gcggtgtgga tcccgacgcg ggcccgagcg tatgctccat
US1 1 stop codon
gttgtgggga gaaggggtct gggctcgcca ggggggcata cttgcccggg ctatacagac ccgcgagcc tacgtggttc 
gcggggggtg cgtggggyr^ggypRTCg gggagaccgg ggcicccggg gagaccgggg|ct(:m ggga gaccggggtt
gtcgtggatc cctggggtca cgcggtaccc tggggtctct gggagctcgc ggtactctgg gttccctagg ttctcggggt
ggtcgcggaa cccggggctc ccggggaaca cgcggtgtcc tggggattgt tggcggtcgg acggcttcag atggcttcga
US10 ATG
gatcgtagtg tccgcaccga ctcgtagtag acccgaatct ccacattgcc ccgccgcttg atcattatca ccccgttgcg
<4----------------1 U S10T A T A
ggggtccgga gatcatgcgc gggtgtcctc gaggtgcgtg aacacctctg gggtgcatgc cggcggacgg cacgcctttt
I S l  1 ATG
aagtaaacat ctgggtcgcc cggcccaact ggggccgggg gttgggtctg gctcalctcg agagccacgg gggggaacca
US12 Stop codon
ccctccgccc agagactcgg gtgatggtcg tacccgggac tcaacgggtt accggattac ggggactgtc ggtcacggtc
ccgccggttc ttcgatgtgc cacacccaag gatgcgttgg gggcgatttc gggcagcagc ccgggagagc gcagcagggg
<4— |-------- ^  US 11 TATA
acgetccggg tcgtgcacgg cggttctggc cgcctcccgg tcctcacgcc cccttttatt gatctcatcg cgtacgtcgg
Fig. 1.6: The genomic location, sequence and structure of the US11 gene.
A: A schematic diagram of the HSV-1 genome. The unique regions are depicted as lines 
and the major repeat regions are represented by white boxes. An enlarged region of the 
US 10, US11 and US 12 genes. The untranslated regions are represented by a line, the 3' 
ends by an arrow head, the 5' ends by a circle and the ORFs by a green box. A red 
dashed line indicates the region of U s component shown in panel B (not to scale). B: 
The sequence of the U s region containing US11. TATA boxes are in bold and 
underlined, US 11 downstream activation sequence (DAS) is in green (Kibler et al., 
1991; Guzowski et al., 1994), first Met-ATG start codons are in red, translational stop 
codons are in blue, sequence reiterations are boxed and in bold, polyadenylation signal 
is in magenta, and the mRNA cleavage site is indicated by an asterisk. (Rixon & 
Clements, 1982; Rixon & McGeoch, 1984, 1985; McGeoch et al., 1986).
MSQTQPPAPVGPGDPDVYLKGVPSAGMHPRGVHAPRGHP 
RMISGPPQRGDNDQAAGQCGDSGLLRVGADTTISKPSEAV 
RPPTIPRTPRVPREPRVPRPPREPREPRVPRAPRD PRV PRDP 
RI)PR(jpi^SPREPijsPREPF(SPREP^TPRTPREPRTARGSV-l61
Fig. 1.7: The amino acid sequence of US11.
The XRP repeats are highlighted in blue and the reiterated sequence is boxed. (Rixon & 
McGeoch, 1984).
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reiterated sequence does not encode a substantial proportion of the tripepide repeats. As 
all the potential codons for proline and arginine are used, it is likely that selection 
allowed US 11 to gain and/or maintain its C-terminal tripeptide repeats whilst not 
constraining US 10 to an extended repeat motif.
Rixon & McGeoch (1984) suggest two evolutionary pathways by which this 
phenomenon could arise. The tandem reiterations originally encoded the entire C- 
terminal domain of US11, and by either random mutations or through selective pressure 
on US 10, acquired its present day sequence. Alternatively, a pre-existing reiterated 
amino acid sequence predisposed the DNA to the formation of tandem duplications 
which could arise without compromising the amino acid sequence.
1.3.3 The structure of the US11 protein
The unusual highly repetitive nature of the C-terminal domain, with the appearance of a 
bulky proline residue every 3 amino acids, suggests that the domain forms a secondary 
structure with frequent turns, as the amido acid, proline, is often associated with 
changes in the direction of the polypeptide. Schaerer-Uthurralt et a l (1998) used 
computer aided modelling to predict the secondary structure of this domain. Two 
structures were predicted to arise from the repeated sequence, a right-handed 3io-helix 
and a poly-L-proline type II helix (PPII-helix) (Fig. 1.8). These helical structures have a 
repeat unit of 3 amino acids per turn, the 31 o-helix forms a more extended structure, 
whilst the PPII-helix is considerably more compact and more stable, and is thought to 
be the structure adopted by the C-terminal domain of US 11 (Roller et a l , 1996; 
Schaerer-Uthurralt et al., 1998). The PPII-helix is a flexible structure and has been 
found to exist for short stretches in a number of globular proteins (Adzhubei et a l, 
1993). Examples include avian pancreatic polypeptide which possesses an 8 residue
13
Fig. 1.8: The predicted structure of the C-terminal domain of US11.
Computer aided modelling of the C-terminal domain of US 11 predicts a helical 
structure of 3 amino acids per turns. Two structures are predicted, the 3io-helix (left- 
hand side) and the poly-L-proline type II helix (right-hand side). Reproduced from 
Schaerer-Uthurralt, et al., 1998.
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Fig. 1.9: Schematic diagram of the structure of the C-terminal domain of US11.
Reproduced from Roller et al., 1996. Residues 76-161 of US11. Arg represented by 
circled plus signs, Pro with a P, the hydrophobic residues, lie, Val and Ala, with shaded 
rectangles, the polar residues, Ser, Thr and Gin with ovals and the acidic residues, Asp 
and Glu, with circled minus signs.
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PPII-helix, GPSQPTYP (Blundell et al., 1981) and carbonic anhydrase B, NRPTQPL. 
The EB2 protein of EBV, an RNA-binding protein, contains 7 XRP repeats spanning 21 
amino acids which lies between amino acids 151-172 RAPRAPRAPRVPRAPRSPRAP 
in a 479 amino acid protein. The PPII-helical structure of US 11 is the longest found in 
nature thus far and represents a substantial structural domain as opposed to the other 
examples where this structure only encompasses several amino acids and at best, a short 
region. Roller et al. (1996) suggested that the PPII-helix, bearing 3 residues per turn, 
would present 3 faces, an uncharged relatively hydrophobic face comprised of proline 
residues, a positively charged, basic face consisting of arginine residues and the third 
face of varying nature, consisting mainly of hydrophobic, uncharged polar and acidic 
amino acids (Fig. 1.9) (Roller et al., 1996).
1.3.4 Localization
The US 11 gene product is incorporated into the virion tegument at an estimated 600- 
1000 molecules per virion and is therefore delivered to the host cell upon infection 
(Roller & Roizman, 1992). Ultrastructure studies have revealed that early in infection 
US 11 co-localizes with viral DNA in the nucleus and perinuclear regions rich in 
ribosomes (Puvion-Dutilleul, 1987). At approximately 6h pi US11 begins to accumulate 
in the nucleolus, and levels increase in the cytoplasmic compartment, correlating with 
late gene expression (MacLean et al., 1987; Puvion-Dutilleul, 1987; Besse, et al., 1996). 
US 11 does not require any viral products for its localization within the nucleolar 
compartment. In cells expressing US 11 the morphology of the nucleoli are altered, 
being more compact and with fewer large fibrillar centres (Besse, et al., 1996). At the
14
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ultrastructure level, US 11 localizes to the dense fibrillar component (DFC) and the 
granular component (GC) of the nucleolus (Besse, et al., 1996).
1.3.4.1 The nucleolus
The nucleolus is a non-membrane bound, sub-nuclear structure involved in ribosome 
biogenesis. It is the site of the transcription of ribosomal DNA (rDNA) encoding 18S, 
5.8S and 28S rRNAs by RNA polymerase I, rRNA processing and base modification, 
and the assembly of pre-ribosomal subunits (Schwarzacher & Mosgoeller, 2000). The 
nucleolus can be divided into three morphological, concentric domains, the inner 
fibrillar center(s) (FC), the dense fibrillar component (DFC) and the outer granular 
component (GC). Transcription of rRNA is thought to occur at the FC/ DFC interface. 
Early rRNA processing occurs in the DFC and assembly of pre-ribosomes in the GC 
(Maxwell & Fournier, 1995).
The nucleolus is a dynamic compartment, and in actively dividing cells rRNA 
represents an estimated 60% of total cellular RNA. As the site of ribosome biogenesis 
the nucleolus is a key target for regulation during events such as cell proliferation, 
senescence and stress response. In addition the nucleolus has been implicated in other 
cellular processes such as 5' end trimming of certain tRNAs, assembly of the signal 
recognition particle, U6 small nuclear (sn) RNA modification, the sequestration of cell 
cycle regulation proteins and has even been implicated in ageing (Srivastava & Pollard, 
1999; Carmo-Fonseca et a l , 2000).
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1.3.4.2 Virus interaction with the nucleolus
The nucleolus is the site of localization of certain viral proteins and is often modified 
during viral infection. The effect of the viral infection on ribosome biogenesis is, in 
general, specific to the particular virus. A few viruses replicate in the nucleolus, such as 
Bouma disease virus and Minute virus of mice (Walton et al., 1989; Pyper et a l , 1998). 
The mRNAs of HIV-1 and HTLV-1 may traffic through the nucleolus (Michienzi et al., 
2000) and it has been suggested that the nucleolar localization of the HTLV-1 Rex 
protein is required for its function in the nucleocytoplasmic transport of intron- 
containing viral transcripts (Nosaka et al., 1989). Adenoviruses and herpesviruses cause 
disruption of the nucleolus. Adenovirus infection inhibits the synthesis and processing 
of rRNA and causes the redistribution of nucleolar antigens. The adenovirus protein V 
can cause the redistribution of the nucleolar proteins, B23 and nucleolin (Matthews et 
al., 2000). Herpesvirus infection is associated with a decrease in the number and size of 
nucleoli, diminished rRNA processing, and rRNA transcription (Kyriakidis & Stevely, 
1982; Besse et al., 1996). Other viruses up-regulate nucleolar activity. The Semliki 
Forest virus protein capsid protein localises to the nucleolus and at low concentrations 
can stimulate protein synthesis, but at high concentrations has an inhibitory effect 
(Elgizoli et al., 1989). Purified preparations of the large T-antigen of SV40 can 
stimulate rRNA transcription in vitro (Whelly et al., 1978).
1.3.4.3 Nucleolar localization
As the nucleolus is not separated from the surrounding nuclear milieu by a membrane, 
nuclear proteins could conceivably traffic into and out of this compartment by simple
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diffusion. However, as the nucleolus is distinctive in its composition there must be a 
mechanism allowing the exclusion and inclusion of factors.
It has been argued that proteins are targeted to the nucleolus by their association with 
nucleolar components. However, there are examples of proteins which interact with 
nucleolar components but do not enter the nucleolus such as p53, which can interact 
with rRNA (Fontoura, et al., 1992), or the HSV-1 transcription factor, ICP4, which can 
interact with the nucleolar/ ribosomal protein L22 (EAP) (Leopardi & Roizman, 1996). 
Specific nucleolar localization sequences (NoLS) have been identified in cellular and 
viral proteins which can direct nucleolar accumulation (Hatanaka, 1990) (Table 1.2). In 
general, the NoLS consists of a stretch of basic amino acids, particularly rich in arginine 
residues which flanks the NLS. Experimentally, it is difficult to separate the NoLS from 
the NLS, as nuclear accumulation is required for access to the nucleolus. An NoLS is 
usually defined by mutations that allow targeting to the nucleoplasm, but exclusion 
from the nucleolus. The nucleolar shuttling protein, B23, has been implicated as a NoLS 
receptor which can direct the nucleolar accumulation of several proteins, notably the 
HIV-1 Tat and Rev proteins, and the cellular rRNA maturation and ribosome assembly 
factor, nucleolin (Dundr et al., 1995; Li, 1996, 1997).
1.3.4.4 US11: Nuclear localization and nucleolar targeting
US11 does not appear to contain a consensus NLS. NLSs are short, modular stretches of 
amino acids which can broadly be divided into three categories. (1) A short stretch of 
basic amino acids, as typified by SV40 large T antigen, PKXKRKV (Kalderon et al., 
1984); (2) a bi-partite NLS, comprising two stretches of basic residues separated by 10- 
12 amino acids, such as the NLS of nucleolin, KRPAATKKAGQAKKKK; (Robbins et
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Protein Function NoLS Ref
MDV MEQ Transcriptional transactivator, 
may bind RNA
RRRKRNDAARRRRRKQ Liu et a l,  
1997.
HIV-1 Rev Nucleocytoplasmic targeting 
of intron-containing viral 
transcripts
RRNRRRRWRERQRQ Cochrane et 
a l , 1990
HIV-1 Tat Transcriptional transactivator GRKKRRQRRRAHQN Dang & Lee, 
1989
HTLV-1 Rex Nucleocytoplasmic targeting 
of intron-containing viral 
transcripts
PKTRRRPRRSQRKRPPTP Nosaka e t a l , 
1989
PRRV N protein Nucleocapsid protein RGKGPGKKNKKKNPEK Rowland et 
al., 1999
Hsp70 Stress response protein, 
chaperone
FKRKHKKDISQNKRAVRR Dang & Lee, 
1989
Topoisomerase I Unwinding supercoiled DNA Residues 157-199. Krich. Mo et al.y 
2000
FXR2P Associates with FMRP, 
ribosomes and RNA
RPQRRNRSRRRRFR Tam an ini et 
aly 2000
Table 1.2: Nucleolar localization sequences.
This table lists several examples of nucleolar localisation sequences (NoLS). 
Abbreviations: MDV (Marek's disease virus), MEQ (MDV Eco Q), HIV-1 (Human 
immunodeficiency virus type-1), HTLV-1 (Human T-cell lyphotropic virus type-1), 
PRRV (Porcine reproductive and respiratory syndrome virus), Hsp (Heat shock 
protein), FMRP (Fragile X mental retardation protein), FXR2P (FMRP related protein 
2).
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12 amino acids, such as the NLS of nucleolin, KRPAATKKAGQAICKKK; (Robbins et 
al., 1991); and (3) NLSs such as that of c-myc, with charged/polar residues interspersed 
with a central basic cluster, PAAKRVKLD (Makkerh et al., 1996). Molecules with a 
molecular weight less than 60kDa can diffuse passively through the nuclear pore, and it 
is therefore reasonable to suggest that US 11 (21kDa) accesses the nuclear compartment 
in this fashion.
The C-terminal of US 11 is highly basic, with an arginine residue every three amino 
acids, and given the broad consensus for NoLS it is easy to envision that this domain 
could function as such. However, as the NoLS is thought to be an extended NLS, and 
US 11 does not appear to possess a consensus NLS, the presence of specific nucleolar 
targeting is questionable. US 11 may be directed to localize to the nucleolus by non­
specific associations with nucleolar components. US 11 can associate with ribosomes, 
RNA and possibly DNA; and its affinity for either of these may concentrate it in the 
nucleolus, a site rich in all three.
The domain responsible for the nucleolar accumulation of US 11 was mapped by Roller 
et a l (1996). Deletion of almost the entire C-terminal domain (amino acids 88-161) 
abolished nucleolar localisation of US11. Deletion of amino acids 91-121 resulted in the 
diminished accumulation of US 11 in the nucleolar compartment, whereas deletion of 
amino acids 123-161 does not effect localisation. Deletions throughout the US 11 
protein do not result in exclusion from the nucleoplasm, indicating that there is no 
specific NLS. The loss of nucleolar association does not strictly correlate with an 
inability to bind RNA or to associate with ribosomes. US11A123-161, which localises 
to the nucleolus, does not co-sediment with the 60S ribosomal subunit and is unable to 
bind RNA.
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1.3.5 Association with ribosomes
US 11 was first detected in ribosomal preparations as a viral protein which migrated as 
several species in 2D gel electrophoresis by Masse et al. (1990). These species were 
termed vl (the unphosphorylated form) via, vlb, v ie and vld (the phosphorylated 
forms), plus other less abundant phosphorylated derivatives migrating above and below 
these species (Masse et al., 1990; Diaz et al., 1993). The identity of these species was 
revealed by CNBr cleavage and N-terminal sequencing, and confirmed by Western 
blotting with a polyclonal antibody raised against US 11 (Diaz et al., 1993). 
Fractionation of the ribosome subunits showed that the US 11 derivatives were 
associated with different ribosomal fractions. Species v l, and via co-sedimented with 
the 40S fraction; vl, via and vlb with the 80S; and vl, via, vlb and vie with the 
polysomal fraction (Masse et al., 1990). Whether the phosphorylation state of US 11 
directs its association with a particular ribosomal complex or whether the differential 
phosphorylation is a consequence of the localisation of US 11 is unclear.
Diaz et al. (1993) found that US 11 could be detected throughout a sucrose gradient 
fractionation of ribosome preparations from infected cells. This suggests that US 11 
associates weakly with ribosomes in a non-specific fashion, and this interaction is 
disrupted upon sucrose gradient centrifugation, leading to the distribution of US 11 
throughout the gradient as either aggregates or multimers. However, Roller & Roizman 
(1992) detected US 11 specifically and differentially associated with ribosomal subunits. 
Separation of ribosomal subunits on a sucrose gradient and Western blotting for the 
presence of US 11 in these fractions showed that US11 was present in small amounts at 
the top of the gradient, and co-sediments with the 60S, 80S and polysomal fractions,
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with the 60S fraction containing the most US11. The fractions containing the 40S 
subunit did not contain detectable amounts of US 11 suggesting that US 11 specifically 
associates with the 60S subunit. Furthermore, they were able to demonstrate that viral 
mutants in which US 11 had been truncated in the C-terminal domain US11A88-161, 
A91-121 and A121-161 were unable to co-sediment with ribosomes indicating that this 
interaction may be specific (Roller et al., 1996).
In the presence of actinomycin D (Diaz et al., 1993) and in the presence of PAA at 2h 
pi, (Roller & Roizman., 1992) US 11 associates with ribosomes and it accumulates in 
ribosomal preparations in a moi-dependent fashion, indicating that virion-borne US11 is 
capable of this interaction. Furthermore, in a stable cell line constitutively expressing 
US11, it was found to associate with ribosomal fractions demonstrating that US11 does 
not require any other viral factors for this interaction (Roller & Roizman, 1992).
1.3.6 US11 and the dsRNA-activated PKR pathway
1.3.6.1 PKR: A host defence mechanism
In order to establish an infection a virus must first overcome the anti-viral responses of 
the host organism. One of the first antiviral defences a virus must face is the innate 
immune interferon (INF) response system. INF are cytokines produced in response to 
viral infection of a cell or other cellular stresses. INF is secreted into the extracellular 
medium and through the binding to cell surface receptors, triggers an intracellular 
signalling cascade and the induction of over 30 genes. This primes the cell to fight viral 
infection or overcome other cellular stresses (Williams, 1999).
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i. PKR activation and translational shut-off
Protein kinase R (PKR, Protein kinase RNA-activated) (also termed DAI, PI-eIF2 or 
p68 kinase) is ubiquitously expressed at low levels in most tissues and is a major anti­
viral effector of the INF system. Its expression is induced by INF and its antiviral action 
results in the global shut-off of translation, preventing viral gene expression, subsequent 
replication and spread, at the expense of the cell. PKR expression alone is not sufficient 
to cause this severe action, the kinase activity of PKR is activated by the presence of 
transcriptionally active virus. Therefore, PKR requires a means of detecting viral 
infection.
PKR can be activated by low concentrations of dsRNA, some highly structured ssRNAs 
(henceforth termed as activator dsRNAs) and polyanions. The kinase activity of PKR is 
stimulated by the binding of activator dsRNAs via its two dsRNA binding motifs 
(dsRBM). It is thought that two molecules of PKR bind to one molecule of activator 
dsRNA promoting dimerization (Consentino et al., 1995). PKR then autophophorylates 
on several Ser and Thr residues, becoming activated (Taylor et al., 1996). Activated 
PKR phosphorylates eukaryotic initiation factor 2 (eIF-2) a  subunit on Ser-51. 
Phosphorylated eIF-2a forms a tight complex with the eIF-2 guaninosine-exchange 
factor, eIF-2p, and inhibits the exchange of GDP for GTP in the eIF-2 complex 
(Rowlands et a l, 1988; Ramaiah et a l, 1992). The recycling of the eIF-2 complex to 
form the eIF-2-GTP-Met-initiator tRNA ternary initiation complex is therefore 
prevented and the translation of mRNA is subject to global shut-off and growth 
arrest/cell death occurs.
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ii. PKR and viral infection
During viral infection dsRNAs are synthesised due to transcription from both strands of 
dsDNA viruses or the highly structured RNA elements of RNA viruses, allowing PKR 
to "detect" a viral infection. Almost all viruses have therefore evolved ways in which to 
subvert the PKR response to allow effective viral gene expression, replication and 
dissemination (Fig. 1.10 and Table 1.3).
Some viruses produce highly structured RNAs at very high levels which mimic the 
activator dsRNAs. Adenovirus provided the first direct evidence that PKR was involved 
in the anti-viral response of INF. Cells infected with the adenovirus mutant dl331, 
which lacked the VAI gene, were blocked in protein synthesis (Thimmappaya et al., 
1982) and subsequent work showed that this was due to the phosphorylation of eIF-2a 
by activated PKR (Schneider et a l, 1985). The VAI RNA transcribed from this region 
was shown to have extensive secondary structure and bind to PKR and inhibit its 
activation. The EBV encoded RNAs (EBERs) are able to functionally substitute for the 
VAI RNAs of adenovirus and act in a similar manner to these RNAs. Another 
mechanism by which viruses can overcome the PKR pathway is to produce dsRNA 
binding proteins such as the vaccinia virus E3L protein or the reovirus ct3 protein, 
which bind to dsRNA activators and mask them from PKR. Influenza utilizes a pre­
existing cellular inhibitory pathway to prevent the activation of PKR. Infection results 
in the release of the 58kDa protein inhibitor of PKR (P58ipk) from an inhibitory 
complex with a member of the heat shock protein (Hsp) 90 family, termed inhibitor of 
P58ipk (I-P58ipk). This allows P58ipk to interact with the dimerization domain of PKR
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Fig. 1.10: The INF-induced, dsRNA-activated PKR pathway and viral 
antagonists.
The unboxed text on the right-hand side of the diagram lists the pathway leading to 
PKR activation and the inhibition of translation, which is diagrammatically depicted in 
the centre. The peach boxes indicate the stages at which this pathway may be 
antagonised by viral proteins, examples of which are listed below the boxes. The 
proposed mechanism of action of these viral proteins are given in Table 1.3.
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Autophosphorylation
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eIF-2aK3L, Tat
eIF-2aeIF-2a
Dephosphorylation of 
eIF-2a
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eIF-2a
ICP34.5
Large T Ag
TRANSLATION
Mechanism Virus/
Factor
Notes Reference
dsRNA
analogues
Adenovirus/ 
VA RNA
Abundant, highly structured RNAs which com pete with 
activator dsRNA for PKR binding and inhibit activation.
M athews & Shenk, 
1991.
EBV/
EBERs
Highly structured RNAs thought to act on PKR by 
com petitive inhibition. Can substitute for VA RNAs. N on- 
essential for EBV growth in tissue culture.
Bhat & Thimmappayes, 
1983; Clarke e ta l ,  1990; 
Swaminathan etal., 
1991.
HIV-1/TAR Highly structured RNA at the 5'end o f  all HIV RNAs. Can 
bind to PKR in vitro. May act by com petitive inhibition. 
May act by recruitment o f  PKR inhibiting protein.
Gunnery et a l,  1990.
dsRNA
binding
proteins
Influenza/
NS1
Thought to bind to and sequester activator dsRNAs in the 
nucleus.
Lu et al., 1995; 
Bergmann et al., 2000.
Vaccinia/ 
E3L (p20 
/25)
Binds to and sequesters activator dsRNAs. W hitaker-Dowling & 
Youngner, 1984; Beatie 
etal., 1995.
Reovirus/ a3 Binds to and sequesters activator dsRNAs. Expression o f  cr3 
protein can rescue vaccinia AE3L virus.
Beattie etal., 1995; Yue 
& Shatkin, 1997; 
Samuel, 1998.
Formation o f 
heteromeric 
complexes 
with PKR
Influenza/
P58ipk
Ubiquitious cellular protein released from com plex with 
inhibitory factors upon influenza infection. Binds to PKR  
dimerization domain and prevents activation.
Lee etal., 1992,1994; 
Gale et al., 1997.
HIV-1/
TRBP
Cellular dsRNA binding protein. Binds HIV-1 TAR. 
Prevents autophosphorylation o f  PKR. Forms heterodimers 
with PKR.
C ostentinoef a /., 1995; 
B en k iran ee /a /., 1997.
HHV-8/
vIRF-2
Interacts with PKR and inhibits autophosphorylation. 
Mechanism unknown.
Burysek & Pitha, 2001
Vaccinia 
Virus/ EL3
Binds to the catalytic and dsRBD o f  PKR and inhibits 
autophosphorylation. May inhibit substrate binding or 
dimerization.
Romano et al., 1998; 
Sharp etal., 1998.
HCV/NS5A Binds to PKR and prevents activation. Thought to prevent 
dimerization. N S 5A  sequence may influence intra-strain 
INF sensitivity.
Gale et al., 1998; 
Pawlotsky & Grmanidis, 
1999.
Pseudo­
substrate for 
PKR
Vaccinia/
K3L
Shares hom ology with eIF -2a  N-terminal. Probably 
com petes with eIF -2a  for binding the catalytic domain o f  
PKR.
Beatie etal., 1991,1995; 
K awagishi-Kobayashi et 
al., 1997.
HIV- 1/Tat Com petes with eIF -2a  for phosphorylation by PKR and 
inhibits PKR autophosphorylation in vitro. Som e sequence 
similarity to eIF-2a.
Brand et al., 1997; Cai et 
al., 2000.
Swinepox/
C8L
Inhibits phosphorylation o f  eIF -2a . Sequence similarity to 
eIF-2a. 43% amino acid identity to Vaccinia virus K3L.
K awagishi-Kobayashi et 
al., 2000.
HCV/ E2 Binds to PKR and inhibits autophoshorylation in vitro. 
Sequence similarity to autophoshorylated residues in PKR. 
Inhibition does not appear to be so lely  due to com petitive 
inhibition.
Taylor et al., 1999, 
2001.
Down
regulation of 
PKR levels
HIV-1/Tat PKR levels reduced in Tat expressing cell lines and HIV-1 
infected cells.
Roy etal., 1990; 
M cM illan et al., 1995; 
Cai et al., 2000.
Poliovirus PKR down regulated in Poliovirus infected cells. 
Mechanism unknown.
Black etal., 1993.
Down­
stream of 
eIF-2a 
phosphory­
lation
HSV-1/
ICP34.5
Redirects the phosphatase activity o f  P P la  to 
dephosphorylate eIF -2a  via its Gadd34 hom ology domain.
M cG eoch & Barnett, 
1991; Chou & Roizman, 
1994; Brown etal., 
1997; He etal., 1997a; 
Lieb etal., 2000.
SV40/ Large 
T-Antigen
Restores translation levels, but does not inhibit PKR 
activation or eIF-2a phosphorylation. M echanism and point 
o f  action unknown.
Rajan etal., 1995; 
Swaminathan etal., 
1996.
Table 1.3: Examples of viral antagonists of the INF-induced, dsRNA-activated 
PKR pathway.
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and prevent activation. Other inhibitors act downstream of PKR activation acting as 
pseudosubstrates for PKR and hence are phosphorylated in preference to eIF-2a such as 
the K3L protein of vaccinia virus. The ICP34.5 protein of HSV-1/-2 acts downstream of 
PKR activation and eIF-2a phosphorylation by redirecting the activity of protein 
phosphatase l a  (PPla) to dephosphorylate eIF-2a (He et a l, 1997a).
1.3.6.2 The ICP34.5 protein of HSV-1, Gadd34/MyDl 16 and the PKR pathway
ICP34.5 possesses at least two functions. It is a neurovirulence factor, allowing the 
replication and spread of virus in the CNS and it is an antagonist of the INF-induced 
dsRNA activated PKR pathway. ICP34.5 (y]34.5, RL1, or neurovirulence factor) is 
located within the inverted repeats of the Ul sequence and is therefore present as two 
copies per genome (Thompson et a l, 1983; Thompson et a l, 1989; Dolan et a l, 1992, 
Mckay et a l, 1993). ICP34.5 consists of three domains, a large N-terminal domain, a 
central tripeptide tandem repeat region of Pro Ala Thr (PAT), repeated 5-10 times 
(strain-dependent) and a C-terminal domain with homology to the C-terminal domain of 
the murine MyD116 and its hamster homologue, the Gadd34 protein (McGeoch & 
Barnett, 1991).
The entire coding region of ICP34.5 is required for its function as a neurovirulence 
factor and mutants in this gene are severely impaired in replication and the 
establishment of latency in the CNS following intracranial inoculation of mice (Chou et 
a l, 1990; MacLean et a l, 1991; Bolovan et a l, 1994; Spivack et a l , 1995).
The C-terminal domain of ICP34.5 is responsible for its inhibition of host mediated 
translational shut-off. In tissue culture, deletion of the ICP34.5 gene or its C-terminus 
restricts viral replication in a cell type-dependent manner. Cell lines such as BHK and
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Vero are permissive for ICP34.5 mutant vims growth, whereas, in non-permissive cell 
lines, such as the neuroblastoma cell line SK-N-SH, vims growth is severely attenuated 
(Chou et al., 1990; Chou & Roizman, 1992). In non-permissive cell lines vims growth 
is almost completely inhibited by host mediated translational shutoff via the PKR 
pathway (He & Roizman, 1994). The high degree of conservation between the C- 
terminal domain of ICP34.5 and that of MyD 116/Gadd34 proteins suggests that ICP34.5 
acquired this domain from this cellular gene during evolution in order to counteract the 
PKR pathway.
The MyDl 16 gene, is a member of the MyD (Myeloid differentiation primary response) 
gene family. It is expressed early in differentiation in response to differentiation 
inducers, such as IL-6, and in terminally differentiated myeloid cells (Lord et al., 1990). 
It is thought to act as both a negative regulator of cell growth and of apoptosis 
depending on temporal expression (Leibermann & Hoffman, 1998). It is structurally 
similar to ICP34.5, consisting of a large N-terminal domain, a Pro, Glu, Ser, Thr 
(PEST) rich 38 amino acid sequence repeated 4.5 times, and a C-terminal domain which 
shares homology with that of ICP34.5 (Lord et al., 1990; McGeoch & Barnett., 1991). 
The GADD34 gene belongs to a family of genes, the GADD (growth arrest and DNA 
damage) family, induced in response to certain growth factors, genotoxic stress and 
apoptotic signals (Zhan et al., 1994, Hollander, et al., 2001). Over-expression of 
Gadd34 results in growth arrest and apoptosis. In cells over-expressing the anti- 
apoptotic proteins Bel-2 or cowpox vims CRM-1 there is a decrease in the induction of 
Gadd34 and apoptosis (Hollander et al., 2001). Interestingly, co-expression of the 
ICP34.5 protein and Gadd34 results in the suppression of Gaddis-mediated growth 
arrest (Hollander et al., 2001).
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He et al. (1996) demonstrated that the C-terminal domain of ICP34.5 could be replaced 
by the homologous domain of the MyD116 gene to promote virus growth in non- 
permissive cells lines by restoring translation levels. Using the MyD116 C-terminal 
domain as bait in a two-hybrid screen, He et al. (1997a) detected an interaction with the 
catalytic subunit of protein phosphatase la  (PPla). Furthermore, in GST-pull down 
assays they were able to show that the C-terminal domains of ICP34.5 and MyD116 
could interact with PPla. Previously, it had been observed that whilst PKR was 
activated in cells infected with ICP34.5 virus mutants and wt virus, eIF-2a was only 
phoshorylated in the absence of the ICP34.5 C-terminal domain (Chou et al., 1995). In 
vitro eIF-2a dephosphorylation assays showed that there was a dramatic increase in 
eIF-2a dephosphorylation in the presence of the C-terminal domain of ICP34.5 or 
MyD116. ICP34.5 can be purified from infected cells in a large molecular weight 
complex containing the catalytic subunit of PPla. Mapping of the site of interaction 
between ICP34.5 and P P la  revealed that the binding site for P P la  was within the 
MyDl 16/Gadd34 homology domain. In addition the sequence bound by P P la  is present 
in all the subunits, accessory or regulatory proteins that can bind directly to the catalytic 
subunit of P P la  (He et al., 1998). Substitution of amino acids within the P P la  binding 
consensus sequence in ICP34.5 results in the loss of virus growth and PKR pathway 
inhibition in non-permissive cell lines (He et al.y 1998).
The ICP34.5 gene is conserved in HSV-2, where it appears to performs a similar role 
(Taha et al.y 1989; MacLean et al., 1991; Brown et al., 1994). The only other viral 
homologue found to date is the LMW23-NL protein of the arbovirus African Swine 
Fever Virus (ASFV), which possesses a C-terminal domain with a high degree of 
homology with that of ICP34.5, and the MyDl 16/Gadd34 (Sussman et al., 1992; Zsak 
et al., 1996). Therefore, it would appear that ASFV and HSV-1 and -2 acquired the
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MyD116/GADD34 gene homology domains independently as a means of inhibiting 
host mediated translational shutoff. The MyD/GADD genes generally have a negative 
effect on cell growth whilst ICP34.5 prevents the inhibition of translation. It would 
therefore appear that the MyD/GADD homology domain is context dependent, with the 
N-terminal domains of these proteins defining the action.
1.3.6.3 US11 and the PKR pathway
i. Mapping o f the suppressor locus o f a ICP34.5 mutant virus
US 11 was first implicated in the antagonism of the PKR pathway when isolated as a 
suppressor mutant of the ICP34.5 virus phenotype in a non-permissive cell line. A list 
and description of the viruses mentioned in this text that were used in the study of the 
interaction of US 11 with the PKR pathway is given in Table 1.4.
Mohr & Gluzman (1996) constructed a HSV-1 virus in which both copies of the 
ICP34.5 gene had been replaced by (1-glucuronidase (SPBg5e virus). SPBg5e was 
subjected to serial passage in the non-permissive neuroblastoma cell line, SK-N-SH. 
After 4-5 passages the viruses which displayed a CPE were grown in permissive Vero 
cells. The suppressor isolates grew 50-100 fold better than the parent virus in SK-N-SH 
cells. The protein profiles from SK-N-SH cells or from the non-permissive glioblastoma 
cell line, U373, infected with suppressor mutant isolates, wild type HSV-1 or SPBg5e 
were examined by in vivo labelling with [35S]-methionine/-cysteine for lh at 12h pi. 
This revealed that the suppressor mutants were able to synthesis viral proteins to nearly 
wild type levels and selectively shut-off host protein synthesis, whereas the SPBg5e 
infected cells were almost totally deficient in the synthesis of cellular or viral proteins.
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Virus
Name
Strain Description of genotype Ref.
R3616 F LacZ insertion into both copies of the ICP34.5 gene. Chou et al., 
1990.
R5104 F LacZ insertion into both copies of the ICP34.5 gene 
and deletion of US8-US12. Insertion o f the US 11 
ORF fused to the ICP47 promoter and the US 10 ORF 
into the tk locus.
Cassady et al., 
1998b.
SBPg5e Patton Both copies o f the ICP34.5 gene replaced by the P- 
glucuronidase gene.
Mohr & 
Gluzman, 1996.
Sup-1 Patton Suppressor mutant isolate of SBPg5e. Deletion in US 
component resulting in the disruption of the US 12 
ORF and juxtaposition o f the US 12 promoter to the 
US 11 ORF.
Mohr & 
Gluzman, 1996
Table 1.4: Recombinant viruses used in the investigation of the interaction between 
US11 and the PKR pathway.
This table gives a description of the viruses used in the study of the interaction between 
US11 and PKR mentioned in the text.
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This indicated that the cellular PKR response to viral infection had been effectively 
opposed in the suppressor mutant isolates.
The BamHl genomic fragments of the suppressor isolates were subcloned into a vector 
and subsequent restriction enzyme analysis revealed that the suppressor mutations of all 
the isolates were within the BamHl Z fragment. Further restriction analysis and 
sequencing showed that all the suppressor mutants displayed a common trait. They all 
possessed deletions in the Us/TRs region resulting in the disruption of the US 12 ORF 
(encoding ICP47, or a47), removal of the cis-acting sequences that direct the 
transcription of US11, and juxtaposition of the US12 promoter upstream of the US11 
ORF (Fig. 1.11).
Mulvey et a l (1999) mapped the minimal deletion required in the Us region to bring 
about the suppressor phenotype in the SPBg5e virus by a marker rescue assay. The 
smallest deletion tolerated for the suppression phenotype was a 140bp deletion into the 
Us component and a 51bp deletion into the TRs component (Fig. 1.11).
Examination of the kinetics of US 11 expression in the Sup-1 virus revealed that the 
US11 gene was under the control of the US 12 promoter causing US11 to be expressed 
as an immediate early gene (He et al., 1997b). The immediate early expression of US 11 
was found to be responsible for the suppression of host-mediated translational shut-off 
in ICP34.5 mutant viruses (Cassady et al., 1998a; Mulvey et al., 1999). Additionally, 
Poppers et al (2000) mapped the domain of US 11 responsible for the suppression of the 
AICP34.5 phenotype to the C-terminus.
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Chapter 1 Introduction
ii. IE expression o f US 11 results in a decrease in PKR activation and eIF-2a 
phosphorylation.
The in vivo PKR pathway target of US 11 has yet to be deduced. Both the inhibition of 
PKR autophoshorylation/activation and the block of eIF-2a phosphorylation have been 
suggested to be potential candidates for the mode of US 11 action (Cassady et a l , 1998a 
& b; Mulvey et al, 1999; Poppers et al., 2000).
Cassady et al (1998a & b) suggested that US11 prevents the phosphorylation of eIF-2a 
by activated PKR. Using in vivo [32P] orthophosphate labeling of HeLa cells infected 
with R5104, Cassady et al (1998a) demonstrated that PKR was still activated in the 
presence of ectopically expressed US11. Furthermore, purified eIF-2a incubated in the 
presence of [y-32P] ATP and lysates from cells infected with the R5104 virus showed 
decreased labelling compared to eIF-2a incubated with lysates from cells infected with 
R3616. Using R3616 infected cell lysates as a source of activated PKR, Cassady et al 
(1998b) demonstrated that the addition of GST-US11 could inhibit eIF-2a 
phosphorylation in a dose-dependent manner. In addition, US11 became phosphorylated 
itself, indicating that US11 may act as a pseudosubstrate for PKR.
However, Mulvey et al (1999) demonstrated that PKR phosphorylation was reduced by 
over 50% in the presence of Sup-1 infected cell lysates in an in vitro PKR labelling 
assay. In addition, Cassady et al (1998b) using purified PKR, eIF-2a, [y-32P]ATP and 
the addition of polyl.C. (a dsRNA mimic which activates PKR), demonstrated that the 
phosphorylation of eIF-2a and autophosphorylation of PKR was inhibited by US 11 in a 
dose-dependent manner. The C-terminal domain of US 11 was shown to be necessary 
and sufficient to reduce the autophoshorylation of PKR in vitro in a dose-dependent 
manner (Poppers et a l, 2000).
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The potency of GST-US11 mediated inhibition of eIF-2a phosphorylation and PKR 
autophosphorylation in vitro is greatly increased if it was added prior to the activation 
of PKR, suggesting that PKR activation is the main target of US11. In addition, GST- 
US11 phosphorylation was only detected when higher concentrations of GST-US11 
were added to the reaction in the presence of pre-activated PKR. An interaction between 
US 11 and PKR was detected in a GST-PKR pull-down assay with HSV-1 infected 
HeLa cell lysates. This interaction was not abolished by RNase treatment of the lysates 
(Cassady et al., 1998b).
iii. The target o f US 11 in the PKR pathway
Several hypotheses can be made with respect to the mechanism by which US11 inhibits 
PKR activation and eIF-2a phosphorylation:
(1) US 11 is phosphorylated in the presence of activated PKR in vitro (Cassady et al., 
1998b), and it can be inferred that US 11 acts as a pseudosubstrate for PKR 
phosphorylation, competing with the authentic cellular substrate, eIF-2a. Similarly, the 
HIV-1 transactivitor protein, Tat, and the vaccinia virus K3L protein are thought to act 
as psuedosubstrates for PKR (Beatie et al., 1991, 1995; Brand et a l , 1997; Kawagishi- 
Kobayashi et al., 1997). However, phosphorylation of US 11 observed does not appear 
to directly correlate with the decrease in eIF-2a phosphorylation. In addition, the level 
of US 11 phoshorylation varies between experiments. When US 11 was added prior to 
PKR activation no phosphorylation of US 11 was observed (Cassady et al., 1998b). 
US 11 does not share any obvious homology to eIF-2a and as the level of PKR 
autophosphorylation is decreased, this is more likely to be the primary reason for the 
decrease in eIF-2a phosphorylation. The phosphorylation of US 11 may be an artifact of
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the in vitro phosphorylation assay conditions rather than a true reflection of the in vivo 
situation. However, HIV-1 Tat can both inhibit eIF-2a phosphorylation and PKR 
autophosphorylation (Brand et al., 1997), so this possibility cannot be ruled out.
(2) Cassady et al. (1998b) have suggested that US11 may bind to the active site of PKR 
and inhibit access to eIF-2a. This would be reflected in a decrease of 
autophosphorylation, which is consistent with the available data. The E3L protein of 
vaccinia virus has been shown to interact with the dsRBD and catalytic domain of PKR 
(Sharp et al., 1998). US11 may mask the substrate binding site, and hence prevent elF- 
2a phosphorylation.
(3) US 11 may form a heterotrimeric complex with PKR and dsRNA. US 11 has been 
shown to bind to several RNAs in vivo and in vitro (Roller & Roizman, 1990; Roller & 
Roizman, 1991; Diaz et al., 1996), and the exact details of what constitutes actual in 
vivo activator dsRNA substrates for PKR are unclear (Gunnery & Mathews, 1998). 
Poppers et a l (2000) suggest that US 11 may prevent PKR dimerization by both 
interacting with PKR directly and by interacting with the same dsRNA activator. A 
mechanism similar to this has been proposed for the vaccinia virus E3L protein 
(Romano et a l , 1998; Sharp et a l, 1998). The E3L protein, which possesses a dsRBM 
and can bind to dsRNA, is thought to act by competing with PKR for the binding of 
dsRNA (Davies et a l, 1993). However, Romano et a l (1998) found that E3L can 
interact with PKR directly and suggested that this interaction may be stabilized via the 
mutual binding of an activator dsRNA molecule, resulting in the formation of a 
heterotrimeric complex. TRBP contains a dsRBM and is thought to utilize a similar 
mechanism, forming a heteromeric complex with PKR, an activity which is not 
dependent on dsRNA binding (Consentino et a l, 1995; Benkirane et a l, 1997).
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US 11 can interact with GST-PKR in a pull-down assay, an interaction which is not 
dependent on RNA (Cassady et a l, 1998b). Whether this interaction is direct has yet to 
be established.
(4) As US 11 appears to act upstream of PKR activation and is an RNA-binding protein, 
Poppers et al (2000) have also suggested that US 11 may act as a dsRNA binding 
protein, competing with PKR for activator dsRNA.
(5) PKR is localized to the ER and the nucleolus (Jeffrey et al., 1995). It associates with 
ribosomes via its dsRBM in an RNA-independent manner (Wu et al., 1998). It is 
thought that PKR associates with ribosomes as inactive monomers, and that cytosolic 
PKR is dimeric. The 60S ribosomal protein, L I8, can inhibit PKR activation by 
competing with activator dsRNA for the binding of the PKR dsRBM I, essentially 
masking this site. L I8 may mediate PKRs association with ribosomes and sequester it 
as an inactive form at these sites (Raine et a l , 1998; Kumar et al., 1999).
US11 is associated with ribosomes (Masse et al., 1990; Roller & Roizman, 1992; Diaz 
et al., 1993) and may interact with PKR at this site and sequester PKR. Poppers et al 
(2000) suggested that US11 may tether PKR to ribosomes, and prevent PKR activation 
by soluble activator dsRNA.
The mapping of the PKR domain(s) bound by US 11 will give a greater insight into the 
mechanism of its action. From an evolutionary perspective it is interesting to note that 
HSV-1 apparently encodes two proteins which oppose the PKR pathway, utilizing 
different mechanisms. US 11 may have originally been expressed at early times during 
infection and acted as the primary PKR antagonist in the HSV-1/-2 progenitor. Upon 
the acquisition of the MyD116/GADD34 homology domain by ICP34.5, US11 may 
have become redundant in this pathway, allowing it to evolve other functions and a late 
promoter (Cassady et al., 1998a & b; Mulvey et al., 1999; Roizman, 1999).
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1.3.7 US11 and heat shock
After hyperthermic stress cells respond by shutting off protein synthesis and general 
transcription and elevate the transcription of the genes encoding the heat shock proteins 
(Hsps). The Hsps are molecular chaperones which can interact with denatured proteins 
to prevent aggregation and aid refolding. In addition, Hsps have other less well defined 
functions in the stress response pathway. They can prevent the transcription of 
proinflammatory genes, aid vesicle trafficking, and may be involved in nucleolar 
maintenance (Morcillo et al., 1997). Indeed many Hsp genes encode small nucleolar 
RNAs (snoRNAs), RNAs involved in rRNA processing, within their introns.
PKR is a target and effector for many stress response pathways, such as tumour necrosis 
factor, bacterial lipopolysaccharides and heat shock, leading to the inhibition of 
translation and in some cases apoptosis (Fig. 1.12). During heat shock PKR is activated, 
probably by another cellular kinase, leading to the phosphorylation of eIF-2a and the 
inhibition of protein synthesis.
US 11 can increase the rate of recovery of cells subjected to heat shock. HeLa cells 
transiently or constitutively expressing US11 restore protein synthesis more quickly and 
are less likely to undergo apoptosis (Diaz-Latoud et a l , 1997). This is not due to an 
increase in the levels of Hsps. US 11 most probably exerts its effect by decreasing the 
levels of activated PKR and/or phosphorylated eIF-2a.
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1.3.8 The DNA-binding activity of US11
Several studies have implicated US 11 as a DNA binding protein. Firstly, Bayliss et al 
(1975), isolated 16 virus-specific polypeptides by the chromatography of [35S]- 
methionine labelled protein extracts of HSV-1 infected cells on a native calf thymus 
DNA-cellulose column. One of these species migrated at 21kDa, and may therefore 
correspond to US11. Using 125I labelling of protein bound to purified HSV-1 DNA, 
Hyman (1980) demonstrated that 4 proteins were bound to HSV-1 DNA, one of which 
migrated at approximately 20kDa. Dalzeil & Marsden (1984) also isolated a HSV-1 
21kDa protein by chromatography of infected cell proteins on a DNA-cellulose column. 
Furthermore, this 21kDa protein could be specifically competed off the column by a 
400bp a sequence fragment of HSV-1. Conclusive proof that this 21kDa DNA-binding 
protein was US11 was provided by MacLean et a l (1987), by Western blot analysis of 
proteins which bound to DNA-cellulose with an anti-US 11 polyclonal antibody. 
However, further studies on the DNA-binding proteins of HSV-1 have not shown US11 
to bind DNA and US 11 does not appear to have a role in DNA cleavage or packaging. 
In addition, the localisation of US 11 to the nucleolar compartment, from which HSV-1 
DNA is excluded, would suggest an alternative role (MacLean et al, 1987; Puvion- 
Dutilleul, 1987). Roller & Roizman (1990) suggested that the DNA-binding activity of 
US11 detected in the above mentioned experiments was a result of its high basicity and 
not a specific interaction.
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1.3.9 The RNA-binding activity of US11
To date US11 has been shown to bind five RNA substrates, the antisense transcript of 
the 5' UTR of the US 11 gene, a truncated transcript of UL34 RNA, the retroviral 
intronic export elements, the Rev-Response Element (RRE) of HIV-1 and the Rex- 
Response element (XRE) of HTLV-1, and the rRNA of the 60S ribosome subunit. How 
the interactions between these RNAs and US 11 were elucidated and their interaction 
with US11 are discussed in detail below.
1.3.9.1 The antisense transcript of the 5' UTR of the US11 gene
The interaction between US 11 and the antisense transcript of its own 5' UTR was 
described by Roller & Roizman (1990). It was discovered while looking for ICP4-RNA 
interactions and was the first time that US 11 was found to display RNA-binding 
activity. Roller & Roizman (1990) used partially purified ICP4 from a crude nuclear 
extract of HSV-1 infected HeLa cells in an electrophoretic mobility gel shift assay 
(EMSA) with a radiolabelled transcript derived from the plasmid pRB3881, which 
includes the antisense transcript of the 5’ UTR of US11. This transcript was retarded in 
EMSA with the crude ICP4 extract. However, the mobility shift generated was not as 
large as would be expected from ICP4 and could not be super-shifted when incubated 
with an anti-ICP4 antibody. Using the pRB3881 RNA probe with a crude nuclear 
extract of infected HeLa cells, the probe could be protected from RNase T1 digestion. It 
was noted that on native gels the pRB3881 RNA probe ran as two species, about 30% of 
the probe migrated as a slower species and 70% as the faster migrating species. Of the
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two, only the slower migrating species shifted in EMSA with infected cell nuclear 
extract demonstrating that the binding was dependent on the secondary structure 
adopted by the probe. Deletions of the pRB3881 plasmid were made and the minimal 
binding element found to be 87nt, mapping within the 5' UTR of US 11 on the rightward 
strand. The interaction between the component in the nuclear extract and the RNA was 
shown to be sequence-specific in competition assays. Infected cell nuclear extracts of 
HSV-1 x HSV-2 intertypic recombinants were used in RNase T1 protection assays to 
map the location of the gene encoding the RNA-binding protein, using the observed 
difference in mobility of the protected complex the two virus types as the basis for 
mapping. Furthermore, two viruses R7023 and R3630, which lack the US 12 and US 11 
ORFs, did not possess the RNA binding activity. Using PAA it was shown that this 
activity was dependent on the expression of a late gene, and therefore, most likely to be 
US11. Using in vitro transcribed and translated US11 and an epitope tagged US11 virus 
construct the RNA-binding activity was shown to be due to US11.
The transcript of the antisense 5* UTR of the US 11 could not be detected in infected 
cells. Roller & Roizman (1990) suggested that this RNA is either a substrate analogue 
or it is down-regulated by US 11 to an extent that it is undetectable in infected cells. 
However, recently, transcripts which are anti-sense to the US 11 have been detected in 
infected cells: a 7.4kb polyadenylated transcript, and three non-polyadenylated species 
of 7, 1.3, and lkb (McCormick et al., 1999). Furthermore, in a virus in which 222bp of 
OriS is deleted, US 11 accumulation is diminished and an approximately 16kb 
polyadenylated transcript which is antisense to the US 11 ORF is expressed. This raises 
the possibility that transcripts antisense to the US11 ORF may regulate its expression.
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1.3.9.2 A34RNA
Roller & Roizman (1991) demonstrated that US 11 could bind a truncated viral 
transcript in HSV-1 infected cells using co-immunoprecipitation of US 11 and RNA. 
Total infected cell extracts of HeLa cells were incubated with a mouse anti-US 11 mAh 
followed by the addition of goat anti-mouse antibody conjugated to agarose. To remove 
non-specific binding of RNA the reaction mixture was treated with RNase T1 and the 
US 11/RNA/antibody complexes washed extensively. When RNAs were eluted and 5' 
end labelled using T4 polynucleotide kinase (PNK) and [y-32P]ATP as the phosphate 
donor and separated by denaturing gel electrophoresis. With a US 11 null virus with or 
without the addition of an anti-US 11 antibody or with wt virus without the anti-US 11 
antibody, no labelled RNA species were pulled out, but, using a anti-US 11 antibody to 
pull out US11/RNA complexes from wt infected cells many RNA species were obtained 
which varied greatly in size (Fig. 1.13) The end labelled RNAs were used to probe a 
Southern blot of BamRl digested HSV-1 DNA, a weak hybridization was seen with the 
1.3kb BamHl C' fragment.
Using the BamHI C  region as a probe in a Northern blot of cytoplasmic RNAs, a small, 
non-polyadenylated RNA was shown to be expressed at 6-8 fold higher levels in wt 
virus infected cells compared to a US11" virus. Mapping of the transcript found that this 
485nt RNA was derived from the UL34 region and that it has the same 5' end as UL34 
but was truncated by 1015nt at the 3' end, terminating within the ORF. This RNA was 
termed A34 RNA.
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Fig. 1.13: Co-immunoprecipiation of US11-RNA complexes.
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experiment is shown and is reproduced from Roller & Roizman (1991).
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Using an RNase T1 protection assay and native gel electrophoresis to resolve the 
protected species it was demonstrated that a protected complex formed when HSV-l(F) 
infected cell extracts were used, which could be supershifted with the inclusion of an 
anti-US 11 mAh. Deletion mutants of the transcript were constructed and used to map 
the site of interaction with US11. As much as 257nt could be deleted from the 5' end of 
the transcript and still retain binding activity, whereas deletion of 36nt from the 3’ end 
resulted in loss of binding. The binding site therefore resides within the terminal 264nt 
of A34.
Roller & Roizman (1991) suggest that the A34 RNA is derived either by 
endonucleolytic cleavage or premature termination of the full length UL34 mRNA . The 
sequence at and around the 3' end of the RNA consists of a run of T residues embedded 
in a G+C-rich sequence, and is capable of forming a secondary structure similar to that 
of termination sites of attenuated products of the c-myc, adenovirus major late, SV40 
late and mouse minute virus P4 promoters. They therefore suggested that US11 may act 
as an anti-terminator for UL34 RNA or enhance its degradation. However, expression 
of full-length UL34 is not affected by the presence of US11, which would be expected 
if US 11 were acting as an anti-terminator.
From the data presented by Roller & Roizman (1991) it can be concluded that U Sll 
down-regulates the level of A34 RNA in infected cells. U S ll may achieve this by 
preventing the truncation of UL34 mRNA either by acting as an anti-terminator within 
the nucleus or preventing endonucleolytic cleavage in the nuclear or cytoplasmic 
compartments. US11 may act within the nuclear compartment to retain the A34 RNA or 
target it for degradation. Alternatively, U Sll may act in the cytoplasmic compartment 
to target the RNA for degradation.
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1.3.9.3 Ribosomal RNA
U Sll is strongly associated with the ribosomes which is thought to be at least in part 
responsible for its nucleolar localization. Roller & Roizman (1992) have shown by 
sucrose gradient fractionation that U Sll co-sediments with the 60S, 80S and polysomal 
fractions, whereas, Masse et al. (1990) and Daiz et al. (1993), have also detected it in 
40S fractions.
Using rRNA, in vivo labelled with [32Pi], Roller & Roizman (1992) purified rRNA from 
the 40S (18S rRNA) and the 60S (28S rRNA, 5.8S rRNA and 5S rRNA) ribosomal 
subunits. The ability of a recombinant (3-galactosidase-USll fusion protein to bind 
rRNA in vitro was examined. A fragment of rRNA derived from the 60S rRNA was 
protected in an RNase T1 protection assay and the RNA/protein complex could be 
supershifted with the inclusion of an anti-US 11 mAb in native gel electrophoresis. 
However, with the 18S rRNA derived from the 40S subunit was not protected from 
RNase T1 digestion by |3-galactosidase-USl 1. It was therefore concluded that U Sll 
was associated with the 60S subunit of ribosomes by virtue of its rRNA binding 
activity. Indeed the ability to associate with ribosomes and bind RNA do reside in the 
C-terminal domain of US 11 which supports this data.
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1.3.9.4 Rex- and Rev-response elements
i. Nuclear export o f intron-containing viral transcripts by HIV-1 Rev
In eukaryotic cells mRNAs undergo a variety of post-transcriptional processing events 
such as polyadenylation and splicing, prior to their export to the cytoplasm as mature 
mRNAs. Indeed, transcription, processing and export are very tightly linked processes 
(reviewed by Cullen, 2000b; Hirose & Manley, 2000; Proudfoot, 2000). Nascent RNAs 
are retained in the nucleus until they are processed or degraded. Such a mechanism 
allows, not only another level of regulation on gene expression, but also prevents 
immature mRNAs from entering the cytoplasm where the proteins that they encode may 
be non-functional or deleterious to the cell.
Retroviruses express some of their proteins from incompletely spliced transcripts, these 
intron-containing transcripts would therefore be seen as immature mRNAs by the host 
cell machinery and hence retained in the nucleus. However, retroviruses have evolved 
ways of promoting the export of these mRNAs, and HIV-1 is one such example (Cullen, 
1998). During its life cycle HIV-1 produces fully spliced transcripts encoding Nef, Rev 
and Tat, unspliced transcripts Gag, and Gag-Pol, and a singly spliced transcript 
encoding Env (Cullen & Greene, 1990). HIV-1 overcomes the nuclear retention of these 
intron-containing mRNA by encoding the Rev protein (Malim, et a l , 1988). Rev is 
essential for the expression of Gag, Pol and Env proteins and the cytoplasmic 
accumulation of their mRNAs. Rev acts by binding to a c/s-acting intronic sequence in 
these mRNAs, termed the Rev-Response Element (RRE) via an arginine-rich RNA- 
binding motif (ARM) (Zapp & Green, 1989; Malim et al, 1990). Upon binding, Rev
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multimerizes via hydrophobic domains that flank its ARM, creating a ribonucleoprotein 
complex consisting of one molecule of RRE-containing RNA and over 10 Rev 
molecules (Malim & Cullen, 1991). Rev possesses an NLS (the ARM of Rev also 
functions a NES) and a leucine-rich NES, allowing it to shuttle in and out of the 
nucleus. The inactivation of the NES, by mutation of critical residues, results in a 
dominant-negative phenotype, in that, when co-expressed with wt Rev, both the mutant 
and wt Rev and intron-containing transcripts are retained in the nucleus (Venkatesh & 
Chinnadurai, 1990). This is because the dominant negative mutant can both bind the 
RRE and multimerise with functional Rev molecules, forming a complex which cannot 
be exported.
The NES of REV interacts with Crm-1, a member of the importin family of 
nucleocytoplasmic translocation factors which interact with nucleoporins of the nuclear 
pore complex (NPC) (Fomerod et al., 1997; Neville et al., 1997; Stade et al., 1997). 
The Crm-1 dependent pathway is essential for the export of the cellular U-rich small 
nuclear RNAs (U snRNAs) and 5S rRNA (Cullen, 2000a). The export of intron- 
containing viral mRNAs is therefore achieved by Rev binding to the RRE and accessing 
a cellular export pathway.
Since the discovery of the ability of Rev to transactivate the cytoplasmic accumulation 
of intron-containing mRNAs, other viral and cellular proteins have been shown to be 
able to functionally substitute for Rev in this activity, among them are the Rev- 
homologues from other lentiviruses, the Rex protein of HTLV-1, and the U S ll protein 
of HSV-1 (Table 1.5).
U Sll and the HIV-1 protein Rev are both small, basic phosphoproteins which bind 
RNA and localize to the nucleolus. It was these similarities which prompted Diaz et al.
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Table 1.5: Proteins that can functionally substitute for the complex retroviral 
proteins, Rex and Rev.
This table documents proteins which can functionally substitute for complex 
retrovirus Rev/Rex-related export proteins in promoting the export of their respective 
intron-containing RNA. The biological properties of these proteins are compared. A 
list of the column headings and abbreviations used are listed below in alphabetical 
order.
Atypical hydrophobic NES: A stretch of hydrophobic amino acids in which Leu 
residues are important but there is no core tetramer. BLV: Bovine leukaemia virus. 
Co-operation with Rev: Refers to the ability of a protein to synergise with Rev when 
co-transfected, resulting in higher levels of export of intron-containing RNA than 
either protein transfected alone or the sum of their individual transactivation. EIAV: 
Equine infectious anaemia virus. FIV-1: Feline immunodeficiency virus type-1. 
HERV-K: Human endogenous retrovirus-K family. HIV-1: Human
immunodeficiency virus type-1. HIV-1 rev’ virus rescue: The ability of a protein 
restore replication/late gene expression of a rev' provirus in a transfection assay. 
HTLV-1/-2: Human T-lymphoma virus type-l/-2. Homo-oligomers: The ability of a 
protein to interact with itself forming homo-oligomers. ICVR: Intron-containing viral 
RNA. KH domain: HnRNP K homology RNA-binding sequence. Leu-rich NES: A 
stretch of hydrophobic amino acids which possess a critcal core tetramer, LXLX. 
ND: Not done. NES: Nuclear export signal. NLS: Nuclear localization signal. RGG 
box: Arg Gly Gly repeat RNA-binding motif. RPX repeats: Arg Pro, X = any amino 
acid. RRM: Arginine-rich motif. SIV-1: Simian immunodeficiency virus. Shuttling: 
Active transport of the protein between nuclear and cytoplasmic compartments in 
both directions. Substitution: Refers to the ability of a wild type protein to 
functionally substitute for the wild type Rev/Rex proteins of complex retroviruses in 
promoting the cytoplasmic accumulation of RNA derived from reporter constructs 
containing the complex retroviral RNA response elements. TD negative: A trans­
dominant negative phenotypic mutant. The ability of a mutant in a given protein to 
inhibit the function of a wild type protein when co-expressed and cause the nuclear 
retention on intron-containing viral mRNA.
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Chapter 1 Introduction
(1996) to examine whether U Sll could functionally substitute for the Rev protein in 
promoting the export of intron-containing retroviral mRNA.
ii. U Sll interacts with theXRE ofHTLV-1
In transfection assays Diaz et a l (1996) demonstrated that U S ll could promote the 
export of a non-spliceable and spliceable primary transcript of the HTLV-1 env gene 
and hence, transactivate glycoprotein expression. In vitro binding assays were 
performed with the XRE and recombinant GST-US11, demonstrating that U Sll is 
capable of binding this element. The XRE and A34 RNAs were equally good substrates 
for US11 in vitro , with a Kd of 100-130nM. However, US11 has a greater affinity for 
the XRE than the RRE (Schaerer-Uthurralt et a/., 1998).
iii. U Sll interacts with the RRE o f HIV-1
US11 can promote the cytoplasmic accumulation of a non-spliceable primary transcript 
of HIV-1 env mRNA and hence, glycoprotein expression. US11 and the Rex protein can 
transactivate the expression of HIV-1 env to a similar degree, about 5-6 fold less than 
that of Rev itself. In vitro binding assays have demonstrated that U Sll can bind to the 
HIV-1 intronic export element in the RRE (Diaz et a l , 1996). However, the binding of 
US11 does not exactly mirror that of Rev. While Rev binds to the Stem-Loop (SL) II of 
the RRE, U Sll cannot bind this element either because it requires additional sequences 
or as it binds elsewhere on the RRE (Due Dodon et a l , 2000). This is not surprising as 
US11 and Rev share no real sequence homology.
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As with A34 RNA, deletion of the C-terminal domain of US 11 prevents it from binding 
the XRE and RRE. Deletion of the first 40 amino acids of US11 do not effect its ability 
to bind the XRE/RRE. However, US11A1-40 is unable to transactivate env expression 
and when co-transfected with the full-length protein acts in a trans-dominant negative 
fashion (Diaz et al., 1996). This indicates that US11A1-40 may be multimerizing with 
full length US11, forming non-functional complexes and preventing transactivation. 
Unlike the transactivation of HTLV-1 env expression, U Sll is unable to support the 
cytoplasmic accumulation of a spliceable HIV-1 env transcript. It is also unable to 
rescue a rev' infectious pro-virus (Diaz et a l , 1996; Due Dodon et a l , 2000), but can 
co-operate with sub-optimal amounts of Rev protein to promote rev' HIV-1 replication 
by promoting cytoplasmic accumulation of singly spliced and unspliced mRNAs (Due 
Dodon et a l , 2000). The transactivation of glycoprotein expression is dependent on the 
presence of the Rev-NES and the first 40 amino acids of US 11 as constructs with either 
domain deleted are unable to rescue rev' HIV-1.
Co-transfection of a U Sll expression construct with a construct containing the RRE 
fused to an intron-containing CAT gene and suboptimal amounts of a Rev-expressing 
vector also allowed the export of unspliced CAT mRNA. This export was shown to be 
mediated by the Crm-1 pathway as it was inhibited by leptomycin B to a similar extent 
with optimal amounts of Rev alone and with U Sll and sub-optimal amounts of Rev 
(Due Dodon et a l , 2000).
iv. U Sll can interact with Rev
Using the mammalian monohybrid assay Due Dodon et a l (2000) demonstrated that 
U S ll can interact with Rev bound to the SLII of the RRE. Additionally, in
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immunoprecipitation and GST-pull-down assays U Sll could be co-precipitated with 
Rev. A mutant of Rev (GST-mlORev) with the NES removed could still interact with 
U Sll.
v. The functional significance o f USll and the RRE/XRE
Although many retroviral proteins have been shown to be able to substitute for Rev in 
the export of intron-containing HIV-1 mRNA, U Sll is the first example of a protein 
from a heterologous viral system performing such a role. It is not clear how US11 acts 
in this instance, but it is reasonable to propose that it either works by preventing the 
nuclear retention of these transcripts or by accessing the export pathway. Intron- 
containing retroviral transcripts may be retained in the nucleus either by being trapped 
in spliceosomes (Chang & Sharp, 1989) or by nuclear retention factors that interact with 
czs-acting regulatory sequences (CRS) (King et al., 1998). The threshold level for Rev 
in infection and transfection assays is thought to arise because Rev is competing with 
spliceosomal components or factors which bind CRS to prevent nuclear retention and to 
direct them to export pathways, rather than a threshold for transport itself (Bakker et al., 
1996). U S ll alone can support the cytoplasmic accumulation of a HTLV-1 spliceable 
env transcript, but not for the HIV-1 env RNA, which requires an unspliceable transcript 
(Diaz et al., 1996). If U Sll is acting to prevent nuclear retention this can, at least in 
part, be explained by the higher affinity US11 has for the XRE, allowing it to exclude or 
compete with retention factors. Removing the splice sites from the RRE or co-operation 
with Rev may bypasses the need for high affinity binding by US11. Alternatively, US11 
may act to promote the nuclear export of these mRNAs by acting as an auxiliary 
protein, accessing and recruiting other factors. In the presence of US11 and sub-optimal
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levels of Rev export is still dependent on the Crm-1 pathway and the Rev-NES, 
demonstrating that, in this instance, US11 is not the primary factor for export.
Why U Sll binds the XRE and RRE is unclear, as they share no real sequence 
similarities with the HSV-1 RNAs bound by U S ll. The XRE and RRE are highly 
structured and may act as a substrate analogue for U S ll, mimicking the secondary 
structure adopted by its natural RNA partners.
In the monohybrid assay, immunoprecipitation and GST-pull down experiments U Sll 
was shown to interact with the Rev protein, however no satisfactory explanation for this 
interaction can be given (Due Dondon et al., 2000). As these proteins share an RNA- 
binding partner, it is conceivable that in these experiments RNA was acting to bridge 
the proteins, rather than a direct protein-protein interaction.
One interesting aspect of the ability of U Sll to co-operate with suboptimal amounts of 
Rev to promote viral replication, is that HSV-1 infection could increase the likelihood 
of HIV-1 replication and the progression of the disease to AIDS (Due Dondon et al., 
2000). The potential interaction of HSV-1 and HSV-2 with HIV-1 has been studied in 
CD4+ T lymphocytes and in monocyte-macrophages and results in increased replication 
for both viruses. ICP0 and ICP27 have been implicated in the up-regulation of HIV-1 
replication (Golden et a l , 1992). ICP0 increases transcription from the LTR of HIV-1 
in association with NF-kB (Vlach & Pitha, 1993). ICP27 presumably acts either through 
its ability to bind RNA and promote 3' end processing, its involvement with RNA 
export, or its disruption of splicing components (Phelan et a l , 1996). U S ll, therefore, 
represents another factor that could contribute to the increased efficiency of HIV-1 
replication with co-infection of HSV-1 or -2.
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1.3.9.5 The XRP motif as an RNA-binding domain
As discussed in Section 1.3.3, the C-terminal domain of U Sll consists almost entirely 
of a tandemly reiterated tripeptide, XRP (where X is any amino acid). This domain is 
predicted to form a poly-L-proline type II helix (PPII-helix) with 3 amino acids per turn. 
Both Roller et al (1996) and Schaerer-Uthurralt et al. (1998) have found that deletion 
of this domain or within this domain disrupts RNA binding. This domain is an unusual 
RNA-binding domain, as most identified RNA binding motifs are either a-helical (such 
as the HIV-1 Rev ARM) or a P-hairpin (such as with HIV-1 Tat protein). RNA binding 
by p-hairpin motifs is predominantly directed by hydrogen bonds between the protein 
mainchain and the RNA, whereas, in interactions between a-helices and RNA the 
amino acid side chains provide the majority of interactions (Grate & Wilson, 1997). The 
PPIIH, because of its helical nature, would also presumably, rely more heavily on 
interactions directed by its amino acid side chains with RNA. The PPIIH is a flexible 
structure. RNA-protein binding reactions are frequently characterised by a structural 
transition either in the RNA, the protein or both. This involves regions of flexibility or 
disorder adopting more stable and energetically favourable conformations (Guzman, 
1998; Williamson, 2000). The PPIIH represents a structure in which conformational 
changes are easily accommodated particularly in binding reactions.
The C-terminal domain is rich in arginine, a residue which is frequently implicated in 
protein-RNA interactions. Arginine is a very versatile amino acid in protein-RNA 
binding. It may be involved in charge neutralisation of the phosphate backbone and has 
the potential to form a network of hydrogen bonds. Additionally, van der Waals forces
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and hydrophobic interactions from the long hydrocarbon side chain also play a major 
role in its involvement with the binding of RNA (Grate & Wilson, 1997; Weiss & 
Narayana, 1998). Proline, also over represented in the C-terminal domain of U S ll, can 
provide hydrophobic interactions and form hydrogen bonds with RNA. However, more 
frequently proline is involved in mediating protein-protein interactions, requiring a high 
degree of solvation for stability, and could be potentially involved in the formation of 
homomultimers by US 11.
The only other XRP repeat protein that has been implicated in RNA binding is the EB2 
protein of EBV. This protein, which shuttles between the nucleus and the cytoplasm, 
appears to be involved in RNA export and the processing of pre-mRNA (Buisson et a l , 
1989; Forjot et al., 2000). Both the EB2 protein and its 21 amino acid XRP repeat motif 
appear to bind RNA in a non-specific fashion. However, the XRP motif does not appear 
to be required for the effect of EB2 on RNA export or splicing (Buisson et al., 1998).
1.4 Methods for identifying RNAs which interact with proteins
During the course of this work on US 11, a method for the isolation and amplification of 
RNAs that interact with US11 was developed. Prior to this work there were no methods 
specifically available for the identification of native RNAs that interact with a particular 
protein. During the completion of this work however, several methods were published 
by which RNAs that interact with a particular protein may be isolated and identified. 
These methods are described below. In addition, SELEX, a method which allows the 
isolation of synthetic RNAs which bind a protein with high affinity, and the yeast three- 
hybrid system are discussed.
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1.4.1 Systematic Evolution of Ligands by Exponential Enrichment
Systematic evolution of ligands by exponential enrichment (SELEX) was first 
developed by Tuerk & Gold (1990) to enable high affinity RNA ligands for proteins to 
be isolated from a pool of random RNA sequences. The protocol allows a randomised 
pool of RNAs to be selectively enriched for high affinity binders by successive rounds 
of protein binding, RT-PCR and in vitro transcription. A randomised sequence or a 
defined sequence mutated at specific sites is sandwiched between a 5' promoter for the 
binding of a DNA-dependent RNA polymerase and a 3' site for the hybridization of a 
primer for the initiation of reverse transcription. The DNA template is in vitro 
transcribed and the RNA is selected for the binding of a particular protein immobilized 
on a nitrocellulose membrane. The RNAs are eluted, reverse transcribed and PCR 
amplified (Fig. 1.14). The PCR products should therefore be over represented in DNA 
that encodes RNAs with an affinity for the protein in question. This pool of PCR 
products are again transcribed and the RNAs put through the same round of selection. In 
general, after approximately four rounds of selection the population of RNAs is 
sufficiently enriched for high affinity binders to allow the DNA templates to be cloned 
and sequenced.
This elegant technique has several advantages. It allows, without the need of any prior 
sequence information, the elucidation of high affinity RNA ligands for a protein of 
interest. From such information, a consensus binding site may be derived, particularly if 
there are existing native binding sites available for comparison. The establishment of a 
defined consensus sequence may enable the identification of the in vivo targets of a 
protein. Also, this information helps define the nucleic acid residues critical in the
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Fig. 1.14: A schematic diagram of SELEX.
Randomized DNA sequences (black line) flanked by priming sites for 
reverse transcription and PCR (green boxes) and a DNA-dependent RNA 
polymerase promoter (labelled RNA pol) site are transcribed. The RNAs 
are bound to the protein of interest (blue) immobilized on nitrocellulose 
(spotted box). The unbound RNAs are removed by washing and the bound 
RNAs eluted. The bound RNAs are reverse transcribed and amplified by 
PCR. The resulting pool of templates, enriched for sequences encoding 
RNA that interacts with the protein of interest, are subjected to further 
rounds of selection as before. After several rounds the templates are cloned 
and sequenced.
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interaction. Therefore, SELEX can potentially save time over the mapping of binding 
sites and mutation of residues within the RNA element to define the consensus/critical 
residues. SELEX can also give information on whether the conservation of a particular 
RNA secondary structure is important in protein binding by showing if particular base- 
pairing is conserved during the evolution of RNA ligands.
SELEX is also being used to generate biologically active compounds for therapeutic 
applications (Gold et al., 1995). High affinity RNA ligands can, in general, be selected 
for non-RNA binding proteins as well as RNA binding proteins. This is thought to be 
due to the tertiary structure adopted by RNAs which can mimic protein structure 
important in protein-protein interactions. Hence, for a given protein, either RNA or non- 
RNA binding, a high affinity RNA ligand can be selected which can act as a highly 
specific inhibitor of protein function. Thus, if introduced in vivo, this RNA may 
potentially inhibit a deleterious activity of a given protein. For example, SELEX has 
been used to generate an RNA molecule which can inhibit HIV-1 reverse transcriptase, 
which has an affinity for this enzyme over 100 times that of the natural substrate in vitro 
(Tuerk & MacDougal-Waugh, 1993; Kensch et al., 2000) which may have potential 
therapeutic value in the suppression of AIDS in HIV positive individuals. Also, a DNA 
molecule (NX21909), generated by SELEX-like procedure to bind the active site of 
neutrophil released elastase modified by the addition of a valyl phosphonate moiety, can 
non-reversibly cross link with the active site serine of the enzymes catalytic site. This 
molecule has been shown to inhibit inflammation of the lung in mouse models, and 
represents a promising therapy for lung inflammatory diseases such as adult respiratory 
syndrome and ischemic reperfusion injury (Bless et al., 1997).
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In addition to the therapeutic applications of SELEX generated high affinity RNA 
ligands, these RNAs may also be used as diagnostic tools due to their high specificity 
acting similarly to antibody based diagnostic techniques (Jayasena, 1999).
The major disadvantage of SELEX is that the theoretical RNA substrates it generates 
may have no in vivo relevance. SELEX is performed with RNAs in vast molar excess of 
the protein in question to allow a high degree of competition between the RNAs for the 
binding site. Although this selects for very high affinity RNA ligands, an RNA more 
similar to the natural substrate may be lost in the battle for a binding site. Ultimately, 
the RNA ligands generated by SELEX are only as good as the initial randomised pool.
1.4.2 The Yeast three-hybrid system
The yeast three-hybrid system is an extension of the yeast two-hybrid system. Both 
systems rely on the fact that transcription factors can be divided into two domains the 
transcription activation domain and the DNA binding domain (Fields & Stemglanz, 
1994). In the yeast two-hybrid system the fusion of two interacting proteins, one to the 
activation domain and one to the DNA binding domain, allows the two transcription 
factor domains to be brought into close proximity, stimulating transcription of a reporter 
gene down stream of a czs-acting DNA element which is the target of the DNA-binding 
domain. Using this system, a cDNA library can be screened for proteins which interact 
with a protein of interest (Fig. 1.15).
The three-hybrid system is an extension of this principle which allows the proteins 
fused to the activation domain and DNA binding domain to be bridged by a third 
interacting molecule, either RNA or protein (Zhang et al., 1999). Where RNA is used as 
the bridging molecule, the DNA binding domain is fused to the bacteriophage MS2 coat
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Fig. 1.15: A schematic representation of the yeast two-hybrid system.
The activation domain (purple) is brought into close proximity of a DNA binding 
domain (yellow) by the interaction of two proteins (blue and pink) so that 
transcription of a reporter gene (green) lying down stream of a cis-acting DNA 
element (red) bound by the DNA binding domain can be stimulated.
Fig. 1.16: A schematic representation of the yeast three-hybrid system.
The activation domain (purple) is brought into close proximity of a DNA 
binding domain (yellow) by the interaction of a protein ( pink) with its 
target RNA which is fused to MS2 RNA (black line) which in turn interacts 
with the MS2 coat protein (blue) fused to the DNA binding domain 
(yellow). This allows the transcription of a reporter gene (green) lying down 
stream of a cA-acting DNA element (red) bound by the DNA binding 
domain.
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protein and the protein of interest or a cDNA library to the activation domain. RNA is 
expressed from a third vector in which an RNA of interest is fused to two copies of 
MS2 RNA. In this way the activation domain is brought in close proximity to the DNA 
binding domain when the protein it is fused to interacts with the RNA of interest via the 
binding of the MS2 coat protein to its specific RNA (Fig. 1.16).
1.4.3 RT-PCR based methods of isolating RNAs which interact with a protein of 
interest
1.4.3.1 Isolation of RNAs which interact with polycytidylate-binding protein a-complex 
protein 1
Polycytidylate-binding protein a-complex protein 1 (aCPl) has been implicated in 
mRNA stability and translational regulation. Trifllis et al. (1999) investigated the ability 
of a GST-aCPl fusion protein to pull out RNAs from infected cell lysates which were 
subsequently amplified by RT-PCR.
GST or GST-aCPl bound to glutathione-agarose were incubated with nuclear extracts, 
the complexes washed and the RNAs eluted. The RNAs were amplified by differential 
display RT-PCR (DD RT-PCR). Firstly, the RNA was reverse transcribed using Tn 
primers anchored at the 3' end which anneal to the poly(A) tail, with one nucleotide (G, 
C or A). The cDNA was amplified by one round of PCR in the presence of [a- P] 
dCTP, one of the 3' primers and random primers. The products were separated on a 
sequencing gel and those specific to GST-aCPl were extracted and PCR amplified in 
the presence of the same primers. Ten different sequences were pulled out: four of 
which did not have any homologous sequences in data base searches, two mitochodrial
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enzyme mRNAs, two membrane receptor RNAs, one ribosomal RNA, and managanese 
superoxidase dismutase mRNA.
1.4.3.2 Isolation of RNAs that interact with hnRNP A2
HnRNP A2 is a shuttling protein which associates with polysomes and has been 
implicated in the export of mRNAs, the regulation of translation and possibly the 
control of mRNA stability (Shyu & Wilkinson, 2000). Brooks & Rigby (2000) 
immunoprecipitated hnRNP A2-RNA complexes and amplified the co- 
immunoprecipitating RNAs using RT-PCR.
HnRNP A2 was immunoprecipitated from polysome preparations from a THP-1 
myelomonocytic cell line. The isolated complexes were treated with proteinase K and 
the RNA extracted. The isolated RNAs were reverse transcribed in the presence of an 
oligo d(T) primer. The ss cDNA was homopolymer tailed with terminal 
deoxynucleotidyl transferase and dATP. The tailed cDNA was PCR amplified with an 
oligo d(T) primer, which could hybridize to both the 5' and 3' ends. The resulting 
products were examined by agarose gel electrophoresis. The products derived from 
immunoprecipitation performed with pre-immune serum yielded a smear ranging from 
100-500bp, but those derived from hnRNP A2 immunoprecipitation produced a larger 
smear ranging from 100-2000bp. The products were labelled by random priming in the 
presence of [a-32P] dCTP and used to probe a THP-1 Lambda Zap library. No overlap 
was observed of plaques which bound non-specific (pre-immune precipitated) species 
and hnRNP A2 immunoprecipitated species. 31 unique sequences were pulled out, of 
these 74% of the mRNAs contained U-rich elements and 13% were derived from RNAs 
encoding ribosomal proteins.
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1.4.3.3 Isolation of RNAs that interact with fragile X mental retardation protein
Fragile X syndrome is one of the most common causes of mental retardation and is 
caused by the lack of expression of the Fragile X mental retardation protein (FMRP). 
FMRP is an RNA binding protein which is thought to associate with a subset of foetal 
brain mRNAs, a few of which have been defined, FRMP mRNA, myelein basic protein 
(MBP) mRNA, and 60s rRNA (Ashley et al., 1993; Siomi et al., 1996).
Sung et al. (2000) used recombinant FMRP to pull out interacting RNAs and amplified 
the RNAs using DD RT-PCR. Biotinylated FMRP bound to avidin beads and incubated 
with total parietal cortex RNA, the complexes washed and the RNA extracted. First 
strand synthesis of cDNA was carried out using one of three poly(A) tail-dependent 
primers (T12GC, Ti2 GG9 or T 1 2GA). PCR amplification was carried out in the presence
of [a- PJdCTP with one of the poly(A)-dependent primers and with one of six random 
15-mer primers (this set of 18 primer combinations amplifies approximately 10-12% of 
the mRNA content of human brain mRNA). The products from this reaction were 
separated by electrophoresis, and bands specific to FMRP were excised from the gel 
and re-amplified with the corresponding primer sets. The amplified products were 
cloned into the pCR-3.1 vector and sequenced. In total nine DD RT-PCR bands were 
isolated and sequenced, one corresponding to the known binder, FRMP mRNA, three 
with homology to mRNAs and four representing unknown RNA, and one with 
homology to mitochondrial rRNA. Five of the sequences (excluding FMRP mRNA) 
were assayed for the binding of FRMP in vitro and all were found to bind.
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1.5 Aims
To date, US11 has been shown to interact with five RNAs, which appear to share little 
in common in terms of sequence or biological role. Roller & Roizman (1990) first 
demonstrated that US 11 possessed an RNA-binding ability, identifying an interaction 
with an in vitro derived transcript antisense to the 5' UTR of US 11. Subsequently, US11 
was shown to bind and down-regulate A34, a truncated transcript of UL34 (Roller & 
Roizman, 1991). US 11 has also been shown to be able to promote the cytoplasmic 
accumulation of HIV-1 and HTLV-1 RNAs containing export elements (Diaz et a l , 
1996). In vitro, US11 also displays an affinity for rRNA derived form the 60s ribosome 
subunit (Roller & Roizman, 1992).
It would seem reasonable to suggest that US 11 may bind to and influence the 
expression of other RNAs in infected cells. The aim of this project was therefore to test 
this hypothesis and characterise the interaction of US 11 with any novel RNA partners 
discovered.
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2.0 Materials & Methods
2.1 Materials
2.1.1 Plasmids
pQE-USll: Contains the US 11 ORF cloned into the Hindlll and Sail sites in pQE-30; 
expresses 6xHis N-terminally tagged US11.
pQE-16: Enodes the dihydrofolate reductase gene C-terminally 6xHis tagged (Qiagen). 
GST-US11 constructs: Schaerer-Uthurralt et al. (1998). A gift from J-J Diaz and J-J 
Madjar, Immuno-virologie Moleculaire et Cellulaire, Universite Lyon, France.
2319: The entire US 11 ORF cloned into the pGEX-2T vector at the Smal and 
EcoKl sites; expresses full length GST-US11.
2450: The sequence encoding residues 85-149 of US 11 cloned into the pGEX- 
2T vector at the Smal and EcoKl sites; expresses GST-US11A1-84.
2625: The sequence encoding residues 1-87 of US 11 cloned into the pGEX-2T 
at the Smal and EcoKl sites; expresses GST-US11A88-149. 
pGMl: Contains the y-actin sequence (Amersham International). 
pT-12/14: Sequence 585nt derived from “Sequence-Independent” RT-PCR of RNAs 
that interact with US11; homologous to 27332-26748nt of HSV-1 cloned into pGEM-T 
Easy.
pT-A34: A 451nt sequence (69462-69913nt) sequence derived from of the UL34 ORF 
of HSV-1 cloned into pGEM-T Easy.
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2.1.2 Primers
The names and sequences of primers used in PCR for the cloning of inserts, the 
construction of in vitro transcription templates and for RT-PCR are given in Table 2.1.
2.1.3 Enzymes
Restriction enzymes were obtained from Boehringer Mannheim or New England 
Biolabs. T4 DNA ligase (lOU/pl), RNase T 1 (1 OOU/jlaI) and polynucleotide kinase 
(lOU/pl) were obtained from Boehringer Mannheim. Superscript™ reverse 
transcriptase (200U/pl) and terminal deoxynucleotydyl transferase were obtained from 
Gibco BRL. Taq DNA polymerase (5U/pl) was purchased from Applied Biosystems. 
Lysozyme was obtained from Sigma. RNase-free DNAse I (lU/jal) was obtained from 
Roche Diagnostics. T7 RNA polymerase (15U/pil) was obtained from Promega. SP6 
RNA polymerase (50U/pl) was purchased from Stratagene.
2.1.3 Bacteria and culture media.
2.1.3.1 Bacteria
Plasmids were propagated and maintained in the E.coli strain DH5a: O80d lacZAM\5, 
recA, endAl, gyrA96, thi-\, hsdR ll Ov, nik+), supE44, relA l, deoR, A(lacZY-argF) 
U169.
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Chapter 2 Materials & Methods
6xHis-tagged proteins were expressed in M15[pREP4]: N a f, Strs, r i f , lac, ara', gat, 
mil, F", recA+, uvr+, (Qiagen), was used to express 6xHis-USl 1.
GST-fusion proteins were expressed in the E.coli strain BL21: F', ompT, r's, m's-
2.1.3.4 Bacteria culture media
All bacterial strains were grown in L-Broth (lOg NaCl, 16g Bactopeptone, 5g yeast 
extract in 1 litre H2O, pH7.5) or in 2YT broth (5 g NaCl, 16g Bactopeptone, lOg yeast 
extract in 1 litre H2 O, pH7.5). LB agar plates were made from 1.5% (w/v) agar in L- 
broth. LB agar and media were supplemented with 25 jug/ml kanamycin for the growth 
of M15[pREP4] and with 25pg/ml kanamycin and 100pg/ml ampicillin for 
M15[pREP4] transformed with pQE-30 or pQE-16. All other plasmids were propagated 
in the presence of lOOpg/ml ampicillin.
2.1.4 Mammalian cells and cell culture
All cell culture media was obtained form Gibco BRL.
The baby hamster kidney clone 13 (BHK-21 C l3) cell line was grown in Glasgow 
Modified Eagle’s Medium (GMEM), 10% NBCS, 10% tryptose phosphate, 100U 
pencillin and lOOpg/ml streptomycin.
HeLa cells, a human cervical carcinoma epithelial cell line, were grown Dulbecco's 
Modified Eagles Medium (DMEM), supplemented with 10% foetal calf serum (FCS), 
5mM L-glutamine, lOOU/ml penicillin and 100pg/ml streptomycin. For [35S] 
methionine metabolic labelling cells were incubated in the presence of Eagles medium 
containing 20% the normal methionine level, 2% NBCS and 30mCi/ml [35S] 1-
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methionine.
2.1.5 Viruses
Two herpes variants were used in this study:
HSV-1 strain 17+ the wild-type (wt) strain (Brown et a l , 1973).
HSV-1 US11 in which the expression of the US11 protein has been knocked out by the 
deletion of the Met-ATG by the deletion of four nucleotides at the Sphl site, at position 
145166nt. A gift from Andrew Davison and Charles Cunningham, MRC Institute of 
Virology, Glasgow.
2.1.6 Antibodies
Anti-US 11 antibodies
Anti-US 11 mAb (28*); mouse mAb raised against a P-galactosidase-USl 1 fusion 
protein (Roller & Roizman, 1992). A gift from B. Roizman, University of Chicago. 
Anti-US 11 pAb: Rabbit pAb (14427); raised against the N-terminal 11 amino acids of 
US11 (MacLean et al., 1987).
Anti-UL12 antibody
UL12 mAb (Ql); mouse monoclonal antibody raised against purified HSV-2 UL12. 
(Banks et a l , 1983).
Anti-UL13 antibodies
Rabbit anti-sera raised against amino acids 149-207 of UL13.
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Rabbit anti-sera raised against 6xHis-UL13 of HSV-2. A gift from Y. Nishiyana, 
Nogoya University School of Medicine, Japan. (Daikoku et al., 1997).
Anti-UL14 antibody
UL14 pAb: Rabbit anti-sera raised against UL14 codons 58-218 fused to GST. A gift 
from J. Baines, Cornell University (Cunningham et al., 2000).
Anti-His tag antibody
Anti-RSG-3xHis mAb: mouse mAb was obtained from Qiagen.
2.1.7 Radiochemicals
All radiochemicals were purchased from Dupont.
[y-32P] ATP 6000Ci/mmol, lOmCi/ml
[a-32P] CTP 800Ci/mmol, lOmCi/ml
[35S]-l-methionine 1175Ci/mmol, lOmCi/ml
[a-32P] UTP 800Ci/mmol, lOmCi/ml
2.1.8 Chemicals and reagents
All chemicals were purchased from BDH Chemicals UK or Sigma, with the following 
exceptions:
Amersham International: ECL Western blotting reagents, Rainbow markers, Hybond-C 
nitrocellulose membrane, Hybond-N nitrocellulose membrane
Beecham Research: Ampicillin sodium BP (Penbritin®)
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Bio-Rad: Ammonium persulphate (APS), Coomassie Brilliant Blue™, TEMED
Fluka: Formaldehyde, formamide
Gibco BRL: lkb DNA ladder, Trizol reagent
Invitrogen: Recombinant RNasin (40U/pl)
Joseph Mills Ltd.: Ultrapure ethanol, methanol 
Kodak: X-Omat film
Prolab: Butan-2-ol, glacial acetic acid, glycerol, isopropanol 
Promega: Recombinant RNasin (40U/pl)
Sigma: Glutathione-agarose
2.1.10 Kits and miscellaneous
Gibco BRL: 5' RACE System (Version 2.0)
Hybaid: Cosmid miniprep kit 
Promega: In vitro trancription kit
Qiagen: Maxi-, midi-, and mini-prep plasmid isolation kits 
Sartorius: 0.5ml Collodion bags
2.1.9 Solutions
30% acrylamide mix 29% (w/v) acrylamide, 1% (w/v) N, N -
methylene bis-acrylamide
40% acrylamide mix 38% acrylamide, 2% (w/v) N, N’-
methylene bis-acrylamide
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6x agarose gel loading buffer
Alkaline lysis:
Solution I
Solution II
Solution III
Bradford’s reagent
Coomassie stain solution
Materials & Methods
0.25% (w/v) bromophenol blue 
0.25% (w/v) xylene cyanol FF 
30% (v/v) glycerol
50 mM Tris-HCl (pH 8.0)
10 mM EDTA
0.2 M NaOH 
1% (w/v) SDS
3 M potassium acetate
11.5% (v/v) glacial acetic acid
0.01% (w/v) Commassie Brilliant Blue™ 
0.0003% (w/v) SDS 
8.5% (v/v) phosphoric acid 
4.75% (v/v) ethanol
0.02% (w/v) Coomassie Brilliant Blue™ 
50% (v/v) methanol 
7% (v/v) acetic acid
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500 ml lOOx Denhardt solution 10 g Ficoll 400
10 g polyvinylpyrrolidone 
lOgBSA
Destain 5% (v/v) methanol 
10% (v/v) acetic acid
EMSA RNA binding buffer 
(ERBB)
10 mM Hepes, pH 7.6 
60 mM KC1 
3 mM MgCl2 
1 mM DTT 
5% (v/v) glycerol
Fixing solution 40% (v/v) methanol
10% (v/v) acetic acid
Giemsa stain 1.5% (w/v) suspension of Geimsa in glycerol
heated to 56°C for 2h and diluted with an equal 
volume of methanol
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Hybrid selection of cDNA
Pre-hybridization buffer
Hybridization buffer
50% (v/v) formamide
0.75 M NaCl
0.1 M Pipes (pH 6.0)
8 mM EDTA
0.5% (w/v) SDS
100 pg/ml salmon sperm DNA
50% (v/v) formamide
0.4 M NaCl
0.1 M Pipes (pH 6.0)
8 mM EDTA
0.5% (w/v) SDS
100 pg/ml salmon sperm DNA
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Immunoprecipitation
Buffer E
Buffer EN
Buffer EB
Materials & Methods
100 mM Tris-HCl (pH 8.0)
100 mM NaCl 
2 mM EDTA 
2 mM EGTA 
1% (v/v) NP40
0.5% (w/v) sodium deoxycholate 
0.5 mM PMSF
100 mM Tris-HCl (pH 8.0)
500 mM NaCl 
2 mM EDTA 
2 mM EGTA 
1% (v/v) NP40
0.5% (w/v) sodium deoxycholate 
0.5 mM PMSF
Buffer E containing 2 mg/ml BSA
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Immunoprecipitation of US 11-RNA complexes:
RNA-binding buffer 10 mM Tris (pH 7.9)
(RBB) 150 mM NaCl
50 mM KC1 
2 mM MgCl2 
0.5 mM DTT 
0.2 mM EDTA 
0.2 mM PMSF 
20%(v/v) glycerol
1 OX MOPS 0.4 M MOPS
0.1 M sodium acetate 
10 mM EDTA 
pH 7.2
Northern blot hybridization solution 50% (v/v) formamide
5x SSC 
2x Denhardt
5% (w/v) dextran sulphate
0.5% (w/v) SDS
250 (ig/ml salmon sperm DNA
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Northern blot pre-hybridization 
solution
PBS A
PBS complete
PBS-T
50% (v/v) formamide 
5x SSC 
5x Denhardt
50 mM Na2HP04 (pH 7.0)
0.1% (w/v) SDS
100 pg/ml salmon sperm DNA
170 mM NaCl
3.4 mM KC1
10 mM Na2HP04 (pH 7.5)
PBS A
1 g/1 CaCl2.2H20  
1 g/l MgC1.6H20
PBS A
0.05% (v/v) Tween 20
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PCR reaction buffer 
(final concentration)
5x Polynucleotide kinase 
(PNK) exchange reaction buffer
3x Protein loading buffer
SDS-PAGE running buffer
I mM dATP, dCTP, dTTP and dGTP 
45 mM Tris-HCl, pH 8.8
II mM (NH4)2S04
4.5 mM MgCl2
6.7 mM (3-mercaptoethanol
4.4 pM EDTA, pH 8.0 
113 pg/ml BSA
350 pi ADP
250 mM imidazole (pH 6.8)
60 mM MgCl2 
5 mM (3-mercaptoethanol
150 mM Tris-HCl (pH 6.8)
30% (v/v) glycerol 
6% (w/v) SDS 
300 mM DTT
0.3% (w/v) bromophenol blue
0.05 M Tris base 
0.05 M glycine 
0.1% (w/v) SDS
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2.5x Random priming buffer
5x RNA loading buffer
0.5 M Hepes (pH 6.6)
12.5 mM MgCl2
25 mM (3-mercaptoethanol
125 mM Tris (pH 8.0)
50 mM dGTP 
50 mM dATP 
50 mM dTTP
50% (v/v) glycerol 
1 mM EDTA
0.4% (w/v) bromophenol blue
Small scale nuclear and cytoplasmic extracts
Buffer A 10 mM HEPES (pH 7.9)
1.5 mM MgCl2 
10 mM KC1 
0.5 mM DTT
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Buffer C
Buffer D
20x SSC
50x TAE
20 mM HEPES (pH 7.9)
25% (v/v) glycerol
0.42 M NaCl
1.5 mM MgCl2
0.2 mM EDTA
0.5 mM PMSF
0.5 mM DTT
20 mM HEPES (pH 7.9) 
20% (v/v) glycerol 
0.1 MKC1 
0.2 mM EDTA 
0.5 mM PMSF 
0.5 mM DTT
3 M NaCl
0.3 M Tri-sodium citrate 
pH 7.0
0.2 M Tris base 
0.05 M EDTA (pH 8.0)
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lOx TBE
TE
Towbin (transfer buffer)
Tris-saline
Trypsin
1.25 M Tris-HCl (pH 8.0)
0.14 M boric acid 
10 mM EDTA (pH8.0)
10 mM Tris-HCl 
1 mM EDTA 
(pH 8.0)
25 mM Tris base 
192 mM glycine 
20% (v/v) methanol
140 mM NaCl 
30 mM KC1 
280 mM Na2HP04 
25 mM Tris-HCl (pH 8.0)
1 mg/ml glucose 
0.1 mg/ml streptomycin 
100 U/ml pencillin 
0.0015% (w/v) phenol red
0.25% (w/v) trypsin in Tris-saline containing 
phenol red (pH 7.5)
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Versene
Materials & Methods
0.6 mM EDTA
0.0002% (w/v) phenol red 
in PBS A
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2.2 Methods
2.2.1 DNA manipulation, cloning and construction of templates for in vitro 
transcription.
2.2.1.1 Preparation of DNA.
For the small-scale isolation of plasmid DNA the Hybaid cosmid miniprep kit or the 
Qiagen plasmid miniprep kit were used according to the manufacturer’s protocol. 
Alternatively, alkaline lysis, was performed as described here. 1.5-3ml of bacterial 
culture was pelleted by centrifugation at 12,000rpm in a benchtop centrifuge for lmin. 
The supernatant was removed and the pellet resuspended in lOOpl of solution I. 200pl 
of solution II was added, mixed by inversion and incubated for 5min on ice. 150pl of 
solution III was added and mixed gently. Cell debris was pelleted by centrifugation at 
12,000rpm for lOmin. The supernatant was transferred to a fresh microfuge tube and 
extracted twice with phenol/chloroform and ethanol precipitated. The DNA pellet was 
washed with 70% ethanol and air-dried. The DNA was resuspended in lOOpl of TE 
buffer and lOpg RNase A and incubated for 30min at 30°C.
For larger scale DNA preparations the Qiagen Midi- or Maxi-prep kit were used 
according to the manufacturer’s protocol.
2.2.1.2 Phenol/chloroform extraction and ethanol precipitation of DNA
Typically, the volume of the DNA in solution was made up to 200(4.1 with (IH2O and 
200pl of 50% phenol/chloroform (v/v) was added. After vortexing for 30s the mixture
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was centrifuged at 12,000rpm in a benchtop microfuge for 5min and the upper phase 
removed carefully and transferred to a clean microfuge tube. This was repeated until 
there was no precipitate visible at the interface (usually just once). The upper phase was 
transferred to a fresh microfuge tube and precipitated with the addition of 1/10 of a 
volume of 3M sodium acetate (pH 5.2), 2.5 volumes of ice-cold ethanol were added and 
incubated at -20°C for lh. The DNA was recovered by centrifugation at 12,000rpm for 
lOmin, washed once in lOOpl of 70% ethanol and resuspended in the desired volume of 
TE or dH20.
2.2.1.3 Restriction endonuclease digestion of DNA and blunt-ending DNA
For restriction of vector DNA approximately 500ng of DNA was incubated in the 
presence of 2U of the restriction enzyme in lx the appropriate buffer supplied by the 
manufacturers in a total volume of 20pl for lh at 37°C. For the cloning of PCR 
products approximately 5pg of DNA was digested in the same manner for 3h at 37°C. 
For filling in over-hanging DNA ends 2U of Klenow large DNA polymerase subunit 
was incubated with DNA for 30min at 37°C in the presence of all four dNTPs at a final 
concentration of ImM each.
2.2.1.4 Agarose gel electrophoresis of DNA
DNA was resolved in a horizontal slab gel of 1-1.5% (w/v) agarose in lx TBE or lx 
TAE containing lpg/ml ethidium bromide and electrophoresised in a buffer of lx TBE 
or lx TAE. Electrophoresis was performed at 80-120V. DNA was visualized by UV- 
illumination.
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2.2.1.5 Acrylamide gel electrophoresis of DNA
DNA fragments were separated in a 6% polyacrylamide/lx TBE gel by electrophoresis 
in a Bio-Rad mini-electrophoresis gel system. Electrophoresis was carried out at lOOmV 
for 45-60min. The gel was stained with 5pg/ml ethidium bromide in lx TBE, washed 
twice with lx TBE and visualized under UV-illumination.
6% acrylamide gel:
Acrylamide (30%) 3ml
1 Ox TBE 1.5ml
dH20  10.5
APS lOOpl
TEMED 12pl
2,2.1.6 Isolation of DNA from agarose gels
DNA was extracted from agarose gel slices using Spin-X columns (Costar). The gel 
slice was frozen for 20min at -20°C in a Spin-X tube and then centrifuged in a benchtop 
centrifuge for 20min at 8,000rpm. The DNA was isolated from the eluate by 
phenol/chloroform extraction and ethanol precipitation.
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2.2.1.7 Isolation of DNA from acrylamide gel slices
An acrylamide gel slice containing the DNA fragment of interest was excised. The 
DNA was eluted in 0.4M NaCl at 4°C o/n. The DNA was recovered by 
phenol/chloroform extraction followed by ethanol precipitation.
2.2.1.8 Ligation of insert into vector
Ligation of an insert into a vector with compatible ends was carried out by incubation of 
the insert with the vector at the molar ratios 3:1, 1:1, and 1:3. The ligation was 
performed in a volume of lOpl in the presence of lpl of lOx ligation buffer and 1U of 
T4 DNA ligase at 16°C o/n.
For ligation into the pGEM-T Easy vector (Promega) 3 pi of the insert was incubated 
with 0.5pl of the vector (25ng), 5 pi of 2x rapid ligation buffer and lpl of T4 ligase 
(3U/pl from Promega) and 0.5pl dH20 . The reaction was incubated at RT for lh.
2.2.1.9 Construction of the 6xHisUSl 1 expression plasmid
The ORF of US 11 was PCR amplified from HSV-1 (17+) EcoKl fragment H (wt) using 
primers GTAGGTCGACTCGAGATGAGCCAGACCCAAC and GATGAAGCTTG 
AGCGTATGCTCCATGTTGTG, which incorporated the Sail and Hindlll sites at the 
5' and 3' ends of the US 11 ORF respectively. The PCR product was digested with 
Hindlll and Sail and ligated into pQE-30 which had been linearised by the same
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enzymes. The ligation mix was used to transform DH5a cells and the transformants 
plated out on agar plates lOOpg/ml ampicillin. Ampicillin resistant colonies were 
screened for the presence of the US 11 ORF in the pQE-30 backbone was checked by 
restriction enzyme analysis. The presence of correct insert was checked by sequencing 
with the QIAexpress sequencing primers 'Primer-Type III/IV' and 'Primer- Reverse 
Sequencing'.
2.2.1.10 Construction of the pT-12/14 and pTA34
The pT-12/14 insert was generated by SI RT-PCR and is described in Section 2.2.7.2. 
This insert was cloned into pGEM-T Easy (Fig. 2.1). pT-A34 was generated by the PCR 
amplification of the A34 sequence from the Kpnl C' (wt) fragment of HSV-1 with the 
primers GTGTGCACGGCGAGCTGCTC and AGCACCGACACACGCCGGTG. The 
PCR product was purified and ligated directly into pGEM-T Easy (Fig. 2.1). The inserts 
were sequenced using T7 and SP6 promoter specific primers.
2.2.1.11 Construction of in vitro transcription templates of A34 and for 12/14 and 12/14 
truncations
Templates for in vitro transcription of riboprobes the A34 RNA and the 12/14 RNA and 
progressive 5' deletions of 12/14 RNA were generated by the inclusion of a 5' T7 RNA 
Polymerase promoter sequence upstream of the sequence of interest by PCR. The 
sequences of the primers used are given in Table 2.1.
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Fig. 2.1: Schematic diagram of pTA34 and pT-12/14.
pT-A34 was generated by ligation of a 451nt PCR fragment of the 
UL34 gene into pGEM-T Easy. pT-12/14 was generated by the ligation 
of the 585nt amplification product of SI RT-PCR into pGEM-T Easy. 
The insert is depicted by a yellow box, with the orientation of the RNA 
indicated by an arrow. The position of the restriction enzyme sites 
within the multiple cloning site (MCS, mauve box) used to linearize 
the vectors for the generation of run-off transcripts are indicated. RNA 
was generated by transcription with T7 or Sp6 RNA polymerase (the 
promoters are indicated by blue and pink boxes respectively, with a 
bent arrow). The Ori is depicted by a green box and the ampicillin 
resistance gene by an orange box.
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2.2.2 Bacterial procedures
2.2.2.1 Making competent £. coli
10ml of L-broth was inoculated with bacteria and grown o/n at 37°C in a shaking 
incubator. 2.5ml of the o/n culture was used to inoculate 50ml of media and grown until 
an OD6 0 0  of 0.4 had been reached. The cells were pelleted by centrifugation at 5,000rpm 
for 5min at 4°C in a Sorvall RT 6000B centrifuge. The bacterial pellet was resuspended 
in 20ml of ice-cold 0.1M CaCb and incubated on ice for 30min. The bacteria were 
pelleted as before, resuspended in 10ml of ice-cold 0.1M CaCh and incubated on ice for 
15min followed by centrifugation. The pellet was resuspended in 4ml of ice-cold 0.1M 
CaCh with the addition of 15% glycerol, aliquoted, snap frozen and stored at -70°C.
2.2.22 Transformation of plasmids
10pl of competent E. coli and lOng of circular plasmid or 5 jli1 of ligation mix were 
incubated for 30min on ice in a pre-chilled 15ml falcon tube. Heat shock was carried 
out by incubation at 42°C for 90s. The bacteria were left to recover for 5-10min at RT. 
lml of L-broth was added to the transformation mix and incubated for lh at 37°C in a 
shaking incubator. 200jul of the transformation mix was spread on LB agar plates 
containing the appropriate antibiotic and incubated o/n at 37°C.
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2.2.23 Bacterial protein expression
i. 6xHisUSll expression
Plasmid preparations were used to transform M15[pREP4] cells which were plated out 
on agar plates containing 25pg/ml kanamycin and lOOpg/ml ampicillin. Resistant 
colonies were used to inoculate 10ml of L-broth, which was incubated o/n at 37°C in a 
shaking incubator. This 10ml culture was used to inoculate a 100ml L-broth which was 
grown at 25°C until an ODgoo of 0.6 had been reached. The cultures were then induced 
with ImM IPTG and grown for a further 5h at 25°C. 1ml of the culture was removed 
and pelleted by centrifugation at 12,000rpm for lmin in a benchtop centrifuge. The 
supernatant was removed and the bacterial pellet was resuspended in lOOpl lx protein 
gel loading buffer,
ii. Expression and purification o f GST-US11
BL21 cells were transformed with pGEX-2T, or the pGEX-2T US 11 constructs, 2319, 
2540, or 2625, and plated out on agar plates containing 100pg/ml ampercillin. After 
incubation o/n at 37°C, resistant colonies were picked and used to innoculate 10ml of L- 
broth containing ampicillin. This starter culture was incubated o/n at 37°C in a shaking 
incubator. The starter culture was used to innoculate 100ml of L-broth. When an OD6 0 0  
had been reached protein expression was induced with the addition of O.lmM IPTG and 
incubated for a further 3h at 37°C.
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The bacteria were pelleted by centrifugation at 9,000rpm in a GS3 rotor for lOmin at 
4°C and resuspended in 10ml of PBS. The bacteria were lysed by the addition of lmg/ml 
lysozyme and incubated on ice for 30min. 1% (v/v) Triton X-100 was added and the 
cell debris pelleted by centrifugation at 9,000rpm at 4°C. The supernatant was removed 
and added to 1ml of 50% suspension of glutathione-agarose in PBS and mixed on a 
rotating wheel for 2min. at RT. Three washes were performed with 50ml ice-cold PBS 
A and the pellet resuspended in 1ml of 5mM reduced glutathione/5OmM Tris-HCl 
(pH8.0) and place on a rotating wheel for 2min at RT. The beads were pelleted by 
centrifugation 3,000rpm for 5s and the supernatant removed. The beads were subjected 
to a further two rounds of elution.
The purified protein was dialysed against lx ERBB in 0.5ml Collodion bags at 4°C for 
lh. The lx ERBB was replaced with fresh ERBB and the protein sample dialyzed for a 
further 2h at 4°C. 20% glycerol (v/v) was added and the protein stored in 20pl aliquots 
at -70°C.
2.2.3 Cell culture and virus growth
2.2.3.1 Mammalian cell culture
Cells were grown in the appropriate media at 37°C supplied with 5% C 02 in a 
humidified incubator.
Cells were harvested by washing with versene and removed by washing with 
trypsin/versene. Cells were diluted 1 in 10 in the appropriate medium for passaging.
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2.23.2 Preparation of virus stocks
BHK21 C l3 cells were grown in roller bottles to a confluency of 80% and infected at an 
moi of 1 in 300 in 40ml of media at 31°C for 3-5 days until a cytopathic effect (CPE) 
was observed. Cells were harvested by shaking the roller bottles to detach the cells and 
collected by centrifugation at 2,000rpm for 30min at 4°C in a Sorvall RT 6000B 
centrifuge. To harvest the cell released virus the supernatant was removed and 
centrifuged at 12,000rpm for 2h (Sorvall GSA rotor). The pellet was resuspended in 
1 ml/roller bottle, sonicated briefly, aliquoted, frozen on dry ice and stored at -70°C. The 
cell associated virus was harvested by resuspending the cell pellet in 5ml BHK medium 
and sonicated for lOmin in a sonibath. The cell debris was pelleted by centifugation at 
2,000rpm for lOmin and the supernatant removed. The pellet was again resuspended in 
5ml of BHK medium, sonicated and pelleted. The supernatant was added to that gained 
in the first round, aliquoted, frozen on dry ice and stored at -70°C.
Serial dilutions (10_1-10-8) of the virus stock were titrated in BHK21 C13 cells. 90% 
confluent BHK21 C13 cells in 60mm sterile dishes were infected for lh at 37°C. The 
cells were overlaid with BHK medium/1 % methylcellulose. After 2-3 days the media 
was removed and the cells stained with Giemsa stain for 2h, washed and the plaques 
counted under a dissecting microscope. The titre was calculated as plaque forming 
units/ml (pfu/ml).
Virus stocks were checked for contamination by streaking on to blood agar plates and 
incubated at 37°C for 5 days.
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2.2.3.3 Infection of cells
80% confluent BHK or HeLa cell monolayers were infected with HSV-1 wt or HSV 
US 11 null mutant at a multiplicity of 10 or no virus (mock-infected). Adsorption was 
for lh at 37°C. The cells were washed with PBS, overlaid with the appropriate medium 
and infection allowed to proceed at 37°C in a humidified incubator supplied with 5% 
C 02.
2.2.4 Preparation of cell extracts
2.2.4.1 Preparation of total cellular protein extracts
For preparation of cell extracts monolayers were washed with PBS, and cells lysed by 
suspension in 1ml cell extract buffer (50mM Hepes (pH 7.5), 50mM NaCl, 0.1% (v/v) 
NP-40, 10pl of protease inhibitor cocktail). Extracts were sonicated on ice, cell debris 
was pelleted, and the protein concentration determined by the Bradford assay.
2.2.4.2 Preparation of small-scale nuclear-cytoplasmic extracts
Cytoplasmic and nuclear fractionation was performed as described by Lee et at. (1990). 
Cells were harvested by scraping into PBS using a rubber policeman and washed twice 
in 30 packed cell volumes (PCV) of ice-cold PBS and pelleted by centrifugation at 
3,000rpm in a benchtop centrifuge at 4°C. The cells were resuspended in 1 PCV of
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buffer A and allowed to swell on ice for 15min. The cells were lysed using 6 strokes 
through a 26-gauge needle attached to a 1ml syringe. The nuclei were pelleted by 
centrifugation at 12,000rpm for 20s at 4°C. The supernatant was removed, aliquoted, 
snap frozen in liquid nitrogen and stored in liquid nitrogen. The nuclear pellet was 
resuspended in two-thirds PCV in buffer C and incubated on ice for 30min with 
occasional agitation. The nuclear debris was pelleted by centrifugation at 12,000rpm for 
5min. at 4°C. The supernatant was removed and dialysed against buffer D in 0.5ml 
Collodion bags at 4°C for 2h. The dialysed nuclear fraction was aliquotted, snap frozen 
in liquid nitrogen and stored in liquid nitrogen.
2.2.5 Protein analysis
2.2.5.1 SDS-PAGE
SDS-PAGE was performed in a vertical gel system, using the Bio-Rad Mini Protean 
II™ electrophoresis apparatus. The resolving gel was poured between two glass plates 
which were separated by spacers. The resolving gel was overlaid with butan-2-ol and 
allowed to set at RT. The butanol was removed by washing with water. The stacking gel 
was poured on top of the resolving gel, into which a slot-forming comb was inserted. 
The stacking gel was left to set. The protein gels were assembled in a Bio-Rad 
electrophoresis cell with running buffer. Protein gel loading buffer was added to protein 
samples. The samples were boiled for 5min and loaded into the wells. The samples were 
electropherised at 150V until the dye front had reached the bottom of the gel.
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Resolving gel (10ml) Stacking gel (5ml)
10% 12% 15% 5%
Acrylamide (30%) 3.3 ml 4 ml 5 ml 0.83 ml
1.5M Tris-HCl (pH 8.8) 2.5 ml 2.5 ml 2.5 ml -
1M Tris-HCl (pH 6.8) - - - 0.63 ml
10% (w/v) SDS 100 pi 100 pi 100 pi 50 pi
dH20 4 ml 3.3 ml 2.3 ml 3.4 ml
10% (w/v) APS 100 pi 100 pi 100 pi 50 pi
TEMED 4 pi 4 pi 4 pi 5 pi
2.2.5.2 Western blotting
Proteins were separated by SDS-PAGE and transferred to nitrocellulose using a Bio- 
Rad transblot cell. For transfer a sandwich was built in the following order: fibre pad, 
3mm Whatman paper, SDS-PAGE gel, Hybond-C nitrocellulose, 3mm Whatman paper, 
fibre pad, pre-soaked in Towbin buffer. The sandwich was placed inside the Bio-Bad 
apparatus and transferred at 250mA for lh or o/n at 30mA at 4°C.
The nitrocellulose membrane was blocked in PBS A/5% dried milk powder at RT for lh 
or o/n at 4°C. The membrane was washed three times in PBS A. For the detection of a 
specific protein the antibody was diluted in PBS A/0.05% Tween-20 (PBS-T) and 
incubated with the membrane for lh on a rotating shaker at RT. The membrane was 
washed three times in PBS-T followed by the addition of protein A-horse radish 
peroxidase (HRP) or anti-mouse IgG-HRP added at a dilution of 1/1000 in PBS-T and
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incubated for lh on a rotating shaker at RT. The membrane was washed with PBS-T 
five times. To visualise the protein of interest the membrane was incubated with ECL 
detection reagents for lmin (1:1, v/v), covered with clingfilm and exposed to X-Omat 
film.
2.2.5.3 Immunoprecipitation of UL13
HeLa were labelled with [35S]-methionine (30 pCi/ml) for 6h in Eagle's medium 
containing 20% of the normal methionine level and 2% newborn calf serum. The 
monolayers were washed with PBS and total protein extracted as described in section 
2.2.4.1. For immunoprecipitation 5pl of the anti-UL13 pAb and 50pl of 
immunoprecipitation buffer, buffer E, was added to lOOpg of the cell extract and 
incubated at 4°C for 2h. 75 pi of protein A-Sepharose (50% w/v) was added and mixed 
at 4°C for lh. The beads were pelleted and were washed twice with buffer EB, once in 
buffer EN and four times with buffer E. 50pl of boiling buffer was added to the washed 
beads and the samples boiled for 3min. The samples were electrophoresed on a 10% 
SDS-PAGE gel and visualised by phosphoimager analysis.
2.2.6 Manipulation of RNA
2.2.6.1 Isolation of total RNA
Total cellular RNA was prepared by Trizol (Gibco BRL) extraction according to the 
manufacturer's protocol, phenol/chloroform extracted twice, chloroform extracted once 
and ethanol precipitated.
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2.2.6.2 Isolation of cytoplasmic RNA
lxlO7 cells were harvested, pelleted at 2000rpm for 5min at 4°C and washed in 20ml of 
ice-cold PBS complete. The cells were resuspended in 2ml ice-cold lysis buffer (0.14M 
NaCl, 1.5mM MgCl2, lOmM Tris-HCl (pH7.4), 5mM DTT, 0.5% (w/v) NP40) and 
incubated on ice for 15min. The cells were lysed by 5 strokes in a 1ml Dounce 
homogeniser and the nuclei pelleted by centrifugation at 3,300rpm for 15min at 4°C. 
The supernatant was removed, lOOpg/ml proteinase K and 0.2% (w/v) SDS added and 
incubated at 37°C for 30min. The RNA was isolated by phenol/chloroform extraction 
and ethanol precipitation.
2.2.6.3 DNase treatment of RNA
RNA was incubated with 10pl New England Biolabs Restriction Enzyme Buffer 3, 80U 
of RNasin and made up to a volume of lOOpl with DEPC-H20  and incubated for 30min
at 37°C. The RNA was extracted twice by phenol/chloroform extraction, once with 
chloroform and ethanol precipitated.
2.2.6.4 Phenol/chloroform extraction and ethanol precipitation of RNA
Typically, the volume of RNA in solution was made up to 200pl with dH20  and 200pl 
phenol:chloroform:isoamyl alcohol (25:24:1) added. After vortexing for 30s the mixture 
was centrifuged at 12,000rpm in a benchtop microfuge for 5min and the upper phase
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removed carefully and transferred to a clean microfuge tube. This was repeated until 
there was no precipitate visible at the interface (usually just once). The upper phase was 
transferred to a fresh microfuge tube and the RNA precipitated with the addition of 0.5 
volumes of 7.5M ammonium acetate and 2.5 volumes of ice-cold ethanol and incubated 
at -20°C for lh. The RNA was recovered by centrifugation at 12,000rpm for lOmin, 
washed once in lOOpl of 70% ethanol and resuspended in the desired volume of TE or 
dH20.
2.2.6.5 Co-immunoprecipitation of US 11 and RNA
The protocol used was taken from Roller & Roizman (1990). Pooled cytoplasmic and 
nuclear extracts (Section 2.2.4.2) were diluted with RBB to a concentration of 500pg/ml 
of protein. 1000U of RNasin was added and the US 11 mAb (28*) was added at a 
dilution of 1 in 1000 and incubated at RT for 30min. 250pl of anti-mouse IgG-agarose 
(50% solution in RBB) was added This was mixed on a rotating wheel for 30min. 
RNase T1 was added to a final concentration of 3U/pl and the mixture incubated for a 
further lOmin at RT (this step was omitted if the RNAs were to be reverse transcribed). 
This was followed by the addition of lpg/pl of heparin and incubation for a further 
lOmin. The beads were pelleted and washed three times in RBB containing 1 mg/ml 
BSA, 500mM NaCl, and 5mg/ml heparin. The beads were washed once with binding 
buffer and the complexes solubilized by boiling for 2min in 500pl 0.5% (w/v) SDS/TE. 
The RNA was extracted twice by phenol/chloroform (1:1) extraction, once with 
chloroform and ethanol precipitated. The RNA was treated with DNase I followed by 
phenol/chloroform extraction and ethanol precipitation. The RNA pellet was 
resuspended in 20pl of dH20.
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22.6.6 GST-US11 RNA pull downs
For the GST-fusion protein pull-downs purified 50pg recombinant GST-US11 or GST 
was pretreated with 50U of micrococcal nuclease at 30°C for 15min to remove 
contaminating bacterial RNA. The reaction was stopped by the addition of EGTA to a 
final concentration of 5mM and incubated for lOmin. on ice. Glutathione-agarose beads 
were pre-swollen and washed in RBB and resuspended to form a 50% slurry. lOOpl of 
the 50% slurry was incubated with 50jag of protein on a rotating wheel for 5min at RT. 
The beads were then pelleted, washed 5 times with RBB and resuspended in lOOpl of 
RBB. The cell extracts (prepared as described above) were precleared with GST- 
glutathione-agarose by adding lOOpl of GST-glutathione-agarose to lOOpl total (pooled 
nuclear and cytoplasmic fractions) HeLa cell extract (diluted with RBB to 500p,g/ml) 
and incubated for 30min at 4°C on a rotating wheel. The beads were then pelleted and 
the precleared extract used in the pull-down.
Heparin was added to the extract at lpg/pl and lOOpl of either GST-glutathione agarose 
or GST-US11-glutathione agarose and incubated at 4°C for lh. RNase T1 was added to 
a final concentration of 3U/pl and the mixture incubated for lOmin at RT (this step was 
omitted if the RNAs were to be reverse transcribed). The beads were pelleted and 
washed three times in RBB containing 5mg/ml BSA, once with RRB containing 
500mM NaCl and three times with binding buffer. The beads were then resuspended in 
500pl 0.5% (w/v) SDS/TE and boiled for 2min to elute the protein-RNA complexes. 
The RNA was extracted with phenol/chloroform twice and chloroform once and ethanol
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precipitated. The RNA was treated with DNase I followed by phenol/chloroform 
extraction and ethanol precipitation. The RNA pellet was resuspended in 20pl of dH2 0 .
2.2.6 .7 T4 polynucleotide end-labelling
For 5' end-labelling of nucleic acids with [3 2 P], lOpl of RNA or 5pi of lkb DNA 
molecular weight marker was added to the end-labelling mix which consisted of 40U 
RNasin, lx PNK exchange reaction buffer, lOpCi of [y-3 2 P] ATP, followed by the 
addition of 10U of T4 PNK. The total reaction volume was 25pl. Following incubation 
at 37°C for 30min, lOpl of Sequenase kit stop solution (Amersham International) was 
added. The sample was heated to 100°C for 2min and lOpl of RNA or 2pl of lkb DNA 
marker was loaded on to a 6 % denaturing gel and electrophoresed for approximately 2 h 
at 70 Watts.
6 % denaturing gel:
Urea 40g
Acrylamide (40%) 10.1
1 Ox TBE 10ml
dH20  40.5
10% APS 600pl
TEMED 50pl
A 6 % denaturing gel mix was poured between two glass sequencing size plates 
separated by thin spacers. Wells were formed by the use of a sharks tooth comb.
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Electrophoresis was performed using the Gibco BRL model S2 electrophoresis 
apparatus.
2.2.6. 8  In vitro transcription
Riboprobes were transcribed in vitro from inserts cloned into pGEM-T Easy or 
templates with a T7 promoter at the 5' end by the appropriate polymerase (either SP6 , 
T7 RNA polymerase) in the presence of [a-3 2P] rUTP using the Promega in vitro 
transcription system.
For transcription from the pGEM-T Easy plasmids the templates were prepared in the 
following fashion. The templates were linearized with the appropriate restriction 
enzyme, the positions of which are given in Fig. 2.1. For transcription with T7 RNA 
polymerase to generate the anti-sense transcript pT-A34 was digested with Sail. For 
transcription with SP6  to generate the sense transcript, pT-A34 was digested with Sphl. 
For transcription of pT-12/14 to generate the sense transcript, pT-12/14 was digested 
with Sacl. For transcription of pT-12/14 to generate the anti-sense transcript, pT-12/14 
was digested with Ncol. The templates were blunt-ended. The digested templates were 
separated by agarose gel electrophoresis and purified.
For transcription from the PCR-derived templates the PCR products were separated on 
an acrylamide gel and extracted. The templates were transcribed with T7 or SP6  RNA 
Polymerase as appropriate.
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For in vitro transcription the following components were combined and the reaction 
incubated for lh at 37°C.
5x transcription buffer 2 .5 pi
lOOmMDTT ljul
RNasin (40U/pl) 0.5pl
2.5mM rATP, rGTP, rCTP (each) 2pl
lOOpMUTP 1.2pl
Template ( 1  pg/pl) 0 .5pi
[a-3 2P] UTP 2.5|il
T7 or SP6  RNA polymerase 0.5pl
RNA loading buffer was added to the in vitro transcription reaction, and heated for 
2min at 80°C. The riboprobes were loaded on to a 6 % denaturing polyacrylamide gel 
and electrophoresed at 200V for 3-4h. The bands were excised after autoradiography. 
The probes were extracted by incubation with 0.5% (w/v) SDS/TE at 37°C o/n, 
followed by phenol/chloroform extraction and ethanol precipitation. The riboprobes 
were resuspended in 60pl lx ERBB.
The components of a 6 % denaturing gel are given in Section 2.2.6 .7. The gel mixture 
was poured between two large plates separated by spacers and a comb inserted to form 
the wells according to the manufacture’s instructions. Electrophoresis was performed 
using a Bio-Rad PROTEAN® xi cell kit.
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2.2.6.9 Gel mobility shift assay
GST or GST-fusion protein was incubated on ice in lx ERBB in the presence of lOng 
of tRNA and 40U RNasin for lOmin. 10,000cpm of probe was denatured for lmin at 
80°C and followed by incubation on ice for 2min before being added to the binding 
reaction, which was then incubated at 4°C for lOmin. Complexes were resolved on 
native 4% polyacrylamide gels electrophoresed at 200V for 4h at 4°C. The gel was 
dried under vacuum and exposed to X-Omat film with an intensifying screen at -70°C 
o/n.
4% non-denaturing polyacrylamide gel:
Acrylamide (30%) 2.5ml
lOx TBE 6.7ml
50% glycerol 5ml
dH20 35ml
APS 500pl
TEMED 50pl
The gel was poured between two medium sized glass plates that were separated by 
spacers. Wells were formed by the insertion of a comb and electrophoresis carried out 
using Gibco BRL electrophoresis kit, model V I5.17.
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2.2.6.10 Dot blot RNA-binding assay
The RNA binding reaction was set up as in EMSA. Hybond-C nitrocellulose membrane 
was washed with dt^O for lh and then lx EMSA RNA binding buffer (ERBB) for 30 
min. The membrane was placed above 3mm Whatman paper (wetted with lx ERBB) in 
dot blot apparatus and the apparatus assembled. The sides of the apparatus were taped to 
ensure a good seal and the holes not to be used were taped. 80pl of lx ERBB was added 
to the RNA binding reaction on ice. The reaction mix was applied to the membrane and 
the vacuum was applied. When all the liquid had passed through the membrane the 
membrane was washed twice with 500pl of lx ERBB. The vacuum was broken and the 
membrane retrieved. The regions of membrane to which the reactions had been applied 
were excised and counted by liquid scintillation counting.
2.2.6.11 Northern blotting
lOpg of total RNA was dried under vacuum and resuspended in a buffer containing 
50% (v/v) formamide, 16.6% (v/v) formaldehyde, and lx MOPS. 3pi of 3x RNA 
loading buffer was added and the sample boiled for 2min and chilled on ice. The RNAs 
samples were loaded on to a 2 .2 % (v/v) formaldehyde/1 .2 % (w/v) agarose horizontal 
slab gel which had been pre-run for 30 min) and elctrophoresised in lx MOPS buffer at 
140mV until the dye front had migrated to two thirds of the gel. The marker lane was 
removed and stained in 5pg/ml acridine orange for 2 0 min, washed twice in dfhO and 
left to destain o/n in 500ml of (IH2 O. The gel was stained in 5pg/ml of ethidium 
bromide in lx MOPS and visualized under UV-illumination to ensure equal loading of
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the samples. The gel was washed three times with 2x SSC and the transfer set up. For 
the transfer of RNA to Hybond-N nitrocellulose membrane a tower of 3mm Whatman 
paper, gel slab, membrane, and paper towels was constructed and 2x SSC allowed to 
move up thought the tower by capillary action. For this a 14 x 9 cm horizontal gel slab 
tray was stood upsides down in about 2cm of 2x SSC in a tray to be used as a support. 
To form the “wick” by which 2x SSC can travel into the tower two pieces of 14 x 18 cm 
3mm Whatman filter paper were pre-wet in 2x SSC and laid over the support so the 
overhanging edges dipped into the 2x SSC. This was overlaid by four 14 x 9cm 3mm 
paper pre-wet in 2x SSC. The gel slab was placed on the filter paper and a nitrocellulose 
membrane cut to the same size as the gel was placed on top. The tower was completed 
by the addition of 2 pieces of 3mm paper cut to the same size as the gel and a stack of 
paper towels. A glass plate was placed on the top and the tower weighted down. To 
prevent the 2x SSC soaking though the top layers without passing through the gel- 
membrane sandwich areas exposed from the layers below were blocked by the used of 
strips of developed X-Omat film. At all times care was taken to ensure the removal of 
all air bubbles. Transfer was left to occur o/n at RT.
To prepare the blot for probing the tower was disassembled and the nitrocellulose 
membrane left to air dry. The RNA was cross-linked to the membrane for 2min by UV 
irradiation.
To probe the blot for specific RNAs a purified random primed probe was used. For this 
the membrane was pre-hybridized for 5h at 42°C in 5ml of pre-hybridization buffer. 
2xl06 cpm of the purified, [3 2P]-labelled DNA probe was denatured for lOmin at 100°C, 
chilled on ice and added to 2 ml hybridization buffer and incubated with the membrane 
o/n at 42°C. The blot was washed at 65°C, twice in 3xSSC/0.1% (w/v) SDS at 65°C and 
then twice with lx SSC/0.1% (w/v) SDS at 65°C and monitored for radioactivity. If the
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blot was still fairly radioactive (> 5cpm) it was washed a further 3x in O.lx /0.1% (w/v) 
SDS at 65°C. The blot was sealed in a heat sealable bag and exposed to X-Omat film 
o/n (or longer if required) at -70°C.
2.2.7 RT-PCR procedures
2.2.7.1 Hybrid selection of cDNAs
In order to isolate cellular y-actin RNA from a cDNA pool of total cytoplasmic RNA, 
hybrid selection was performed. The plasmid pGMl, containing a y-actin sequence, was 
digested with Xbal and Bglll and the products separated on a 1% agarose gel. A band of 
840bp was excised and the DNA extracted. lOpg of the insert was spotted 1 pi at a time 
on to (1cm Hybond-N nitrocellulose which had been previously incubated in 0.4M 
NaOH for 30min) and air dried between applications. To remove unbound DNA the 
membrane was washed twice in ammonium acetate (pH 5.5) and 2 times in 2x SSC. 
After the membrane was air-dried the DNA was cross-linked by UV irradiation for 
2min. The membrane was boiled in dH2 0  for lmin, chilled on ice and washed five 
times with dH2 0 . Pre-hybridization was performed in 2ml of pre-hybridization solution 
at 42°C for 4h. Cytoplasmic homopolymer tailed ss cDNAs were dried under vacuum 
and resuspended in 1 ml of hybridization solution and incubated with the membrane o/n 
at 42°C. The membrane was washed 10 times at 50°C with lx SSC/0.5% (w/v) SDS, 
five times with 5x SSC/0.5% (w/v) SDS, and once with 5mM Tris (pH 7.4), ImM 
EDTA. To elute the captured cDNAs 1ml of elution buffer (5mM KC1, 2mM EDTA) 
was added to the membrane in a 1.5ml ependorf tube and boiled for lmin followed by 
snap freezing in a dry ice/ethanol bath. The eluate was removed and the procedure
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repeated. The eluates were pooled and ethanol precipitated. The pellet was resuspended 
in 20pl of dH2 0.
2.2.7.2 RT-PCR
RT-PCR was carried out using the Gibco BRL 5' RACE kit with some modifications to 
the protocol. The primers used for each stage are listed in Table 2.1. For reverse 
transcription 5pi of RNA, 2.5pmol of primer and dH20  were mixed in a 0.5ml 
microfuge tube to give a total volume of 15.5pl and the mixture incubated at 70°C for 
lOmin and on ice for lmin. The liquid was collected by a brief centifugation in a 
benchtop microfuge. To this mixture 2.5pl lOx Gibco BRL PCR buffer was added 
(200mM Tris-HCl (pH8.4), 500mM KC1), 2.5pl 25mM MgCl2, Ipl dNTPs (lOmM of 
each) and 2.5pl 0.1M DTT. This mixture was incubated at 42°C for lmin and lpl of 
reverse transcriptase was added. The reaction mixture was incubated at 70°C for 50min. 
The liquid was collected by brief centrifugation and lpl of RNase H was added 
followed by incubation at 37°C for 15min. The cDNA was isolated using GlassMAX 
spin columns (Gibco BRL) according to the manufacturer’s protocol. For the 
amplification of unknown RNAs isolated by GST pull down the single stranded cDNA 
(ss cDNA) was homopolymer tailed with cytosine. For this 6.5pl dH2 0 , 5pl 5x tailing 
buffer (50mM Tris-HCl (pH8.4), 125mM KC1, 7.5mM MgCl2), 2.5pl 2mM dCTP and 
lOpl of purified ss cDNA were combined in a 0.5ml microfuge tube. The mixture was 
incubated for 2-3min at 94°C, then placed on ice for lmin. lpl of terminal 
deoxynucleotidyl transferase was added and the reaction incubated at 37°C for lOmin. 
The enzyme was inactivated by incubation at 65°C for lOmin.
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In the first round of PCR the reaction contained 5 pi of dC-tailed ss cDNA, 20pmol of 
each primer and 1 mM dATP, dCTP, dTTP and dGTP, 45mM Tris-HCl (pH 8.8) 1 ImM 
(NH4 )2 S0 4 , 4.5mM MgC12, 6.7mM p-mercaptoethanol, 4.4pM EDTA, pH8.0, 
113pg/ml BSA and 4U Taq DNA polymerase (Applied Biosystems) in a 0.2ml thin 
walled microfuge tube. The PCR cycle consisted of a hot start (3min at 95°C in which 
the DNA polymerase was added, followed by 2min at 72°C) followed by 35 cycles of 
denaturation at 94°C for 30s, annealing at 55°C for 30s and elongation at 72° for 4min. 
Followed by an elongation step at 72°C for 15 min. For the second round of PCR 5pl of 
a 1 in 100 dilution of the first PCR reaction was used in the same reaction conditions as 
detailed above. The products were visualised after separation on a 1.2% agarose gel in 
the presence of ethidium bromide under UV illumination.
2.2.8 Miscellaneous techniques
2.2.8.1 Random priming
Random priming was used to generate [ P]-labelled DNA fragments for probing 
Northern blots. lOOng of DNA fragment in 6.75pi of dH20 and 1.25pi of random 
hexamers (0.1 OD2 6 0 Units/ml) were combined in a 1.5ml microfuge tube and boiled for 
2-5min. The mixture was collected by brief centrifugation in a benchtop centrifuge. To 
this mixture, lpl of BSA (lOmg/ml), 2.5x random priming buffer, 5pl [a-32P] dCTP, 
and 1 pi of Klenow was added. The reaction mix was mixed by vortexing, collected by 
brief centrifugation and incubated at 37°C for lh. lpl of Klenow was added and the 
reaction incubated for a further lh at 37°C. The reaction volumn was made up to 60pl 
with dH20 and the labelled DNA was purified using a mini-quick spin column.
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2.2.8.2 Purification of DNA probes
The DNA was purified by mini-quick spin column. The cap was removed from the spin 
column, ensuring that no beads were lost and the base snapped off. The spin column 
was placed in a 1.5ml microfuge tube and centrifuged at 6,500rpm for 2min in a 
benchtop centrifuge. The spin column was placed in a clean microfuge tube. The 
volume of the probe to be purified was made up to 60pl with dH2 0  and pipetted 
carefully on to the surface of the matrix. The column was centrifuged at 6,500rpm for 
2min to elute the probe.
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Chapter 3,0 Isolation of novel RNA binding partners for US11
To date, a limited number of RNA binding partners for US 11 have been isolated; two 
HSV-1 derived RNAs, the anti-sense transcript of the US 11 5' UTR (Roller & Roizman, 
1990), a truncated transcript of the UL34 gene, A34 RNA (Roller & Roizman, 1991); a 
cellular RNA, rRNA derived from the 60S subunit (Roller & Roizman, 1992); and two 
retroviral intronic export elements, the RRE of HIV-1 and the XRE of HTLV-1 (Diaz et 
a l , 1996).The role of these RNAs in vivo is unclear; the anti-sense transcript of the 
US11 5' UTR and A34 RNA do not appear to encode a protein and as yet, have no clear 
role in infection and two are derived from heterologous viral systems. It would therefore 
be reasonable to hypothesise that they may serve as substrate analogues for US11, which 
is probable for at least the retroviral RNAs and that there are further HSV-1 or cellular 
transcripts which can bind US 11 which have yet to be identified. In order to test this 
hypothesis it was necessary to attempt the isolation and identification of RNAs which 
bind US11 in infected cells.
Firstly, methods by which US 11-RNA complexes could be isolated from infected cell 
lysates were examined. This required the production of recombinant US11, which is 
outlined in the first section of this Chapter. Secondly, RT-PCR was used as a means of 
identifying RNAs that interact with US11.
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3.1 Production of recombinant US11
3.1.1 Production of recombinant 6xHis-USll
The system chosen for the bacterial expression of the US 11 protein was the 
QIAexpress™ system (Qiagen). This system allows the gene of interest to be fused to an 
RSG-6xHis-tag either at the N- or C-terminus and the expressed 6xHis tagged proteins 
to be purified on a Ni-affinity column. In this purification system nitrilotriacetic acid 
(NTA) is bound to Sepharose® C6-LB beads. NTA is a tetradentate chelating agent. Ni2+ 
ions are chelated by NTA, which occupies four of the six available sites in the co- 
ordination sphere of Ni ions. The remaining two sites are available to interact with the 
6xHis tag. 6xHis tagged proteins can therefore be isolated from bacterial lysates by 
binding them to the Ni-NTA matrix and can be eluted from the column by washing with
9-himidazole, which competes with histidine to chelate the Ni ion.
The C-terminus of US 11 has been shown to bind RNA (Roller et ah, 1996; Schaerer- 
Uthurralt et al., 1998) and so the N-terminus of US 11 was chosen as the location for the 
6xHis tag to minimise the potential for interference with RNA binding.
The US11 ORF was PCR amplified and cloned into the pQE-30 vector as described in 
Materials and Methods and was termed pQE-USll (Fig. 3.1). The pQE-USll plasmid 
was used to transform E.coli M15(pREP4) cells. A 10ml starter culture was used to 
inoculate a 100ml culture which was grown at 37°C until an OD6 0 0  of 0.6 had been 
reached. The cultures were then induced with ImM IPTG and grown for a further 5h at 
37°C. Bacterial proteins were separated by SDS-PAGE gel electrophoresis and 
expression was examined by Coomassie staining or by Western blot analysis using an
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pQE-USll
Fig. 3.1: A schematic diagram of pQE-USll.
The US11 ORF was PCR amplified incorporating a 5' Sail site 
and a 3' HindlU site. The vector and insert were digested by 
Sail and HindlU and ligated. The the turquoise box represents 
the US 11 gene red box, the T5 promoter and lac operator 
sequence, the mauve box the ribosome binding site, the pink 
box 6xHis tag, the green box the ampicillin resistance gene 
(Ampr) and the blue box the Ori.
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anti-RSG-His monoclonal antibody (mAb). The QIAexpress control plasmid, pQE-16, 
which encodes the dihydrofolate reductase (DHFR) gene C-terminally 6xHis tagged was 
used as a control for protein expression.
The 6xHis-DHFR protein can be readily visualised in induced cells by Coomassie 
staining of an SDS-PAGE gel migrating at 26kDa (Fig.3.2A). However, the recombinant 
6xHis-USll protein could not be detected in this fashion (Fig. 3.2B). In order to 
examine whether 6xHis-USll is being expressed at levels too low to be detected by 
Coomassie staining, a Western blot of bacterial extracts was probed with the anti RSG- 
3xHis mAb (Fig.3.2C). Although expression of 6xHis-DHFR can be detected (lane 2), 
no expression of 6xHis US11 could be detected (lane 4).
A range of temperatures, 15, 25, 30 and 37°C, were tested to see if 6xHis-USl 1 could be 
expressed at any of these temperature (Fig. 3.3). A 10ml starter culture was used to 
inoculate 100ml of L-broth which was incubated at the respective temperatures. When 
the O D 6oo of the cultures reached 0.6 they were induced by the addition of ImM IPTG 
and cultured at the repective temperature for a further 5h, except for the culture induced 
at 15°C which was induced for 12h due to the slow rate of growth. The expression of 
6xHis-USll was examined by probing a Western blot with the anti-RSG-3xHis mAb. 
At 37°C no expression of 6xHis-USll could be observed (lanes 1 and 2). However, at 
30, 25 and 15°C expression of 6xHis-USll could be detected (lanes 3-8). The 
expression of the 6xHis-USl 1 was greatest at 25°C. Never the less expression of 6xHis- 
US11 could not be detected by Coomassie staining of SDS-PAGE gels of bacterially 
expressed proteins suggesting that it is expressed at very low levels (data not shown).
In order to confirm the identity of the recombinant protein, a Western blot of a bacterial 
extract induced for 5h at 25°C was probed with the anti-RSG-3xHis mAb and an anti-
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Fig. 3.2: Expression 6xHis-USll protein at 37°C.
lml of the culture was pelleted at 12,000rpm and resuspended in 
lOOpl of lx protein gel loading buffer and boiled for 5min. 20pl 
were separated by electrophoresis on an SDS-PAGE gel and either 
stained with Coomassie or Western blotted. A: Coomassie stain of 
a 12% SDS-PAGE gel of 6xHis DHFR expression. Lane 2 shows 
the uninduced and lane 3 the induced protein profile. An arrow 
marks the position of the 26kDa DHFR band. B: Coomassie stain 
of a 15% SDS-PAGE gel of 6xHis US11 expression. Lane 2 shows 
the uninduced and lane 3 the induced protein profile. C: A Western 
blot of a 15% SDS-PAGE gel probed with an anti-RSG 3xHis 
antibody. Lanes 1 and 3 show uninduced 6xHis DHFR and 6xHis 
US11 respectively. Lanes 2 and 4 show induced 6xHis DHFR and 
6xHis US11 respectively. An arrow indicates the position of 6xHis 
DHFR.
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3.3: Expression of 6xHis US11 at different temperatures.
Expression was carried out at different temperatures. 6xHis US11 was 
induced at 37°C (lane 2), at 30°C (lane 4), at 25°C (lane 6) and at 15°C (lane 
8). Lanes 1,3,5 and 7 correspond to the uninduced cultures at the respective 
temperatures. All cultures were induced for 5h except for the culture at 15°C, 
which was induced for 12h. The proteins were separated on a 15% SDS- 
PAGE gel and Western blotted. The blot was probed with anti-RSG-3xHis 
antibody. An arrow indicates the position of 6xHis US11.
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US 11 polyclonal antibody (pAb). The anti-RSG-3xHis mAb and the anti-US 11 pAb 
reacted with a doublet migrating below the 21.5kDa marker (Fig 3.4). This suggests that 
this doublet represents 6xHis-USl 1.
Despite attempts to optimize the conditions of expression, 6xHis-USll could not be 
produced in sufficient amounts to be visualised by Coomassie staining. In addition, 
attempts were made to purify the 6xHis-USll protein by Ni-NTA chromatography. 
However, even though the culture size was scaled up, sufficient amounts of 6xHis-USl 1 
were not produced to allow visualisation by Coomassie staining of SDS-PAGE gels.
The low levels of 6xHis-USl 1 expression suggests that it is expressed very inefficiently. 
This inefficient expression may be due proteolytic degradation, a preponderance of 
codons not used in bacteria or that 6xHis-USl 1 is toxic. The lower temperature required 
to achieve expression suggests that toxicity or proteolysis plays a major role in the low 
levels of expression observed.
As it seemed unlikely that the problems with this system could be solved, another source 
of recombinant US11 was considered.
3.1.2. Production of recombinant GST-US11
Expression and purification of recombinant proteins tagged with glutathione S- 
transferase (GST) is commonly used. GST fusion proteins can be readily purified from 
bacterial lysates using glutathione, the substrate for GST, immobilized on agarose beads. 
The GST-fusion protein can be eluted from the beads using free glutathione.
A US11 (HSV-1 KOS strain) construct in which US11 is N-terminally tagged with GST 
(vector 2319) was obtained from J-J. Diaz and J-J. Madjar (Schaerer-Uthurralt et 
al., 1998). The KOS strain US11 is slightly smaller than 17+, the only difference between
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3.4: Western blot analysis of recombinant 6xHis-USll.
Expression of 6xHis US11 was carried out at 25°C for 5h post­
induction. The proteins were separated on a 15% SDS-PAGE gel 
and Western blotted. Lanes 1 and 5 represent uninduced and 2 
and 4 induced 6xHis US11. The blot was probed with anti-RSG- 
3xHis antibody (lanes 1 and 2) and an anti-USll pAb (lanes 4 
and 5). Arrows indicate the positions of the cross reacting bands.
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HSV-1 17+ and KOS is that the former is 161 amino acids, and the latter, lacking two 
SPREPR repeats in the C-terminus is 149 amino acids in length.
Plasmids 2319 and pGEX-2T were transformed into BL21 cells. The GST-US11 
constructs were expressed and purified as described by Schaerer-Uthurralt et al. (1998) 
and in Materials and Methods. In brief, a 10ml o/n culture was used to inoculate 100ml 
of LB media and when an OD600 of 0.4 was reached was induced by the addition of 
O.lmM IPTG for 3h at 37°C. The bacteria were harvested by centrifugation and lysed 
and cell debris pelleted by centrifugation. The GST-fusion proteins were bound to 
glutathione-agarose beads which were washed extensively and eluted in three rounds 
with free reduced glutathione. GST-US11 could be purified in one step as a single band 
free of contaminants as visualised by Coomassie staining of SDS-PAGE gels (Fig 3.5 A), 
as previously demonstrated by Schaerer-Uthurralt et al (1998). However, the stability of 
the full-length GST-US11 diminished rapidly either with storage at 4°C or -70°C, even 
with the addition of 20% glycerol and breakdown products could be seen sometimes 
within a month with storage at -70°C, and in less time at 4°C.
To assess the functionality of the purified protein the RNA binding activity of the GST- 
US11 protein was tested by electrophoretic gel shift mobility assay (EMSA) with the 
known RNA substrate, A34. The basis of EMSA is the ability of a protein that binds an 
RNA to retard its progress in a non-denaturing polyacrylamide gel. An in vitro 
transcribed [a-32P] UTP labelled A34 riboprobe was incubated in the absence of protein, 
or in the presence of 12.5ng/pl of GST or GST-US11 at 4°C for lOmin and the products 
resolved on a 4% non-denaturing polyacrylamide gel (Fig. 3.5B). Without the addition 
of protein the A34 riboprobe migrates as a free unbound species (lane 1) and with 
addition of GST the probe also migrates as an unbound species (lane 2). However, with 
the addition of GST-US11 the probe is retarded, demonstrating that the probe is in
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Fig. 3.5: Purification of GST-US11.
A: GST and GST-US11 were expressed in E. coli BL21 cells. The 
recombinant proteins were bound to glutathione-agarose beads and 
eluted with three washes in 1ml of 5mM reduced glutathione. 
Protein loading buffer was added to 20pl of each elution and the 
samples boiled for 5min. The samples were electrophoresed on a 
12% SDS-PAGE gel and Coomassie stained . Lanes 1-3 GST, 
elutions 1-3 respectively. Lanes 4-6 GST-US11, elutions 1-3 
respectively. B: 10,000cpm of a [32P]-labelled A34 riboprobe was 
incubated without protein (lane 1) or 12.5ng/pl of GST (lane 2) or 
GST-US11. The Complexes were resolved on a native 4% 
polyacrylamide gel and visualised by autoradiography.
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complex with the recombinant protein (lane 3). The recombinant protein therefore 
behaved as previously shown by Schaerer-Uthurralt et al (1998).
It was observed that the full length GST-US11 fusion protein rapidly lost RNA binding 
activity when stored at -70°C. In addition, when glycerol stocks of BL21 cells 
transformed with 2319 DNA (encoding GST-US11) were used to inoculate the 10ml o/n 
starter culture the yield of and RNA binding activity of the purified recombinant protein 
was diminished. The production of GST-US11 therefore required that BL21 cells were 
transformed immediately prior to expression, as opposed to using glycerol stocks. Also, 
different batches of protein could differ significantly in their ability to bind RNA. 
Therefore new batches were titrated against A34 RNA in EMSA to ensure that fully 
active protein was used.
3.2 Isolation of US11-RNA complexes
The first step in developing the assay was to isolate US 11-RNA complexes from 
infected cells. Roller & Roizman (1991) achieved this by immunoprecipitating US11 
from infected cell lysates, treating the complexes with RNase T l, extracting the 
protected RNA species and 5' end-labelling the RNA using T4 polynucleotidyl kinase 
(PNK) in the presence of [a-32P] ATP. The RNAs were electrophoresed on a denaturing 
gel and visualised by autoradiography (Fig. 1.13). Roller & Roizman (1991) did not
detect any RNAs using extracts from mock infected, US 11 HSV-1 infected cells, or 
without the addition of the secondary antibody. However, numerous RNA species of 
varying size were co-immunoprecipitated from HSV-1 infected cell lysates. The end- 
labelled RNAs were used to probe a Southern blot of a BamHl digest of HSV-1 DNA. 
The only fragment that hybridized contained the UL34 sequence and subsequent
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analysis identified the A34 RNA as a binding partner for US11. As only one RNA 
hybridized, this suggests that other RNAs may have been present but at levels below the 
limit of detection by Southern blot hybridization and autoradiography. Alternatively, 
some of the labelled RNAs may have been derived from cellular RNAs.
An alternative approach to immunoprecipitating native US 11-RNA complexes from 
infected cell lysates is to use the GST-US11 fusion protein to isolate RNAs which bind 
US 11. GST-US11 protein bound to a glutathione-agarose could be incubated with 
infected cell extracts, the complexes pelleted and washed and the RNAs extracted. This 
method would allow high concentrations of US 11 to be used, far in excess of virus 
infected cellular levels of US 11, thus the potential for isolating interacting RNAs is 
increased. However, US 11 is phosphorylated in vivo and one potential problem is that 
recombinant US 11 may not possess the necessary post-translational modifications 
required for RNA binding.
3.2.1 Co-immunoprecipitation of US11-RNA complexes
In order determine whether the co-immunoprecipitation of US 11 and RNA employed by 
Roller & Roizman (1991) could be used in conjunction with an RT-PCR based 
amplification the protocol was repeated.
An anti-USll monoclonal antibody (28*) was used to immunoprecipitate US 11 from 
mock infected and infected HeLa cell lysates (16h pi). The immunoprecipitation and 
end-labelling of RNAs was preformed as described by Roller & Roizman (1991). 
However, in the example shown in Fig. 3.6, the following modifications were made to 
the protocol. The cell lysates were pre-cleared with the secondary antibody, and the 
isolated RNA was pre-treated with DNase I in an attempt to reduce the non-specificity
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Fig. 3.6: Co-immunoprecipitation of US11 and RNA.
A: An autoradiograph of a 6% denaturing gel of [32P]-end labelled RNAs. US 11 
was immunoprecipitated from infected cell extracts (lane 4), a control 
immunprecipitation was performed using mock infected cell extracts (lanes 2), or 
without the anti-US 11 antibody (lane 3). A lkb ladder was end labelled as a control 
for the reaction (lane 1). B: The corresponding Western blot of immunoprecipitated 
proteins electrophoresed on a 12% SDS-PAGE probed with a US 11 antibody. 
Abbreviations: Anti-USll monoclonal antibody (Ab), infected cell extract (In), 
mock infected cell extract (M).
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of the immunoprecipitation as described below. RNAs which co-immunoprecipitated 
with US 11 were isolated by boiling the beads for 2min in 0.5% (w/v) SDS/TE. The 
RNA was recovered by phenol/chloroform extraction and ethanol precipitation. The 
isolated RNAs were end-labelled with [y-32P] ATP in the presence of PNK. The end- 
labelled RNAs were resolved on a denaturing gel. Fig. 3.6A shows the labelled RNAs 
generated by such a pull down. Many RNA species were isolated from both mock 
infected cells plus the anti-USll mAb and infected cells minus the anti-USll mAb 
(lanes 2 and 3). The labelling seems to be slightly heavier with immunoprecipitation 
from infected cells plus the anti-USll mAb (lane 4), but in general, the pattern of 
products is similar. Many species were isolated and the pattern obtained varied between 
experiments, but overall appeared to be similar for mock infected, infected minus 
secondary antibody and infected cell lysates. Western blot analysis demonstrated that 
US 11 was co-immunoprecipiated (Fig. 3.6B). The reason for the non-specific reactivity 
of the secondary antibody is not clear. The apparent lack of US 11-specific RNA species 
may be due to the conditions not being optimal for US 11-RNA interactions or that 
insufficient amounts of US 11 were precipitated and hence the RNA co- 
immunoprecipitated could not be visualized by end-labelling especially in light of the 
high background labelling. Therefore, alternative solutions to isolating RNAs that bind 
to US 11 were explored.
3.2.2 Isolation of GST-US11/RNA complexes from infected cell lysates
Trifillis et al. (1999) used a recombinant GST-aCPl fusion protein to successfully pull 
out interacting RNAs. The ability of GST-US11 to pull down RNAs from infected cells 
was examined (a schematic outline of the protocol is given in Fig. 3.7). Firstly, 50pg of
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Fig. 3.7: Schematic diagram of the pull down of GST-US11/RNA 
complexes.
Schematic diagram of the method used to isolate US11-RNA complexes. 
GST-US11 bound to glutathione-agarose is incubated with infected HeLa 
cell extracts. The reaction is incubated with RNase T l. The complexes are 
washed and the RNA extracted.
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purified GST or GST-US11 were pretreated with miccrococal nuclease to remove any 
contaminating bacterial RNA and then bound to glutathione-agarose beads in RNA 
binding buffer (RBB). Infected HeLa cell extracts were pre-cleared by incubation with 
GST-glutathione-agarose to remove RNAs that inadvertently bind GST or the 
glutathione-agarose beads. The pre-cleared extract was incubated with GST- or GST- 
US11-glutathione-agarose beads. RNase Tl was added and the complexes washed 
extensively to remove non-specific RNAs. The beads were resuspended in 0.5% (w/v) 
SDS/TE and boiled for 2min. The RNA was extracted by phenol/chloroform and ethanol
79precipitated. The RNA was 5' end-labelled with PNK in the presence of [y- P] ATP, 
and the RNAs resolved on a denaturing gel (Fig. 3.8A).
Both from the pull down with GST and GST-US11 no labelled species could be detected 
(lanes 3 and 4). A 47nt RNA derived from RSV (a gift from Lindsay Rowlands) was 
used as a positve control for RNA end-labelling reaction (lane 1).
Reverse transcription coupled with PCR amplification (RT-PCR) is a very sensitive 
method to detect low abundance RNAs. Therefore, in order to assess whether RNAs 
were present at an amount to low to be detected by end-labelling, the presence of A34 
RNA, known to bind US11, was examined by RT-PCR (Fig. 3.8B). The pull-down was 
performed as before except that the RNase Tl step was omitted. The RNA was reverse 
transcribed in the presence of a A34 sequence-specific primer (A34R). The ss cDNA was 
subjected to two rounds of PCR in the presence of A34 specific primers. In the second 
round of PCR the primers were nested inside the sequence of the first. With GST alone 
no amplification product was observed, however, with GST-US11 a band migrating at 
approximately 250bp was seen corresponding to the expected amplification product of 
A34. This species was isolated, cloned into pGEM-T Easy and its identity as A34 
confirmed by sequencing.
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Fig. 3.8 Pull down of GST-US11/RNA complexes.
A: Autoradiograph of 6% denaturing gel. GST (lane 4) or GST-US11 (lane 3) wereT9used to in a GST pull down, the RNA extracted, [ Pl-end labelled and separated on a
• • • T9sequencing gel. A 49nt RNA derived from RSV was used as positive controls for [ P] 
RNA labelling in the end labelling reaction (lane 1). Lane 2 contains an end labelled 
1Kb marker. B: GST or GST-US11 were used to pull out RNAs from infected cell 
lysates. The RT-PCR of the RNA was performed with primers specific for A34 RNA. 
5pl of the products were separated on a 1.5% agarose gel. The position of the amplified 
product is indicated with an arrow.
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3.3 RT-PCR based assay for detecting RNAs bound by U Sll
Using GST-US11 bound to glutathione-agarose beads it was possible to isolate a known 
binder RNA, A34 RNA, which could be detected using RT-PCR with specific primers. 
Other RNAs which interact with US11 could also be represented. Therefore, a RT-PCR 
method which allowed the RNAs to be reverse-transcribed and amplified without the 
need for sequence information had to be devised. Two methods were tested, one that 
depended on the RNA species being polyadenylated, and the other which was 
independent of the presence of a poly(A)+ tail.
3.3.1 Poly(A) tail dependent RT-PCR assay.
The first method examined was based on a combination of 3' and 5' Rapid Amplification
of cDNA Ends (RACE). 3' RACE relies on the presence of a poly(A)+ tail, which is 
added to the 3' end of mRNA. Reverse transcription is carried out using a oligo-d(T) 
primer, and subsequent rounds of amplification utilize a gene specific primer and a 
primer specific for the poly(A):(T) sequence or an anchor site that has been incorporated 
during RT or the first round of PCR. In 5' RACE a gene specific primer is used in RT 
and the resultant cDNA is homopolymer tailed with one of the dNTPs using terminal 
deoxynucleotidyl transferase (TdT). This serves as primer site in subsequent PCR cycles 
in conjunction with a gene specific primer.
Using the poly(A)+ tail and homopolymer tailing as a primer hybridization site in RT- 
PCR, it was reasoned that this would bypass the need for any gene specific sequence 
information for RT-PCR and hence allow the amplification of unknown RNA species.
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This method was termed poly(A) dependent RT-PCR (PA RT-PCR). Thermostable Taq 
DNA polymerase adds a single deoxyadenosine to the 3' ends of amplified product. By 
using a vector such as pGEM-T Easy, which possesses a single deoxythymidine 
overhang, PCR products can be directly ligated into the vector and subsequently 
sequenced. This method is described in detail below and schematically illustrated in Fig. 
3.9.
The RNA is reverse transcribed in the presence of an oligo d(T)n primer and the RNA is 
removed by digestion with RNase H. The single stranded (ss) cDNA is 
homopolymertailed with dCTP by TdT, The C-tailed ss cDNA is amplified by two 
rounds of PCR with primers specific for the 5' and 3' ends of the template. In the first 
round of amplification the Gibco BRL 5' RACE primer, Abridged Anchor Primer (AAP) 
and Primer 01igo-d(T)i7-Anchor Primer (OTAP) were used. The AAP contains a 3' GI 
sequence of 16nt (GGCCACGCGTCGACTAGTACGGGIIGGGIIGGGIIG) that can 
hybridize to the homopolymer tail of the cDNA and a 5' anchor sequence, which serves 
as site for the primer to anneal to in the second round of PCR. The OTAP primer 
contains an oligo(T)17 sequence and an anchor site for hybridization in the second round 
of PCR (TCGAGCATCGGATCCTTACCTTTTTTTTTTTTTTTTT). The products of 
the first round of PCR are diluted 1 in 100, and 5 pi used in the second round of PCR. In 
the second round of PCR the Gibco BRL 5' RACE primer, Abridged Universal 
Amplification Primer (AUAP) and 3' Anchor Site Primer (3r ASP) were used. The 
AUAP (GGCCACGCGTCGACTAGTAC), anneals to the anchor site incorporated by 
the AAP in the first round of PCR and 3' ASP (TCGAGCATCGGATCCTTACC) 
anneals to the anchor sequence incorporated by the OTAP primer.
This method was first tested using a known substrate, y-actin. Cytoplasmic Hela cell 
RNA was reverse transcribed using an oligo-d(T)i7 , treated with RNase H and purified .
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Fig. 3.9: Schematic diagram of po!y(A)-dependent RT-PCR.
A schematic diagram for reverse transcribing and PCR amplifying RNA that 
interacts with U Sll. Reverse transcription is performed using an oligo-d(T)n 
primer and Superscript™ reverse transcriptase. RNA in RNA/DNA hybrids is 
digested with RNase H. The cDNAs are homopolymer tailed with d(C) using 
terminal deoxynucleotidyl transferase. Two rounds of PCR are performed. The first 
using the primers Abridged Amplification Primer (AAP) and 01igo-d(T)i7-Anchor 
Primer (OTAP) both containing anchor sites for the hybridization of the primers in 
the next round. In the second round of PCR the primers Abridged Universal 
Amplification Primer (AUAP) and the 3' Anchor Site Primer (3'ASP) are used. The 
products of the reaction can be resolved on an agarose gel, excised and cloned into 
pGEM-T Easy for subsequent sequencing.
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The cDNA was homopolymer tailed with dCTP in the presence of TdT. A technique 
known as hybrid selection of cDNAs was used to isolate the y-actin homopolymer tailed 
cDNA. In brief, a DNA fragment containing 840bp of the y-actin sequence was UV 
cross-linked to Hybond-N nitrocellulose membrane. The poly(A) reverse transcribed, en­
tailed ss cDNA was hybridized to the membrane, washed and the cDNA eluted by 
boiling and snap freezing the membrane. The eluate was subjected to ethanol 
precipitation and the pellet resuspended in dk^O. The eluted RNA was amplified by two 
rounds of PCR as described above. As the OTAP, AAP, ASP, and AUAP primer have 
such different annealing temperatures, 34, 52, 62 and 60°C, respectively, the PCR was 
therefore performed at a range of different temperatures to determine whether an 
optimum temperature to yield a product could be found (Fig. 3.10).
At an annealing temperature of 60°C no PCR products are observed. However, when the 
annealing temperature is lowered to 57°C a smear running from lkb to the bottom of the 
gel is observed. At an annealing temperature of 54°C no products are observed but, at 
51 °C specific amplification of y-actin RNA is seen, at 49°C a smear running at about 
0.2kb is seen. From this it appears that the specific amplification of cDNA has a limited 
temperature range, 51 °C producing a specific product, which the annealing temperatures 
49°C and 54°C are unable to do. The non-specific smeared products may result from the 
formation of primer dimers or annealing at multiple sites within the y-actin sequence. 
51°C was therefore chosen as the temperature to perform PA RT-PCR with.
In order to isolate RNAs which interact with US 11 the pull-down of GST-US11/RNA 
complexes was achieved as detailed above, but as this required full length mRNA the 
RNase T1 step was omitted. RT-PCR was carried out as described above and the 
products separated by agarose gel electrophoresis. A typical profile gained from such an 
amplification protocol is shown in Fig. 3.11. With GST alone a low molecular weight
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Fig. 3.10: Poly(A)-dependent RT-PCR of y-actin cDNA at different 
PCR annealing temperatures.
Total cytoplasmic RNA was reverse transcribed using an oligo d(T)i7 
primer, y-actin RNA was pulled out of the cDNA pool by hybrid 
selection and subjected to two rounds of PCR amplification by the PA 
RT-PCR scheme outlined in panel A. The two rounds of PCR were 
performed at different annealing temperatures, 60, 57, 54, 51, and 49°C. 
The 5pl of the products were separated on a 1.5% agarose gel. The band 
was excised and cloned into pGEM-T and its identity as y-actin 
confirmed by sequencing.
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Fig. 3.11: Poly(A)-dependent RT-PCR of RNAs pulled down with 
GST-US11.
GST (lanes 1 and 3) or GST-US11 (lanes 2 and 4) were used to pull 
out RNAs from infected cell lysates (16h p.i.). The RNAs were 
reverse transcribed (lanes 3 and 4) and amplified by two rounds of 
PA RT-PCR. The amplified products were resolved on a 1.5% 
agarose gel, stained with ethidium bromide and visualised under UV- 
illumination.
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smear of between 0.4 and 1.6kb was observed, whereas with GST-US11 a product smear 
is located between 0.4 and 6 kb. The smeared nature of the products probably arises 
from the primers mis-hybridizing on the cDNA template, hybridization of the oligo- 
d(T)n primer in various locations within the RNA poly(A) tail or the fragmentation of 
RNA. In order to see if a RT-PCR method could be developed which resulted in a more 
distinct banding pattern of amplified products another RT-PCR method was examined.
3.3.2 Sequence-independent RT-PCR assay.
The second RT-PCR method examined is based on the 5' RACE method in combination 
with random primers. In brief, GST and GST-US11 were used to pull down RNA from 
infected cell extracts as before. The RNA was reverse transcribed using random 9-mer 
primers and the RNA removed using RNase H. The resultant ss cDNA was 
homopolymer tailed using terminal TdT and dCTP. The C-tailed ss cDNA was 
amplified by two rounds of PCR. In the first round the random 9-mer primers and the 
AAP were used. The products were diluted 1 in 100 and amplified in the second round 
of PCR using random 9-mer primers and the AUAP.
Fig. 3.12 shows a schematic illustration of this protocol. This method theoretically 
allows RT-PCR without sequence bias i.e. independent of the presence of a poly(A) tail. 
This method was therefore termed sequence-independent RT-PCR (SI RT-PCR). US 11 
binds at least one non-polyadenylated transcript, A34 RNA (Roller & Roizman, 1991) 
and therefore, a method which does not rely on the presence of such a sequence would 
be advantageous in the isolation of RNA which binds to this protein. Fig. 3.13A shows 
the results of such an assay. A3 4-specific primers were used in reverse transcription and 
PCR amplification of the RNA as a positive control, with GST alone no amplification
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Fig 3.12: A schematic diagram of sequence-independent RT-PCR.
Scheme of the sequence-independent amplification of RNAs that interact with US11. 
RNAs are reverse transcribed using 9-mer random primers and Superscript™ reverse 
transcriptase. The RNA in DNA:RNA hybrids is digested with RNase H. The cDNA is 
homopolymer tailed with deoxycytosine using terminal deoxynucleotidyl transferase. 
The C-tailed cDNAs are subjected to two rounds of PCR. The first round with random 
9-mer primers and AAP. The second round is performed with random 9-mer primers 
and AUAP. The products of this reaction are separated on an agarose gel, the bands 
excised and cloned into pGEM-T Easy.
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Figure 3.13: Sequence-independent RT-PCR of RNAs that interact with 
GST-US11.
A: Separation on a 1.5% agarose gel of 20pl of the reaction products 
derived from the SI RT-PCR of RNAs pulled down with either GST (Lanes 
2, 4, 6 and 8) or GST-US11 (Lanes 3, 5, 7, and 9), with (lanes 2-5), or 
without (lanes 6-9) reverse transcription. Gene specific primers to the A34 
RNA were used as a positive control for US11-RNA interactions (lanes 2, 3, 
6 and 7). Sequence-independent (SI) RT-PCR was performed on the RNA 
derived from the pull down (lanes 4, 5, 8 and 9). Arrows show the position 
of the A34 product amplified by gene specific primers and the unknown 
amplification product MX" amplified by SI RT-PCR. B: The annealing 
temperature of both PCR cycles for SI-PCR of RNAs that interact with 
GST-US11 were performed at 50 (lane 2), 53 (lane 3) and 55°C (lane 4). 
The products were resolved on a 1.5% agarose gel.
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products are observed (lane 2), but with GST-US11, an amplifcation product migrating 
at approximately 250bp is seen (lane 3). The identity of this species as A34 was 
confirmed by cloning and sequencing. SI RT-PCR was performed on the pulled down 
RNAs. With GST alone no amplification products are observed (lane 4), but with GST- 
US11 a single product migrating at approximately 600bp is seen (lane 5). Without 
reverse transcription no amplified products are seen (lane 8 and 9). To determine 
whether any further products could be amplified the annealing temperature of PCR 
cycles was varied. Lowering of the annealing temperature of the PCR should allow less 
stringent hybridization between the random primers and the cDNA template, therefore, 
potentially more PCR products will be generated. However, when the annealing 
temperature was lowered to 53°C or 50°C, although the amount of the 600bp product 
was increased, no novel bands were observed (Fig. 3.13B). Touch-down PCR, in which 
the first 5 rounds of amplification were performed at 60°C, and the annealing 
temperature was lowered by 0.5°C for each subsequent round for 30 cycles, did not 
yield any further products (data not shown).
3.4 A sequence derived hv SI RT-PCR is a potential RNA ligand for US11
The 600bp fragment was excised from the gel and cloned into pGEM-T Easy and 
sequenced. The sequence was analysed by BLAST-N (see Appendix) and was found to 
have homology to a 585nt sequence in the Ul region containing a 3' co-terminal RNA 
family encoding UL12, UL13 and UL14. The region lies within the 3TJTR of UL14, the 
3' ORF and 3' UTR of UL13 and the 5' UTR and 5' ORF of UL12 mRNA (Fig. 3.14). 
The plasmid was therefore named pT-12/14. A34 is pulled out by GST-US11, as 
confirmed by RT-PCR with gene-specifc primers, but it is not amplified in the SI RT-
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B1 CUGGAGUUGGUGGUUAGCGUGUACGUCGCCCCGAGCCUGGGCGUACCCGU 
51  GACCCGGUUUCCCGGUUACCAGUAUUUUAACAACCAGCUGUCGCCGGACU 
1 0 1  UCGCCCUGGCCCUGCUCGCCUAUCGCUGCGUGCUGCACCCAGCCCUGUUU 
1 5 1  GUCAACUCGGCCGAGACCAACACCCACGGCCUGGCGUAUGACGUCCCAGA 
2 0 1  GGGCAUCCGGCGCCACCUCCGCAAUCCCAAGAUUCGGCGCGCGUUUACGG
251  a u c g g u g u a u a a a u u a c c a g c a c a c a c a c a a g g c g K u a c u g u c g u c g g u g
3 0 1  GCGCUGCCUCCCGAGCUUAAGCCUCUCCUGGUGCUGGUGUCCCGCCUGUG 
3 5 1  UCACACCAACCCGUGCGCGCGGCACGCGCUGUCGUGAGAAUCAGCGUUCA 
4 01 CCCGGCGGCGCGCUCAACCACCGCUCCCCCCACGUCGUCUCGGAAAUGGA 
4 51 GUCCACGGUAGGCCCAGCAUGUCCGCCGGGACGCACCGUGACUAAGCGUC 
5 0 1  CCUGGGCCCUGGCCGAGGACACCCCUCGUGGCCCCGACAGCCCCCCCAAG 
5 5 1  CGCCCCCGCCCUAACAGUCUUCCGCUGACAACCAC-585
Fig. 3.14: Location and sequence of UL12-14.
A: The genomic location of the UL12-14 genes.The upper line shows a 
schematic diagram of the HSV-1 genome, the unique elements are 
represented by lines and major repeat elements by boxes. The expanded 
region of the genome, UL11-UL14 is depicted below. The arrow heads 
represent the 3' terminus and the circles the 5' terminus of the RNAs. The 
585nt region of homology with the sequence derived from SI RT-PCR is 
highlighted by a red box. B: The RNA sequence of the region highlighted in 
B. The the transcription iniation site of UL12 is indicated by an arrow, stop 
codon of UL13 is highlighted in blue and the Met-AUG of UL12 in red.
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Fig. 3.15: EMSA of US11 interaction with 12/14 RNA.
10,000cpm of in vitro transcribed 12/14 RNA (lanes 1-3) or A34 RNA 
(lanes 4-6) was incubated without the addition of protein (lanes 1 and 4), 
in the presence of 12.5ng/pl GST (lanes 2 and 5) or 12.5ng/pl GST- 
US11 (lanes 3 and 6). Complexes were resolved on a 4% non-denaturing 
gel and visualised by autoradiography.
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SI RT-PCR.This does indicate that either some bias has been introduced during the RT- 
PCR procedure, either as sequence-bias or due to the relative abundance of these 
transcripts.
The sequence pulled out by GST-US11, termed the 12/14 RNA, was tested for 
authenticity with regards to an interaction with US11. 12/14 RNA was transcribed from 
linearized pT-12/14 with T7 RNA polymerase and was radiolabelled with [a-32P] UTP. 
In vitro binding of US 11 to the 12/14 sequence was assayed using EMSA (Fig. 3.15). 
The A34 and 12/14 riboprobe was incubated either without the addition of protein or in 
the presence of GST or GST-US11. Without the addition of protein both the A34 and 
12/14 riboprobe migrate as free, unbound RNA (lanes 1 and 4). No change in the 
mobility of the riboprobes is detected when incubated in the presence of GST (lanes 2 
and 5). When incubated with GST-US11 a shift in the mobility of both riboprobes is 
generated (lanes 3 and 6), demonstrating that the US 11 component can bind both the 
positive control RNA, A34, and the RNA amplified by SI RT-PCR, 12/14 RNA. 
Therefore, it can be concluded that the 12/14 fragment has the potential to interact with 
the US 11 protein. The authenticity of this interaction is examined in subsequent 
Chapters.
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3.5 Summary and discussion of results.
This Chapter describes the development of a protocol to enable the isolation and 
identification of unknown RNAs which bind a specific protein of interest. US 11 is 
known to bind a limited number of RNAs: the RRE and the XRE, the anti-sense 
transcript of its own gene’s 5' UTR and a truncated RNA derived from the UL34 gene, 
A34. As the function of these interactions in HSV-1 infection is unclear it was 
hypothesised that US11 could potentially bind other RNAs of significance.
Other methods are now published for the identification of RNAs which interact with a 
particular protein and are discussed in Chapter 1. These methods are compared to the 
protocol described here in Chapter 7. This section shall deal with the comparison of 
methods used in the identification of RNA partners for US11.
Three methods were used previously to identify US11-RNA interactions: (1) the in vitro 
transcription of HSV-1 DNA fragments coupled with EMSA (Roller & Roizman, 1990), 
(2) the immunoprecipitation of US 11-RNA complexes followed by radiolabelling of 
RNAs and hybridization with HSV-1 genomic fragments (Roller & Roizman, 1991); (3) 
testing candidate RNAs for US 11 binding, the assumptions being based on the 
biological and physical properties of the protein (Diaz et al., 1996; Roller et al., 1992). 
All have their limitations based on the assumptions they make. The first two are limited 
to the identification of HSV-1 RNAs. The former could potentially involve a large 
amount of screening and the latter is limited by the sensitivity of detection. The third 
method is limited to what RNAs are reasonable to test, and is therefore self limiting. 
RT-PCR can overcome the limitations outlined above. It is a highly sensitive method 
allowing the identification of low abundance RNAs. It can potentially lead to the
112
Chapter 3 Results
identification of both cellular and viral RNAs and it is a relatively quick method, taking 
approximately 5 days from the pull down to the picking of positive colonies.
The first step in developing the protocol was to isolate US 11-RNA complexes from 
infected cell lysates. Immunoprecipitation of US 11 yielded a non-specific profile of 
RNAs. A GST-US11 pull down did not yield any RNAs detectable by end-labelling, but 
RNAs could be detected using RT-PCR, suggesting that an RT-PCR based protocol may 
allow the identification of interacting RNAs as it is a more sensitive method.
Two RT-PCR methods were tested, a poly(A)-dependent RT-PCR (PA RT-PCR) 
protocol and a sequence-independent RT-PCR (SI RT-PCR) protocol. The products of 
PA RT-PCR migrated as a smear on agarose gel electrophoresis. From this it was 
difficult to isolate specific products. The smeary nature of the products probably results 
from aberrant primer hybridization, multiple priming sites within the poly(A) tails or 
RNA fragmentation. SI RT-PCR was advantageous in one major way. US 11 can bind 
non-polyadenylated RNAs and these would be selected against using PA RT-PCR. SI 
RT-PCR therefore allows the non-bias amplification of RNAs. Using random 9-mer 
primers in SI RT-PCR one product was detected. Unexpectedly, when this product was 
sequenced it was found not to be the known binder, A34 RNA, but a sequence derived 
from the 3' co-terminal RNAs of UL12, UL13 and UL14. This demonstrates that there is 
some degree of bias, in that the A34 RNA is present in the RNAs pulled down, as 
detected by gene specific primers, but is not amplified in this assay. However, despite its 
limitations, SI RT-PCR has allowed another potential RNA binding partner for US11 to 
be found.
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4.0 Investigation into the in vitro binding of the 12/14 RNA by 
US11
In an attempt to isolate novel RNAs which associate with US 11 in infected cells a 
protocol was devised to allow US 11-RNA complexes to be captured and the RNA 
amplified and cloned by RT-PCR. One species of RNA was identified from this 
procedure with homology to a sequence found in three 3' co-terminal HSV-1 RNAs, 
UL12, UL13 and UL14 mRNAs, and has been designated 12/14 RNA. In order to 
examine whether this interaction is authentic, the interaction between US 11 and the 
12/14 RNA was examined in vitro.
4.1 Authentic 12/14 derived RNA can bind to US11
To confirm that the sequence identified from the SI RT-PCR assay was derived from 
the HSV-1 Ul region encoding UL12-14, and did not arise due to contamination of the 
sample, the corresponding region from the genome was used to construct a template for 
in vitro transcription. The 585nt region containing the 12/14 sequence and a 451nt 
sequence encoding A34 RNA were PCR amplified from the EcoRl D and the Kpnl C' 
fragments respectively, of HSV-1 using primers to incorporate a T7 promoter sequence 
upstream. These templates were transcribed in vitro in the presence of [ a -32P] UTP and 
the interaction with US 1 land the riboprobes examined by EMSA.
10,000cpm of the 12/14 or the A34 riboprobe were incubated without protein, with GST 
or with GST-US11 and the complexes resolved by native polyacrylamide gel 
electrophoresis (Fig. 4.1). Without the addition of protein, or with the addition of GST 
both the 12/14 probe and the A34 probe migrated as free species (lanes 1, 2, 4 and 5).
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Fig. 4.1: EMSA of the interaction between authentic 12/14 RNA 
US11.
10,000cpm of in vitro transcribed [32P]-labelled A34 (lanes 1-3) or 12/14 
RNA (lanes 4-6) were incubated without protein (lanes 1 and 4), with 
12.5ng/ ng/pl GST (lanes 2 and 5) or with 12.5ng/pl GST-US11 (lanes 3 
and 6). The complexes were resolved on a 4% non-denaturing acrylamide 
gel and the complexes visualised by autoradiography.
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However, when GST-US11 was included in the reaction the mobility of both probes 
was retarded, indicating that they are able to form a complex with US11 (lanes 3 and 6). 
This confirms that US 11 can bind RNA transcribed from a fragment derived from the 
Ul region of HSV-1 containing the transcripts of UL12-UL14 in vitro.
4.2 The effect of protein concentration on the interaction of US11 and 12/14 RNA
It has been proposed that GST-US11 can multimerise when in complex with RNA. In 
EMSAs with US 11 and the A34 RNA, the XRE or the RRE RNAs, increasing 
concentrations of GST-US11 leads to the progressive retardation of the riboprobe 
indicating that the size of the complex is increasing (Schaerer-Uthurralt et al., 1998). 
This has been suggested to be a result of the homomultimerization of US11. 
Additionally, by sucrose gradient centrifugation of infected cell extracts, US11 has been 
shown to associate in large complexes, which are thought to comprise largely of US 11 
homomultimers (Diaz et al., 1993).
To examine whether 12/14 RNA is bound in a similar fashion and to compare the 
strength of interaction of US 11 with the known binder, A34, the effect of protein 
concentration on binding was examined on the binding of 12/14 and A34 RNA (Fig. 
4.2). 10,000cpm of the A34 or the 12/14 riboprobe was incubated in the absence of 
protein, or in the presence of 25ng/pl GST or increasing concentrations of GST-US11 
from 5ng/pl to 25ng/jul and the complexes resolved on a non-denaturing polyacrylamide 
gel (Fig 4.2 A). In the absence of protein or in the presence of GST or 5ng/pl or lOng/pl 
GST-US11 the A34 riboprobe migrated as free, unbound species (lanes 1-4). When 
15ng/jul GST-US11 was incubated with the probe a mobility shift was observed (lane 
5). In the presence of 20ng/pl GST-US11 the mobility shift generated is greater that that
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Fig. 4.2. EMSA of 12/14 and A34 RNA incubated with increasing 
concentrations of GST-US11. 10,000cpm of the A34 (panel A) or the 
12/14 (panel B) riboprobe were incubated either without protein (lane 
1), with 25ng/pl GST (lane 2) or with increasing concentrations of 
GST US11 (lanes 3-7). Complexes were resolved by electrophoresis on 
a 4% non-denaturing polyacrylamide gel and visualised by 
autoradiography.
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generated with 15ng/jLxl GST-US11 (lane 6). Incubation of the riboprobe with a higher 
concentration o f GST-US11 (25ng/pl) again results in a further increase in the 
retardation of the riboprobe (lane 7).
As seen with the A34 riboprobe, the 12/14 riboprobe migrated as a free, unbound probe 
in the absence of protein and in the presence of GST or 5ng/^l and 10ng/jL4,l 
concentrations of GST-USl 1 (Fig. 4.2B, lanes 1-4). In the presence of 15ng/pl GST- 
USl 1 the probe is retarded (lane 5). The retardation is increased in the presence of 
20ng/pl GST-USl 1 and even more so in the presence of 25ng/pl GST-USl 1 (lanes 6 
and 7).
This indicates that GST-USl 1 has a similar affinity for A34 and 12/14 RNA, both being 
bound at 15ng/(il GST-USl 1. As previously observed in the interaction between US11 
and RNA, the size of the RNA/ GST-US11 complexes increase in size as increasing 
amounts of GST-USl 1 are added, indicating that larger multimers are being formed.
4.3 The specificity of the 12/14 interaction with US11
To test the sequence specificity of the interaction between US 11 and the 12/14 probe, 
binding assays were performed with antisense transcripts of A34 and 12/14 and 
competition assays were performed in the presence of [32P]-labelled 12/14 RNA and 
unlabelled RNA.
To examine the sequence-specificity of the US 11-RNA interaction its binding of an 
antisense transcript of A34 (A34AS) was tested (Fig. 4.3A). 10,000cpm of A34 or 
A34AS riboprobe were incubated in the presence of 25ng/pl GST or 25ng/p,l GST-USl 1 
and the complexes resolved on a non-denaturing polyacrylamide gel. With GST both 
the A34 and the A34AS riboprobes migrate as free species (lanes 1 and 3). With the
116
ABound
probe
Free
probe
[r
Lane
Protein g  g
Probe A34 A34AS
B
Lane
[GST-USl 1] o 
(ng /p l)
Protein - GST
Probe
GST-USl 1 
-A3 4-----------
( i » « *
9 
0
GST
V
GST-USl 1
■12/14 AS-
t f
10 11 12 13 14
^  A? _____ J
Fig. 4.3: EMSA of US11 interaction with antisense RNA.
A: 10,000cpm of [32P]-labelled A34 (lanes 1 and 2) or A34AS 
riboprobe (lanes 3 and 4) were incubated with 25ng/pl GST (lane 
1 and 3) or 25ng/pl GST-USl l(lane 2 and 4). B: 10,000cpm of 
A34 (lanes 1-7) or 12/MAS (lanes 8-14) riboprobe were incubated 
in the absence of protein (lanes 1 and 8), or in the presence of 
25ng/pl GST (lane 2 and 9) or in the presence of increasing 
concentrations of GST-USl 1 (lanes 3-7 and 10-14). The 
complexes were resolved by electrophoresis on a 4% non­
denaturing polyacrylamide gel and visualised by autoradiography.
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addition of GST-USl 1 the A34 riboprobe is retarded in the gel indicating that a complex 
between GST-US11 and A34 has been formed (lane 2). However, when A34AS is 
incubated in the presence of GST-US11 no retardation of the riboprobe is observed. 
Therefore, under the conditions that permit GST-USl 1 to bind A34, GST-USl 1 cannot 
interact with the antisense transcript of A34.
To further examine the sequence-specificity of the US 11 interaction with RNA, its 
binding of a 12/14 antisense riboprobe (12/MAS) riboprobe was examined by EMSA 
(Fig. 4.3B). A34 RNA was used as a control for binding. The riboprobes were incubated 
in the absence of protein, or in the presence of 25ng/pl GST or increasing 
concentrations of GST-US11 (ranging from 5-25ng/pl). In the absence of protein, or in 
the presence of 5-10ng/pl of GST-USl 1, the A34 riboprobe migrates as a free species 
(lanes 1-4). In the presence of 15ng/pl GST-USl 1 a shift in the mobility of the probe is 
observed (lane 5). As demonstrated in Section 4.2, upon the addition of 20ng/pl GST- 
USl 1 the riboprobe is retarded further and even more so with the addition of 25ng/pl 
GST-USl 1 (lanes 6 and 7). In comparison, the incubation of 12/14AS in the absence of 
protein or with the addition of GST or 5ng/pl-20ng/pl GST-US11 produces no 
retardation of the riboprobe (lanes 8-13). At 25ng/pl GST-USl 1 a small shift is 
detectable (lane 14), but this is not of the order of magnitude seen with A34 RNA. 
Therefore, it would appear that at only at high concentrations of GST-USl 1 (25ng/pl), a 
small amount of binding of the 12/MAS riboprobe could be observed.
The sequence-specificity of 12/14 RNA binding was further assayed by competing non­
specific and specific RNA with US11. The principle of a competition assay is that a 
protein is incubated in the presence of a radiolabelled RNA probe and increasing 
concentrations of an unlabelled RNA. If a particular unlabelled RNA can bind to the
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same site on the protein it should displace the labelled probe which should run as free, 
unbound probe.
In the first instance yeast tRNA, a highly structured RNA, was competed against 12/14 
RNA for the binding of US11. US 11 was incubated in the presence of 3.3pM [32P]- 
labelled 12/14 riboprobe and increasing concentrations of unlabelled yeast tRNA (10-, 
100-, and 1000-fold molar excess) (Fig. 4.4A). In the absence of protein the 12/14 
riboprobe migrates as a free species (lane 1). In the presence of 10-fold molar excess 
tRNA and 333nM GST-USl 1 a shift in mobility is observed (lane 2). In the presence of 
100-fold molar excess tRNA no change in the GST-USl 1/12/14 riboprobe complex is 
observed (lane 3). Similarly, in the presence of 1000-fold molar excess tRNA no 
competition for the binding of US 11 is observed (lane 4). Therefore, a non-specific, 
highly structured RNA cannot compete with 12/14 RNA for the binding of US11.
To further characterise the binding of 12/14 RNA by US 11 the specific RNAs A34 and 
12/14 were assayed for competition.
3.3pM of [32P]-labelled 12/14 riboprobe was incubated in the absence of competitor 
probe or the presence of increasing amounts of unlabelled 12/14 riboprobe at a 10-, 100- 
and 1000-fold molar excess (Fig. 4.4B). When incubated without the addition of protein 
the riboprobe migrates as a free unbound species (lane 1). With the addition of GST, in 
this instance a slight decrease in the mobility of the riboprobe is observed (lane 2). The 
addition of 333nM GST-USl 1 causes the riboprobe to be significantly retarded (lane 3). 
When 10-fold molar excess unlabelled 12/14 RNA is included in the reaction no 
competition is observed (lane 4). At 100-fold molar excess of specific competitor RNA 
a decrease in complex mobility is observed (lane 5) and at 1000-fold molar excess 
complete dissociation is observed (lane 6). A decrease in complex size is apparent when 
100-fold molar excess unlabelled 12/14 RNA is used to compete off labelled 12/14
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Fig. 4.4: Competition assays.
A: 3.3pM of [32P] labelled 12/14 riboprobe was incubated in the absence of 
protein (lane 1), or with 333nM of GST-US11 (lanes 2-4), and with the 
addition of unlabelled yeast tRNA in 10- (lane 1 & 2), 100- (lane 3), and 
1000- (lane 4) fold molar excess of the labelled probe. B: 3.3pM of [32P]- 
labelled 12/14 riboprobe was incubated in the absence of protein (lane 1), 
with 500nM GST (lane 2) or with 333nM of GST-USl 1 (lanes 3-6), without 
the additional RNA (lane 3), or with the addition of unlabelled 12/14 RNA 
at 10- (lane 4), 100- (lane 5), and 1000- (lane 6) fold molar excess of the 
labelled probe. C: 3.3p.M of [32P]-labelled 12/14 riboprobe was incubated in 
the absence of protein (lane 1), with 500nM GST (lane 2) or with 333nM of 
GST-USl 1 (lanes 3-6), without addition of unlabelled RNA (lane 3), or with 
the addition of unlabelled A34 RNA at 10- (lane 4), 100- (lane 5), and 1000- 
(lane 6) fold molar excess of the labelled probe.The complexes were 
resolved by electrophoresis on a 4% non-denaturing polyacrylamide gel and 
visualised by phosphoimaging.
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RNA, and at 1000-fold molar excess complete dissociation of the labelled complex is 
observed. This indicates that there is a specific, saturable, RNA binding site within 
US 11 for the 12/14 RNA.
The addition of unlabelled A34 RNA as competitor for US 11 binding with 12/14 
labelled RNA gave a similar pattern (Fig. 4.4C). Without the addition of protein or the 
addition of GST the 12/14 riboprobe migrates as an unbound species (lanes 1 and 2). 
With the addition of 333nM GST-US11 the riboprobe is retarded (lane 3). The addition 
of 10-fold molar excess does not result in a change in the complex (lane 4). As with the 
competition with 12/14 RNA, a slight decrease in mobility seen at 100-fold molar 
excess (lane 5). Almost complete dissociation of the 12/14 riboprobe observed at 1000- 
fold molar excess cold A34 RNA (lane 6). As A34 RNA can compete with US11 for the 
binding by US 11, this would suggest that the 12/14 and the A34 RNA are bound by the 
same site in US11. The competition of the unlabelled A34 riboprobe with the [32P] - 
labelled 12/14 riboprobe is slightly less than that for the unlabelled 12/14 riboprobe. 
This may indicate that 12/14 RNA is a better substrate for binding than A34. However, 
12/14 did not appear to be a better substrate for binding when the effect of increasing 
GST-US11 concentrations were compared for each substrate (Section 4.2). A more 
likely explanation is that they do bind the same site in US11, but, given their lack of 
sequence similarity, they do not interact with exactly the same specific residues in 
US11.
The only published competition assay for a US 11-RNA interaction available for 
comparison is for the binding of the antisense transcript of the 5' UTR of US 11 (Roller 
& Roizman, 1990). When the binding of the antisense transcript of the US 11 5' UTR 
was competed against the same unlabelled transcript no competition was observed at 
100-fold molar excess competitor. Competition was seen at 300-fold molar excess. At
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this ratio, a decrease in the size of complex is observed. At 1000-fold molar excess the 
size of the complex decreases further, but the competition is by no means complete.
It is interesting to note that here and with the anti-sense 5' UTR of US11, rather than a 
gradual dissociation of the bound probe from the complex in the presence of unlabelled 
competitor RNA, there is a decrease in the mobility of the labelled RNA-GST-US11 
complex. This may indicate that US 11 existing in large multimers in complex with 
radiolabelled RNA can dissociate to complex with specific competitor RNA, forming 
smaller multimers.
4.4 The effect of salt concentration on the binding of the 12/14 RNA by US11
The effect of salt concentration on the binding of the 12/14 probe by US 11 was tested 
by increasing the NaCl or KC1 concentration in the binding reaction. The final 
concentration of KC1 in the binding reaction was tested at 50, 100, 200, 300, 400 and 
500mM (Fig. 4.5A). In the absence of protein or in the presence of GST, both the A34 
and the 12/14 riboprobe migrated as free, unbound species (lanes 1,2, 9 and 10). In the 
presence of GST-USl 1 a shift in mobility of A34 and the 12/14 riboprobe is observed 
(lanes 3 and 11). The shift in mobility of the A34 and the 12/14 riboprobes induced by 
GST-USl 1 are not decreased at KC1 concentrations of 100, 200, 300, 400 or 500mM 
(lanes 4-8 and 12-16). The binding of both the 12/14 probe and the A34 probe by US11 
did not appear to be effected at any of the KC1 concentrations tested.
The variation of the NaCl concentration, 50, 100, 200, 300, 400, and 500mM, was 
examined (Fig. 4.5B). In the absence of protein and in the presence of GST the A34 and 
the 12/14 riboprobes migrate as free species (lanes 1, 2, 9 and 10). The addition of GST- 
USl 1 causes a decrease in mobility of both riboprobes (lane 3 and 12). The addition of
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Fig. 4.5: EMSA of US11 binding of 12/14 and A34 RNA under 
different salt concentrations.
In vitro transcribed, [32P]-labelled A34 (lanes 1-8) or 12/14 RNA 
(lanes 9-16) were incubated without protein (lanes 1 and 9), with 
15ng/pl of GST (lanes 2 and 10) or with 15ng/pl of GST-USl 1 (lanes 
3-8 and 11-16). KC1 (A) and NaCl (B) concentrations were varied in 
each reaction, 50mM (lanes 1-3 and 9-11, lOOmM (lane 4 and 12), 
200mM (lanes 5 and 13), 300mM (lanes 6 and 14), 400mM (lanes 7 
and 15), and 500mM (lanes 8 and 16). The complexes were resolved 
by electrophoresis on a 4% non-denaturing polyacrylamide gel and 
visualised by autoradiography.
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lOOmM or 200mM NaCl does not appear to affect the mobility shift generated by GST- 
USl 1 (lanes 4, 5, 12 and 13). There appears be a slight increase the mobility of both 
riboprobes at 300mM and 400mM NaCl (lanes 6, 7, 14 and 15; the difference the 
intensity of the riboprobe in lane 14 is due to the under loading of the sample). But 
whether this is due to the aberrant running of samples due to the high salt concentrations 
or a genuine effect is unclear. Upon the addition of 500mM NaCl a small decrease in 
the retardation of the A34 riboprobe is observed (lane 8). A greater reduction in the 
retardation of 12/14 riboprobe is seen in the presence of 500mM NaCl (lane 16). Again, 
whether this is due to the aberrant running of samples at high salt concentrations or a 
genuine effect is unclear. In general the binding of both the A34 RNA and the 12/14 
RNA are not perturbed to any great extent in the presence of up to 500mM NaCl.
The binding of 12/14 and A34 RNA does not appear to be greatly perturbed by KC1 and 
NaCl concentrations. However, it appears that 500mM NaCl may affect RNA binding 
to some extent and influence 12/14 binding a little greater than that of A34 RNA. This 
may be a result of the disruption of ionic interactions between the protein and the RNA 
and the difference in the decrease of retardation of A34 RNA compared with 12/14 
RNA is slightly greater for the latter, perhaps reflecting the different specific 
interactions between RNA and the binding domain of US11. Alternatively, the decrease 
in complex size may be due to dissociation of US 11 homomultimers.
4.5 Mapping the US11 RNA binding site for 12/14 RNA
The RNA-binding domain of US 11 has been mapped to the C-terminal domain by 
Roller et al. (1996) and Schaerer-Uthurralt et al. (1998). The structure and properties of 
the C-terminal domain are discussed in detail in Chapter 1. In brief, the C-terminal
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domain of US 11 consists almost entirely of a tandemly repeated tripeptide, XRP, where 
X is any amino acid (Lonsdale et al., 1979; Rixon & McGeoch, 1984). The C-terminal 
domain of US 11 is predicted to form a poly-L-proline type II helix (PPII-helix), a 
flexible structure with three amino acids per turn (Roller et a l, 1996; Schaerer-Uthurralt 
et al, 1998)
In addition to full length GST-USl 1, Schaerer-Uthurralt et al (1998) also constructed 
several GST-USl 1 vectors in which US11 was truncated. Two vectors encoding N- and 
C-terminal domain deletions of the US 11 protein fused to a GST moiety, GST-USl 1 Al- 
84 (named 2540), and GST-USl 1A88-149 (named 2625), were provided by J-J Diaz 
and J-J Madjar. The GST-USl 1 truncations were expressed and purified as described in 
Chapter 3 and by Schaerer-Uthurralt et a l (1998). Fig. 4.6 shows a Coomassie stained 
SDS-PAGE gel of the purified GST-USl 1 truncated proteins.
To examine whether US 11 binds to the 12/14 RNA in a manner similar to that of the 
antisense transcript of the US 11 5' UTR, RRE, XRE and A34 RNAs, the binding of 
GST-US11 fusion proteins deleted in the N- or C-terminal domains were examined by 
EMSA (Fig. 4.7). Without the addition of protein or GST, the 12/14 RNA migrates as a 
free, unbound species (lanes 1 and 2). With the inclusion of full length GST-US11 the 
riboprobe displays a decrease in mobility (lane 3). In the presence of the C-terminal 
domain deletion mutant (GST-USl 1A88-149) the riboprobe migrates as a free species, 
indicating that this truncated protein cannot bind the RNA (lane 4). In contrast the N- 
terminal deletion mutant, GST-USl 1A1-84, is able to retard the probe (lane 5). This 
indicates that like the other RNA substrates of US11, 12/14 RNA is bound by the C- 
terminal domain of US 11.
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Fig. 4.6: Purification of GST-USl 1 Al-84 and GST-USl 1A88-149.
The GST-USl 1 deletion mutants, GST-USl 1 Al-84 and GST- 
USl 1A88-149 were expressed in E. coli BL21 cells. The GST-fusion 
proteins were isolated using glutathione-agarose. The GST-fusion 
proteins were eluted three times with reduced glutathione. Protein 
gel loading buffer was added to 20pl of each fraction and boiled for 
5min. The samples were separated by electrophoresis on a 12% 
SDS-PAGE gel and stained with Coomassie. Lanes 1-3 GST- 
USl 1A1 -84, elutions 1-3 respectively. Lanes 4-6 GST-USl 1A88- 
149, elutions 1-3 respectively.
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Fig. 4.7: Mapping of the US11 12/14 RNA binding domain 
by EMSA. 10,000cpm of the 12/14 riboprobe were incubated 
either without protein (lane l),with 25ng/pl of GST (lane 2) 
with 25ng/pl of GST-USl 1 (lane 3), with 25ng/pl of GST- 
USl 1A88-149 (lane 4), or with 25ng/pl of GST-USl 1 Al-84 
(lane 5). Complexes were resolved on a 4% non-denaturing 
acrylamide gel and visualised by autoradiography.
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4.6 The effect of increasing concentration of GST-USl 1 Al-84 on the binding of 12-
14 RNA
Both the RNA-binding activity and the ability to form homomultimers resides in the C- 
terminal domain (Schaerer-Uthurralt, et al., 1998). The ability of the N-terminal domain 
deletion mutant was therefore tested for the ability to multimerise in complex with the 
12/14 RNA (Fig. 4.8). The A34 and 12/14 riboprobes were incubated without protein or 
with the addition of 50ng/pl GST or GST-USl 1A1-84 at concentrations ranging from 
2.5ng/pl to 50ng/pl. Both riboprobes migrated as free, unbound species without the 
addition of protein and with GST alone (lanes 1, 2, 9 and 10). With as little as 2.5ng/pl 
GST-USl 1 Al-84 a very slight shift in the mobility of the A34 riboprobe was generated 
(lane 3). A34 was increasingly retarded with increasing concentrations of GST-USl 1 Al- 
84 (lane 4-8). The ability to multimerize was not affected by deletion of the N-terminal 
domain as demonstrated by the increase in complex size with increasing protein 
concentrations.
However, the generation of a mobility shift with GST-USl 1 Al-84 and the 12/14 
riboprobe required higher concentrations of protein. The 12/14 riboprobe migrated as a 
free, unbound species in the absence of protein or with the inclusion of GST (lane 9 and 
10). No mobility shift was observed at GST-USl 1A1-84 concentrations between 
2.5ng/pl and 12.5ng/pl (lane 11-13). In the presence of 25ng/pl GST-USl 1 Al-84 the 
12/14 riboprobe is retarded, and the retardation increased upon the addition of higher 
concentrations of protein indicating the formation of multimers (lane 14-16).
The affinity of the N-terminal domain for 12/14 RNA therefore appears to be less than 
that for A34 RNA.
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Fig. 4.8: EMSA of 12/14 and A34 RNA incubated with increasing 
concentrations of GST-USl 1 Al-84.
10,000cpm of the A34 (lanes 1-8) or the 12/14 (9-16) riboprobe were 
incubated either without protein (lanes 1 and 9), with 50ng/pg GST 
(lanes 2 and 10) or with increasing concentrations of GST-USl 1 Al-84 
(lanes 3-8 and 11-16). Complexes were resolved by electrophoresis on 
a 4% non-denaturing polyacrylamide gel and visualised by 
autoradiography.
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12/14 riboprobe is retarded, and the retardation increased upon the addition of higher 
concentrations of protein indicating the formation of multimers (lane 14-16).
The affinity of the C-terminal domain for 12/14 RNA therefore appears to be less than 
that for A34 RNA.
4.7 Discussion and summary of results
This chapter deals with the in vitro analysis of the US 11-12/14 RNA interaction. It 
confirms that US 11 can interact with a fragment derived from HSV-1 which encodes 
the entire 5' UTR of UL12 and the 5' end of the UL12 ORF, the 31 UTR and coding 
region of UL13 and the 3' UTR of UL14. This binding is sequence-specific in that it can 
be competed off with the specific competitors 12/14 and A34 RNA, but not with tRNA 
and US 11 does not bind an antisense transcript of A34 and displays a low affinity for 
antisense 12/14 RNA.
Roller et al. (1996) and Schaerer-Uthurralt et al (1998) have mapped the RNA binding 
domain of US 11 to the C-terminal XRP repeat domain for the XRE, RRE, A34 and anti­
sense US11 5' UTR RNAs. 12/14 RNA is also bound by the C-terminal domain of 
US11.
It is interesting to note deletion of the N-terminal domain of US 11 causes 12/14 RNA to 
be bound with less affinity than A34 RNA, indicating that they are not bound in exactly 
the same way by US11. This difference may be explained if that deletion of the N- 
terminal domain causes the C-terminal domain to adopt a less favourable structure for 
the binding of 12/14 RNA. Alternatively, the binding of 12/14 RNA may be stabilized 
by interacting with residues in the N-terminal domain, whereas A34 binding is 
independent of this domain.
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5.0 The mapping of the RNA-binding site for US11 in 12/14 
RNA
This Chapter deals with the in vitro deletion mapping of the binding site in the 12/14 
RNA. This work illustrates the potential problems of mapping RNA binding sites by 
deletion, namely, that deletion of sequences outlying the binding site may lead to 
structural re-arrangement of the RNA, making the interpretation of such data difficult.
5.1 Mapping of the US11 binding site in the 12/14 RNA
In order to map the site of US 11 interaction with the 12/14 RNA, templates were 
constructed with sequential 5' deletions. The templates were constructed by PCR 
amplification and incorporation of a T7 promoter 5' to the sequence to be transcribed in 
vitro (Fig.5.1A).
GST or GST-US 11 was incubated with one of seven [32P]-labelled in vitro transcribed 
RNA probes (Fig.5.1B). When incubated with the A34 riboprobe or the 12/14 
riboprobe, a mobility shift was generated by the inclusion of GST-USl 1 (lanes 2 and 4) 
but not with GST alone (lanes 1 and 3). Deletion of 80 nucleotides from the 5' end of 
the 12/14 RNA (riboprobe 1/6) did not negate binding of US 11, the probe being 
retarded by the addition of GST-USl 1 (lanes 5 and 6). Deletion of 162 nucleotides from 
the 5' end of the 12/14 RNA (riboprobe 2/6) lead to a slight decrease in incorporation 
into a complex with GST-US 11 to retard the probe in EMSA, but it did retain 
significant binding activity (lanes 7 and 8). However, the loss of 247 nucleotides from 
the 5' end of 12/14 RNA (riboprobe 3/6) resulted in a severe decrease in binding (lanes
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Fig. 5.1: Mapping of the US11 RNA binding site of US11 in 12/14 RNA.
A: At the top of the diagram the UL12, UL13 and UL14 RNA regions represented in the 
12/14 riboprobe are indicated, a black dot indicates the 5' end of UL12 mRNA, a line 
represents an UTR and a green box an ORF. Below is a schematic diagram of the 
riboprobes used to map the RNA binding site of US11. The position of the UL12 mRNA 
initiation start is indicated by an arrow, the UL13 translational stop codon and the UL12 
translation initiation start codon, AUG are indicated on the 12/14 RNA. The 
incorporation of a particular riboprobe into a complex with GST-USl 1 as indicated by 
an increase in mobility of the probe is indicated by + in panel A and non-binding 
riboprobes are indicated by a -. B: 25ng/pl of either GST (lanes 1, 3, 5, 7, 9, 11 and 13) 
or 25ng/pl GST-USl 1 (lanes 2, 4, 6, 8, 10, 12, and 14) were incubated in the presence of 
A34 (lanes land 2) or 12/14 (lanes 3 and 4) riboprobes or with riboprobes with 
successive deletions from the 5' end of the 12/14 RNA; riboprobes 1/6 (lanes 5 and 6), 
2/6 (lanes 7 and 8), 3/6 (lanes 9 and 10), 4/6 (lanes 11 and 12) and 5/6 (lanes 13 and 14). 
Complexes were resolved by electrophoresis on a 4% non-denaturing polyacrylamide gel 
and visualised by autoradiography.
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9 and 10). Consistently, with this probe, a faint smear was seen above the free probe in 
the presence of GST-USl 1, indicting that there may be some binding occuring. GST- 
USl 1 could not retard a riboprobe with 375 (riboprobe 4/6) or 464 nucleotides deleted 
from the 12/14 RNA in EMSA (lanes 11-14).
From this it can be concluded that deletion of up to 162 nucleotides from the 51 end of 
the 12/14 RNA does not have a major impact on US 11 binding. Deletion of a further 85 
nucleotides results in a severe decrease in binding, indicating that this region may be 
important in the interaction between US 11 and the 12/14 RNA. Deletion of a further 
127 nucleotides completely abolished binding.
The site of US11 binding was mapped further by the construction of templates for the in 
vitro transcription of two regions of the 12/14 RNA (Fig. 5.2A). Both probes lacked the 
5' 162 nucleotides, the deletion of which does not fully negate the interaction between 
US11 and the 12/14 RNA. The riboprobes were additionally deleted from the 3' end of 
the 12/14 RNA. Riboprobe 2-5 had 100 nucleotides deleted from the 3' end and the 2-4 
riboprobe 191 nucleotides deleted from the 3' end. GST or GST-US 11 were incubated 
with either 10,000 cpm of the 12/14, 2-5 or 2-4 riboprobe and binding assayed by 
EMSA (Fig. 5.2B). As expected, the 12/14 riboprobe was retarded by GST-USl 1, but 
not by GST (lanes 1 and 2). Both the 2-5 and 2-4 riboprobes were retarded by the 
addition of GST-US 11 and not GST, indicating that they contain a binding site for 
US11 (lanes 3-6). Therefore, deletion of 162 nucleotides from the 5' end and 191 
nucleotides from the 3’ end of the 12/14 RNA does not appear to negate US11 binding. 
This indicates that these regions are not absolutely required for US 11 binding and that 
the binding site for US 11 is contained within a 232 nucleotide portion of the 12/14 
RNA.
When compared to the RNAs encoded by this region, the US 11 binding site maps
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Fig. 5.2: Further mapping of the RNA binding site of US11 within thel2/14 
RNA.
A: At the top of the diagram the UL12, UL13 and UL14 RNA regions represented 
in the 12/14 riboprobe are indicated, a black dot indicates the position of the UL12 
mRNA 5' end, a line represents an UTR and a green box an ORF. A red dashed 
line hightlights the region of these mRNAs corresponding to the 2-4 riboprobe. 
Below a schematic diagram of the deletions. The position of the UL12 mRNA 
initiation start is indicated by an arrow, the UL13 translational stop codon and the 
UL12 translation initiation start codon, AUG are indicated on the 12/14 RNA. B: 
25ng/pl GST (lanes 1, 3 and 5) or 25ng/pl GST-USl 1 (lanes 2, 4 and 6) was 
incubated in the presence of either the 12/14 riboprobe (lanes 1 and 2) or with a 
riboprobe with 162nt deleted from the 5' end and lOOnt from the 3' end of the 
12/14 probe (named 2-5) (lanes 3 and 4), or 162nt deleted from the 5' end and 
191 nt from the 3' end of the 12/14 probe (named 2-4) (lanes 5 and 6). Complexes 
were resolved by electrophoresis on a 4% native polyacrylamide gel and visualised 
by autoradiography.
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within the 3’ UTR of the UL14 mRNA, 225nt of the 3' ORF and 7 nt of the 3' UTR of 
the UL13 gene and 108nt of the UL12 5' UTR (Fig 5.2A).
5.2 Secondary RNA structure of the 2-4 RNA
The complex formation between the 2-4 riboprobe and US 11 was investigated further 
for the following reasons; the purified 2-4 riboprobe migrated as two species in non­
denaturing gel electrophoresis and 2-4/GST-US11 complexes migrated as two species 
in EMSA. This is illustrated in Fig. 5.3. With GST alone, the 2-4 riboprobe migrates as 
two species, labeled A and B (in order of fastest migrating) (lane 1). When incubated 
with GST-USl 1, the intensity of species A is decreased and species B is absence and 
two bound complexes are observed, labelled C and D (in order of the fastest migrating) 
(lane 2). This raises the question of whether the two unbound species represent 
alternative structures formed by the 2-4 riboprobe and whether the two bound species 
represent these alternative structures in complex with US11.
To examine whether these extra bands result from the formation of alternative 
secondary structures, the 2-4 riboprobe was purified on a denaturing polyacrylamide gel 
one band was excised, eluted and electrophoresed on a non-denaturing gel (Fig. 5.4). In 
non-denaturing gel electrophoresis the ribo probe migrated as two species. Extraction of 
the two species from the non-denaturing gel and subsequent electrophoresis of these 
species on a denaturing gel revealed that they migrated to the same position on the gel. 
It was therefore concluded that these species represent different structures adopted by 
the 2-4 riboprobe. An alternative explaination may be that the faster migrating species 
(A) represents monomeric RNA, whereas the slower migrating species (B) represents 
RNA dimers.
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Fig. 5.3: EMSA of the interaction between the 2-4 species and US11.
The 2-4 riboprobe was incubated in the presence of 25ng/pl of GST (lane 
1) or 25ng/pl of GST-USl 1 (lane 2). The positions of multiple unbound 
secondary structures formed by the 2-4 riboprobe are indicated by arrows 
labelled A and B. The positions of multiple bound secondary structures 
formed by the 2-4 riboprobe in complex with US 11 are indicated by 
arrows labelled C and D. The complexes were resolved by electrophoresis 
on a 4% non-denaturing polyacrylamide gel and visualised by 
autoradiography.
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Fig. 5.4: Investigation of the 2-4 riboprobe to form alternative 
secondary structures in vitro.
The 2-4 template was transcribed in vitro in the presence of [a- 
32P] UTP and electrophoresised on a 6% denaturing gel and 
visualised by autoradiography (left-hand panel). The band (boxed) 
was excised, and the RNA eluted. 5 x 106cpm of the probe was 
separated on a 4% non-denaturing gel, exposed to X-Omat film, 
the two species, A and B were excised (boxed bands) and eluted 
(central panel). 20,000cpm of species A and B were separated on 
a 6% denaturing gel and visualised by autoradiography (right- 
hand panel).
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5.3 Differential binding of the 2-4 RNA secondary structures bv GST-USl 1
To characterise the interaction between GST-USl 1 and the different 2-4 RNA structures 
and try to deduce whether the different RNA structures contribute to the different 
shifted complexes, increasing amounts of GST-US 11 were incubated with a [32P]- 
labelled in vitro transcribed 2-4 riboprobe and the complexes examined by EMSA (Fig. 
5.5).
10,000cpm of the 2-4 riboprobe was incubated in the absence of protein or with 
130ng/pl GST, or with GST-USl 1 from 4.5ng/pg to 130ng/pg. In the absence of 
protein, or with GST or concentrations up to 9ng/pg GST-USl 1, both probes migrated 
the two species of free, unbound probe, A and B. In the presence of 20ng/pg GST-USl 1 
a shift of the 12/14 RNA species B (the slowest migrating free species) is generated, 
leading to the formation of complex D. Increasing concentrations of GST-USl 1 lead to 
the further retardation of the complexes in the gel, indicating that multimerization is 
occurring. The intensity of the unbound species A (the fastest migrating free species) 
does not decrease until a concentration of 55ng/pg GST-US 11 and at this concentration 
the retarded complex C is seen. Therefore, complex C appears to be formed from the 
association of GST-US 11 with species A. This complex is further retarded in the 
presence of increasing concentrations of GST-USl 1. However, even at high 
concentrations of GST-USl 1, species A is never completely bound.
From this it can be postulated that GST-USl 1 binds 2-4 species B with a higher affinity 
than species A, leading to the formation of complex . GST-US 11 has a much lower 
affinity for species A, so much so that it is probably a non-specific interaction. The 
binding of species A leads to the formation of complex C.
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Fig. 5.5: Investigation of the differential binding of the 2-4 
secondary structures by US11 by EMSA.
The 2-4 riboprobe was incubated in the absence of protein 
(lane 1), the presence of 130ng/pl of GST (lane 2) or with 
increasing concentrations of GST-USl 1 (lanes 3-11). The 
positions of multiple unbound secondary structures formed by 
the 2-4 riboprobe are indicated by arrows labelled A and B. 
The positions of multiple bound secondary structures formed 
by the 2-4 riboprobe in complex with US 11 are indicated by 
brackets labelled C and D. The complexes were resolved by 
electrophoresis on a 4% non-denaturing polyacrylamide gel 
and visualised by autoradiography.
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To investigate this interaction more thoroughly the interaction of 2-4 and GST-US 11 
was assayed using dot blotting. For the dot blot assay, Hybond-C nitrocellulose 
membrane is place in dot blot apparatus and the protein-riboprobe reaction mixture is 
applied to the membrane and a vacuum applied. The protein is immobilized on the 
membrane, but RNA can pass through if not in complex with the protein. The 
complexes are washed to remove unbound probe. The radioactivity captured on the 
membrane can be assayed by the excision of the regions to which the complexes were 
applied, followed by quantification by scintillation counting. Reasoning behind using 
this method to assay the interaction between US 11 and 2-4 RNA is that weaker 
complexes may become dissociated during electrophoresis or electrophoresis itself lead 
to the formation of these secondary structures.
The dot blot procedure was carried out with increasing concentrations of GST-US 11 
from 4.5ng/pg to 130ng/pg and a graph of protein concentration verses percentage 
binding was plotted (Fig. 5.6). Binding of 2-4 RNA increases between GST-USl 1 
concentrations of 9ng/pg and 55ng/pg, levels off between 55ng/pg and lOOng/pg and 
begins to rise to the last point (130ng/pg). The maximum mean binding of the 2-4 RNA 
is 26.35% of the total probe present at the highest protein concentration used. 
Speculating about the nature of the binding in the dot blot assay, the first initial binding 
phase may represent the binding of species B, the higher affinity binder. The phase 
where that binding tails off may represent the binding of species A. However, as the 
complexes cannot be visualised the binding in this assay may not precisely reflect that 
seen in EMSA.
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Fig. 5.6: Investigation of GST-USl 1 binding of 2-4 RNA by dot blot 
analysis.
The amount of 2-4 bound is expressed as a percentage of the total input 
riboprobe after the value for GST-binding is subtracted. Standard deviation 
is represented by the vertical bars, n=6.
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5.5 Secondary structural modelling of 2-4 RNA
To examine the secondary structure dependent interaction of US 11 with the 2-4 RNA 
the RNA folding programme designed by Zucker, m-fold (Jaeger et al., 1989a & b; 
Zucker 1989; Zucker et al 1999 & Mathews et al. 1999; http:// www.rpi.edu/~mfold/) /  
was used. Here this programme is used, not as a means of deducing the actual secondary 
structure, but as a model for the structural consequences of deleting sequences that flank 
the binding site in RNA.
The most stable predicted secondary structure for the 12/14 RNA (AG= -210.8) is 
shown in Fig. 5.1 A. This predicted structure consists of approximately 17 stem 
structures which incorporate loops and bulges and have been labelled on the diagram 
(Stem I-XVII). The 232 nucleotide portion, 2-4, mapped as a binding site for US11, 
consists of one strand of stem VII, stems VIII-XII and approximately two thirds of stem 
XIII and is highlighted on the diagram.
The most stable structure predicted for the 2-4 RNA (AG= -79.6) consists of one long 
stem with loop and bulges and a small stem loop structure (Fig. 5.7C). This structure 
(named 2-4.1) appears to have little relationship with the predicted structure for the 
same region in 12/14 RNA. However, a predicted secondary structure which conserves 
some of the features seen in the predicted structure of 12/14 RNA is less energetically 
favourable, with a AG of -72.07. This structure, named 2-4.2, is depicted in Fig. 5.7D. 
This structure possesses seven stem structures with loops and bulges. In this structure, 
although much of the base pairing has been disrupted, stems VIII-XI observed in the 
predicted structure for 12/14 are maintained. This region is highlighted in both 
structures and is expanded in Fig. 5.7B. From this it can be seen that a region of
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Chapter 5 Results
secondary structure of 93 nucleotides is maintained in 2-4.2 whereas no regions of great 
length are maintained in 2-4.1.
Although secondary structure modelling for RNA cannot be relied upon to give accurate 
predictions, do not take into account tertiary structural and are by no means any 
substitute for structure probing, they can be used to speculate on what is happening in 
vitro. Assuming that the predicted secondary structure 2-4.1 is equivalent to species A 
and 2-4.2 is equivalent to species B observed in EMSAs, in that A possesses little 
secondary structure similarities to 12/14 RNA, whereas B maintains certain key 
structural features, it may be argued that US 11 would have a much higher affinity for 
species B than for species A. In addition, predicted structure 2-4.1 is more stable than 2- 
4.2, and therefore would represent a much higher fraction of the secondary structure 
species seen in vitro. Species A is the major species observed in EMSA.
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5.6 Summary and Discussion
The binding site for US11 in the 12/14 RNA has been mapped to a 232nt sequence 
which lies within the 3'UTR of UL14 mRNA, within 225nt of the 3' ORF and 7nt 
within the 3' UTR of UL13 mRNA and 108nt of the 5'UTR of UL14 mRNA (Fig 5.2A). 
US11 could therefore potentially bind to and influence the expression of either or all of 
these mRNAs during infection.
When the 232nt portion (2-4 RNA) was tested for binding, the riboprobe migrated as 
two species, which were demonstrated to represent alternative RNA structures. The 2-4 
RNA species bound US 11 with differing affinities. The slowest migrating species 
bound US11 with higher affinity that the fastest migrating species, demonstrating that in 
this case RNA structure may play an important role in binding. The antisense transcript 
of the US 11 5' UTR has been shown to bind US 11 in a secondary structure dependent 
manner (Roller & Roizman, 1990). As the RNAs to which US11 binds are so different 
in their primary sequence it may be inferred that US 11 binding is directed towards 
certain structural motifs.
The structure of RNA can be influenced by ionic and pH changes (Shiman & Draper, 
2000; Zhai et al., 2001). It would be interesting to examine the affect of salt 
concentration or pH on the structure of the 2-4 riboprobe and the antisense US 11 5' 
UTR, to determine whether conditions where the binding RNA structure , B, 
predominates.
Secondary structure modelling was performed on the 12/14 and the 2-4 RNA to help 
determine what may underlie the secondary structure dependent binding of US11. The 
12/14 RNA predicted secondary structure consisted of approximately 17 stems with
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loop and bulges. The most favourable predicted structure for the 2-4 RNA (named 2- 
4.1) did not possess any significant resemblance to the corresponding region of 12/14 
RNA. A less energetically favourable structure (named 2-4.2) did however maintain a 
93nt portion which is found in the predicted structure of 12/14 RNA. Although this 
modelling cannot be guaranteed to reflect the true nature of RNA folding in vitro, 
especially for larger RNA structures, it is therefore used to illustrate the point, namely, 
that truncation of RNA can lead to a gross re-arrangement of the secondary structure 
which may have implications in its interaction with proteins. This highlights the 
potential pitfalls of mapping protein binding sites on RNA using deletion mutants. The 
lack of binding of a protein to a particular truncated RNA may not be due to the 
abolition of the binding site but rather a structural re-arrangement of the RNA itself.
An example which illustrates how deletion of flanking RNA sequences have lead to 
structural re-organisation of the RNA is provided by the RRE of HIV-1. Originally it 
was thought that the RRE was 234nt in length, and its secondary structure was defined 
by prediction programmes and confirmed by structure probing (Kjems et al., 1991). 
This secondary structure consisted of five stem-loop structures. However, as the 234nt 
sequence only conferred 50-80% of the export activity of env RNA in the presence of 
Rev, Mann et al (1994) examined the outlying sequences to see if they contributed to 
Rev binding. When the RRE was extended by 58nt at the 5' end and 59nt at the 3' end 
the secondary structure adopted was similar to some extent, but stems III and IV now 
base paired to give a single stem and stem I was elongated significantly. The elongation 
of stem I caused Rev to bind with a higher affinity, to multimerize on the RNA more 
efficiently and to be more effective on promoting the export of the RRE.
This highlights the problems inherent in the analysis of RNA-protein interactions in 
vitro, namely, taking a small fraction of the full length sequence and expecting it to
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maintain the same secondary structure as when within the context of its native RNA. 
When we consider the binding of US11, a protein whose binding has already been 
shown to be somewhat dependent on RNA secondary structure, to either UL12 (2.3kb), 
UL13 (3.9kb), or UL14 (4.5kb) mRNA it must be accounted for that even 12/14 (585nt) 
represents a small proportion of the native mRNA, and 2-4 RNA (232nt) even more so.
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6.0 The influence of US11 on UL12, UL13 and UL14 
expression.
In previous chapters US 11 has been shown able to bind in vitro, a sequence found 
within three 3' co-terminal RNAs, UL12, UL13 and UL14. US11 may therefore have 
the potential to bind to one or more of these transcripts during infection. The UL12 gene 
encodes alkaline nuclease (McGeoch et al., 1986), a DNase which can act as both 
exonuclease and endonuclease. UL12 is expressed with early gene kinetics and is 
thought to be involved in the packaging of DNA and/or the resolution of brached DNA ^  
structures formed during replication (Weller et al., 1990). UL13 encodes a protein 
kinase, which is expressed with late gene kinetics and has been implicated in the 
phosphorylation of a variety of viral and cellular factors (Cunningham et al., 1992). 
UL14 encodes a nuclear phosphoprotein which is expressed with late gene kinetics and 
is incorporated into the virion (Cunningham et al, 2000). Its function during infection is 
as yet unknown. To investigate whether an interaction of US 11 with RNA derived from 
this region has any significance in infected cells, the levels of the UL12, UL13 and 
UL14 proteins and RNAs were examined.
6.1 Expression of UL12. UL13 and UL14 proteins
To examine whether US 11 has any influence on the expression of UL12, UL13 and 
UL14, the levels of these proteins were compared in cells infected with wt virus and a 
virus in which the expression of US 11 protein has been knocked out by deletion of the 
first methionine ATG.
Antibodies suitable for Western blotting for UL12 and UL14 were available, but for
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UL13, the antibody available could only be used in immunoprecipitation. HeLa cells 
were mock infected or infected with either the wt or US11' virus at an moi of 10 pfu/cell 
and metabolically labelled. The cells were harvested at 3, 6, 12pi. UL12 and UL14 
expression was examined by Western blot analysis (Fig. 6.1 A & B) and UL13 levels 
were assayed by immunoprecipitation of the labelled protein (Fig. 6.1C). UL12 
expression can be observed at 3h pi. There is no detectable difference in UL12 
expression between the wt virus and the US 11* virus infected cells at any time point. 
UL14 can be visualised at 6h pi. Again, there does not appear to be a difference in the 
levels of expression of UL14 at any time point taken. UL13 can be seen at 3h pi., in the 
wt infected cells, UL13 levels are reduced compared to that of the US 11* virus at 3 and 
6h pi. At 12h pi, however, the amount of UL13 immunoprecipitated from wt and the 
mutant virus are the similar. Therefore, US11 does not appear to affect UL12 and UL14 
expression, but seems to down-regulate the expression of UL13 at early times pi. 
However, as immunoprecipitation is generally not a reliable method for protein 
quantification, an antibody which could detect UL13 in Western blot analysis was 
sought.
A rabbit polyclonal antibody raised against HSV-2 UL13 protein kinase was obtained. 
This antibody displayed a very high background reactivity. But conditions were found 
at which a band migrating at the expected position of UL13 (57kDa) which cross-reacts 
with the antibody was detected. HeLa cells were mock infected, or infected with wild 
type virus or the US 11* virus and infection allowed to proceed for 6h. The levels of 
UL12, UL14 and UL13 were examined by Western blot analysis (Fig. 6.2). With both 
viruses the levels of UL12 and UL14 are similar. However, for UL13, a band is seen in 
US11* infected cell lysates, but not in lysates of cells infected with wt.
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Fig .6.1: Expression of UL12, UL13 and UL14 proteins.
HeLa cells were either mock infected (M) or infected with wild- 
type virus (wt) or with a US 11' (11') virus at a moi of 10 and 
metabolically labelled with [35S]-methionine. The cells were 
harvested at 3, 6 or 12 pi. Proteins were separated on a 12% 
SDS-PAGE gel and Western blotted. Panel A: The membrane 
was probed with 1/1000 dilution of an anti-UL12 mAb. Panel 
B: The membrane was probed with 1/500 dilution of an anti- 
UL14 pAb. Panel C: To determined the levels of UL13 
expression UL13 was immunoprecipitated from cell extracts 
and separated on a 10% SDS-PAGE gel.
Bh m
m  wt i r M wt 11
M wt 11
6.2: Western blot analysis of the expression of UL12, UL13 
and UL14 protein expression.
HeLa cells were mock infected (M) or infected with wild- 
type virus (wt) or with a US1 l ' ( l  1') virus at a moi of 10. The 
cells were harvested at 6h pi and the lysates separated on a 
12% SDS-PAGE gel and Western blotted. UL12 (panel A) 
and UL14 (panel B) were detected as before. For the detection 
of U L13 the pAb was incubated with Hybond-C membrane at 
a dilution of 1/50 for lh at RT to remove some of the 
background reactivity, before being used to probe the Western 
blot (panel C).
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It would appear that US 11 can regulate the expression of UL13 at early times post­
infection, but does not affect its levels later in infection. US 11 does not have any 
influence on the expression of UL14 or UL12 proteins under the conditions examined 
here.
6.2 Examination of UL12. UL13 and UL14 RNA levels in infected cells
As US 11 has been shown to bind an RNA sequence present in UL13 mRNA and can 
down-regulate the accumulation of UL13 at 6h pi, it is reasonable to assume that US 11 
may be acting at the RNA level to influence the expression of the protein.
UL12, UL13 and UL14 RNA levels were examined in HeLa cells infected with wt virus 
or the US 11' virus at 6h pi. Total cellular RNA was extracted and examined by 
Northern blot. The Northern blot was probed with a radiolabelled DNA probe capable 
of hybridizing to UL12, UL13 and UL14 mRNAs (Fig. 6.3).
Three bands were detected corresponding to the mRNAs of UL14 (4.5kb), UL13 
(3.9kb) and UL12 (2.3kb). Comparing the levels of these three RNAs in wt and the 
USl l '  virus infected cells, UL14 and UL12 mRNAs are equal in intensity, whereas 
UL13 RNA is significantly reduced in the wt virus compared to the US11" virus.
Thus in the absence of US 11, there is an elevation in the levels of UL13 mRNA at 6h pi 
and this suggests that the increase in UL13 protein levels is due to a increase in the 
levels of its mRNA.
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Fig. 6.3: Northern blot of the expression of UL12, UL13 and UL14 
RNAs. Hela cells were infected with either wild type virus (wt) or with 
a US11' (11') virus at an moi of 10. Total RNA was harvested at 6h pi. 
lOpg of RNA was separated on a 1.2% agarose formaldehyde gel and 
Northern blotted. The blot was probed with a [32P]-labelled 1.6kb Sphl 
fragment of the EcoRl D fragment of HSV-1, which includes the UL12- 
UL14 region. The membrane was stripped and re-probed with a [32P]- 
labelled 840bp fragment of y-actin. The hybridizing RNAs were 
visualised by autoradiography. The positions of UL12, UL13 and UL14 
are indicated.
Size (Kb)
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6.3 Summary and discussion
Examination of UL12, UL13 and UL14 protein levels in a US 11' virus revealed that 
UL13 levels are elevated at 3 and 6h pi compared to wild type virus, whereas UL12 and 
UL14 protein levels are unaffected. At 12h, however, the levels of UL13 are not 
significantly affected by the absence of US11, suggesting that US 11 no longer plays a 
role in the regulation of its expression. The mechanism for the down-regulation of 
UL13 by US 11 is most probably due to down-regulation of its mRNA, as UL13 mRNA 
is elevated in the US 11' virus infected cells. UL12 and UL14 mRNA levels are 
unaffected by US11, this too being reflected in their protein levels.
The RNA binding site has been mapped to a 232nt sequence which lies within the 3' 
UTR of UL14, encompasses 228nt of the 3' UTR and 7nt of the 3' UTR of UL13 and 
includes 108nt of the UL12 5' ORF. US11 could therefore influence the expression of 
any or all of these genes. The differing affect on the expression of these mRNAs may 
reflect a context-dependent effect, differing RNA structures or different factors which 
assemble on these elements, all of which are discussed in Chapter 7.
The influence of US11 on the expression of UL12, UL13 and UL14 mRNA and protein 
in infected cells has only been examined preliminarily here. Certainly, there are many 
further avenues to explore, such as the affect of moi and cell type on this phenomenon.
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Chapter 7: General Discussion
7.1 Summary of work and outline of discussion
The aim of this project was to identify novel RNAs that interact with US11 in HSV-1 
infected cells. This goal was achieved by the design of a RT-PCR protocol which 
allowed the cloning of a RNA sequence that interacted with US11. The RNA, 
homologous to a region contained within a family of three 3' co-terminal HSV-1 
mRNAs, UL12, UL13 and UL14, was identified as a potential substrate for US11. This 
interaction was authenticated in vitro and in infected cells. The US11 binding site was 
mapped to a 232nt portion which maps within the 3' UTR of UL14, 225nt of 3' ORF 
and 7nt of 3' UTR of UL13, and the 108nt of the 5' UTR of UL12 mRNA (Fig. 5.2). 
Examination of the levels of UL12, UL13 and UL14 mRNAs and proteins in infected 
cells revealed that although UL12 and UL14 were unaffected by the presence of US11, 
UL13 was down regulated by this protein at early times post-infection.
The first section of this discussion examines the current methods available for the 
identification of RNAs which interact with a particular protein of interest. The second 
section deals with the interaction between US11 and UL13 mRNA with reference to its 
other known RNA substrates and functions, and the possible implications of such an 
interaction.
7.2 Isolation and identification of RNAs that interact with specific proteins
There are three methods available for identifying novel RNAs which interact with a 
particular protein of interest, SELEX, the yeast three-hybrid system, and several
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variations on RT-PCR based protocols which allow the amplification and identification 
of RNAs that interact with the protein of interest. These methods have been described in 
Chapter 1. This section compares these methods with SI RT-PCR and evaluates their 
potential application for the study of US 11-RNA interactions.
7.2.1 SELEX
The principle of SELEX is the enrichment of a pool of randomised synthetic RNA 
sequences, which are competed against one another for binding by protein, for high 
affinity binders by successive rounds of protein binding followed by RT-PCR and 
transcription. The products are then identified by cloning and sequencing.
The major advantage of SELEX is that no assumptions are made with respect to the 
RNA sequences tested and it allows a large amount of sequences to be screened. The 
identification of interacting RNAs is merely based on their relative binding affinities for 
the protein. Never the less, the RNA species identified rely on the quality of the 
randomised pool and may share little similarity to the in vivo targets of the protein.
It may be potentially interesting to perform SELEX using US11. The RNA binding 
domain of US 11 is highly unusual in its nature, bearing the tandemly repeated XRP 
motif. Also, as its substrates appear to have little sequence similarity, it would be 
potentially interesting to see if a preferred binding sequence emerged in the enriched 
RNAs. However, the RNA binding sequences for US 11 which have been mapped 
extensively, that of the antisense transcript of the 5' UTR of US 11 and the A34 RNA, 
are relatively large, 87nt and 264nt, respectively. The SELEX procedure rarely uses 
randomised RNA sequences of over 40nt, generally because this is sufficient for protein 
binding, but also because of the expense of the synthesis of the randomised templates
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for transcription. The sequence information gained from using 40nt randomised RNA 
sequences in a SELEX procedure with US 11 may, therefore, not reflect its natural in 
vivo targets.
It is conceivable that the randomised nucleotide sequences used in SELEX could be 
replaced by a genomic or cDNA library. In this way potential in vivo targets could be 
identified. Such a system could be used to identify RNA ligands for US 11 by using a 
HSV-1 infected cell cDNA library, and it would be interesting to compare the ligands 
produced from such a screening method with the SI RT-PCR method used in this study.
7.2.2 The Yeast Three-hybrid system
The yeast three-hybrid system allows the interaction between a protein and RNA to be 
assayed by the activation of transcription of a reporter gene in yeast. The three 
components of this assay are: (1) the protein of interest fused to a DNA binding domain 
of a transcriptional transactivator protein; (2) a RNA fused to MS2 RNA; (3) the 
activation domain of a transactivator fused to the MS2 coat protein. The interaction of 
the protein with the RNA is assayed by the ability of the protein to bind the RNA thus 
bringing the transcriptional activation domain in close proximity to the promoter 
stimulate transcription of a reporter gene. In general, either proteins suspected of 
interacting with a particular RNA or cDNA libraries are fused to the activation domain. 
However, the fusion a cDNA library to the MS2 transcripts could allow RNAs to be 
screened against a known protein target. Such a system has some major advantages over 
the SI-PCR based procedure described here. Firstly, US 11 may be modified by post- 
translational modifications, which may influence the binding of US 11 to its target 
RNAs. Expression in yeast would allow such modifications to occur, whereas
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bacterially expressing GST-US11 is presumably unmodified. Secondly, the sequence 
bias that is introduced in RT-PCR, leading the amplification of some RNAs over others 
present in the pull down. This not a factor in the yeast based system, however, the 
quality of the library may be a factor.
7.2.3 RT-PCR based methods
Recently, three RT-PCR based methods designed to identify RNA that interact with a 
particular protein of interest have been described. These methods are discussed and 
compared with those used here.
Brooks & Rigby (2000) used immunoprecipitation of hnRNP A2 with RNA, coupled 
with poly(A)-dependent RT, homopolymer A-tailing and PCR using an oligo d(T) 
primer. In this case, immunoprecipitation of protein-RNA complexes successfully 
yielded RNAs specific for hnRNP A2. The RT-PCR method was similar to the PA RT- 
PCR tested in Chapter 3 for the amplification of RNAs that interacted with GST-US11. 
Indeed, this protocol yielded similar results. A low molecular weight smear was 
observed with the non-specific pull-down and a higher molecular weight smear was 
seen for the pull-down performed with the protein (Fig. 3.11). Brooks & Rigby (2000) 
random primed the amplified sequences and used them to probe a Lambda Zap library 
allowing them to identify the interacting RNAs. Such a screening method has major 
advantages over cloning and sequencing. It allows a population such as this, very 
heterogeneous, with no obvious distinction between what constitutes specific and non­
specific species, to be screened.
However, the method described by Brooks & Rigby (2000), did not identify the known 
binders, myelin basic protein (MBP) mRNA, and growth macrophage-colony
142
Chapter 7 Discussion
stimulating factor (GM-CSF) mRNA, although GM-CSF mRNA could be amplified by 
RT-PCR with gene-specific primers. This is similar to the case with SI RT-PCR 
detailed here, in that the RNA pulled down with the protein and amplified by the non­
specific primers did not contain a known binder.
Sung et al. (2000) also used an RT-PCR based protocol to identify RNAs which interact 
with Fragile X mental retardation protein (FMRP), using biotinylated-FRMP to pull out 
interacting RNAs, which were amplified by differential display RT-PCR (DD RT- 
PCR). They identified nine amplified species, and in this case, a known binder, FRMP 
mRNA, was amplified. Despite the RT-PCR requiring the presence of a poly (A) tail, a 
non-polyadenylated species, mitochondrial rRNA, was isolated. However, MBP 
mRNA, and a non-polyadenylated RNA, 60S rRNA, which are known to bind FRMP 
were not represented in the species pulled out, implying that either at the pull down 
stage or at the RT-PCR stage these sequences were lost.
Trifillis et a l (1999) used a recombinant GST-aCPl protein to isolate interacting RNAs 
from cell lysates. The RNA was amplified, as with the method used by Sung et al. 
(2000), by DD RT-PCR. This allowed ten sequences to be identified as potential 
binding partners for this protein. However, the known binders, 0- and y-globin, which 
could be amplified from those RNAs pulled out by gene-specific primers, were not 
present in the ten DD RT-PCR species.
It would therefore appear that all these methods, including the SI RT-PCR method 
outlined here, can yield novel RNA partners for a particular protein of interest. The 
distinction between these methods is subjective. Each method shows some bias in that 
RNAs known to interact with the protein have not been represented in the amplified 
products. This may either be due to sequence bias introduced in RT-PCR or may reflect 
the relative abundance of these RNAs. The basic dividing feature is how non-specific
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and specific RNAs are distinguished. Whether this is achieved by comparing the species 
by electrophoresis and extracting the bands specific for the protein of interest (Trifillis 
et al., 1999; Sung et a l , 2000 and here), or by screening a cDNA library, a method that 
allows large numbers of sequences to be screened (Brooks & Rigby, 2000), reflects the 
nature of the RT-PCR protocol used (i.e. how many species are generated).
The major advantage of SI RT-PCR is its ability to amplify both polyadenylated and 
non-polyadenylated RNAs, hence no assumption is made as to the nature of the RNAs 
that the protein interacts with. With a protein such as US11, which binds such divergent 
RNAs, this protocol is ideally suited. However, with proteins such as an hnRNPs, a 
slightly different approach is needed. A protocol which limits the number of RNAs 
amplified, such as the method used by Trifillis et a l (1999) or Sung et al (2000), allows 
manageable numbers for sequencing and subsequent analysis. Alternatively, a large 
scale screening programme, such as that employed by Brooks & Rigby (2000), allows 
identification of correspondingly large numbers of binding RNAs.
7.3 US11-RNA interactions
7.3.1 RNA secondary structure
The interaction of US 11 with 2-4 RNA, the region mapped as containing the US 11 
binding site in the 12-14 derived transcript, was shown to be dependent on secondary 
structure. US11 showed a greater preference for the two slower migrating species of 2-4 
RNA as opposed to the fastest migrating species. Interestingly, Roller and Roizman 
(1990) demonstrated that the interaction between US 11 and the antisense transcript of 
its own 5' UTR was dependent on the secondary structure of the RNA, in that US 11
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interacted with the slower migrating minor species of two RNA secondary structures. 
Due to the lack of sequence similarity between the RNA substrates of US 11 (the XRE, 
RRE, A34, and the anti-sense transcript of the US 11 5' UTR) and the secondary 
structure-dependence demonstrated here and by Roller and Roizman (1990), it appears 
that the US 11 RNA recognition motif may be determined primarily by the secondary 
structure of the RNAs over that of the sequence itself. The XRE and RRE are highly 
structured RNAs forming complex elements of stems and loops (Dayton et a l, 1989). 
US11 may potentially interact with these RNAs by virtue of their secondary structures, 
which may share some similarity its natural in vivo substrates.
7.3.2 The US11 interaction with UL13 RNA
7.3.2.1 Mechanism of down-regulation of UL13 and comparison of effects on other 
US11 RNA partners.
The interaction of US 11 with UL13 mRNA appears, at least superficially, to have more 
in common with its interaction with A34 RNA than with the retroviral export elements, 
the RRE and the XRE. Firstly, the binding site for US 11 in A34 lies within the ORF, 
whereas the RRE and XRE are intronic elements; the binding site for US11 was mapped 
to the 3' end of the ORF of UL13 mRNA. Secondly, whilst US 11 promotes the 
cytoplasmic accumulation of RRE- and XRE-containing RNA, A34 and UL13 RNAs 
are down regulated in the presence of US 11.
It is therefore conceivable, that for A34 and UL13 RNAs, US11 acts through a separate 
pathway than for RRE/XRE-containing RNA. Alternatively, a common pathway may 
be used, but the outcome of this activity differs due to later downstream events. For
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example, US11 may act to increase the export of A34 and UL13 RNAs from the nucleus 
to the cytoplasm where their turnover is greater, resulting in a net decrease in these 
RNAs.
Certainly, work to compare these RNA substrates of US 11 may reveal whether there is 
indeed a common mechanism of action, or whether their regulation is unrelated. A 
comparison of RNA half-lives, distribution and in vitro decay profiles in the presence 
and absence of US 11 could provide valuable information on the mechanism(s) of action 
ofUSl l .
1 3 2 2  US11 regulates the accumulation of UL13 RNA but not that of UL12 or UL14
The binding site of US 11 in 12-14 RNA encompasses 108nt of the UL12 5' UTR, 225nt 
of the UL13 3' coding region and 7nt of the UL13 3' UTR, and lies within the UL14 3' 
UTR. However, US11 only seems to regulate UL13 mRNA levels, but not that of UL12 
or UL14.
The 108nt of the UL12 5' UTR does not represent the entire region sufficient for US11 
binding. An alternative explanation is that as US 11 binding has been shown to be 
secondary structure-dependent, the 5r UTR of UL12 may not adopt a secondary 
structure permissive for US11 binding. UL14 mRNA, does contain the entire 232nt 
element. Once again, as US 11 binding is secondary structure-dependent, US 11 may be 
excluded from binding this element in UL14 mRNA due to an unfavourable RNA 
structure formed in this RNA, perhaps via long-range intramolecular RNA interactions. 
Another explanation for the lack of regulation of UL14 and UL12 may be that the 
regulatory effect of US 11 on a RNA is position dependent. US11 appears to bind both 
the UL13 mRNA and the A34 RNA within the coding region of the RNA (Roller &
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Roizman, 1991). When positioned in the 3' UTR or 5' UTR this element may not be a 
target for down-regulation.
7.3.2.3 Why down regulate UL13?
The question arising from this work is why regulate the expression of UL13 at early 
stages in infection? Fundamental to answering this question is to discern whether the 
down-regulation of the UL13 protein kinase itself is the objective of US 11 or merely a 
by-product of a general activity directed towards RNA? In other words, is the purpose 
of this regulation to decrease the levels of the UL13 protein kinase or UL13 RNA itself? 
Firstly, the issue of what function the down-regulation of UL13 mRNA could serve, and 
secondly, what purpose the down-regulation of the UL13 kinase could serve shall be 
addressed.
US 11 has been shown to inhibit the activation of PKR and the subsequent 
phosphorylation of eIF-2a and hence host-induced translational shut-off when 
expressed at an early stage in infection. The antagonism of this anti-viral response is 
discussed in Chapter 1. Several mechanisms for this activity have been suggested for 
US11, that US 11 acts to compete with the substrates of activated PKR for 
phosphorylation, blocks the active site of PKR by forming an inactive complex with 
PKR and dsRNA, competes with PKR for dsRNA binding or tethers PKR to ribosomes. 
The RNA activators of PKR are ill-defined (Gunnery & Mathews, 1998) and it is 
conceivable that the RNAs which US 11 binds represent potent activators of PKR. 
Although the RNAs to which US 11 binds have little sequence similarity, their 
secondary structure may be the most important feature in the binding of US11. The 
XRE and RRE are very highly structured RNAs, possessing many double stranded
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regions (Dayton et al., 1989). US 11 interacts with both the antisense transcript of its 
own 5' UTR (Roller & Roizman, 1990) and the 2-4 RNA (derived from UL13 RNA) 
described here in a secondary structure-dependent manner. It is possible that by binding 
to these RNAs, US11 masks regions in these RNAs which could elicit the activation of 
PKR. As US 11 appears to down-regulate the expression of at least two RNAs, namely 
A34 and UL13, it is also conceivable that US11 acts by suppressing the accumulation of 
RNAs which could activate PKR.
US 11 has been shown to interact with PKR in GST-pull down experiments and can 
inhibit the activation of PKR and the phosphorylation of PKR if added prior to the 
activation of PKR in vitro (Cassady et a l, 1998b). Poppers et al. (2000) have suggested 
that US11 may form a heterotrimer complex with PKR by binding to the same activator 
dsRNA. The binding of US 11 in this complex may prevent the dimerization and hence 
the activation of PKR. The HSV-1 RNAs that US 11 binds may participate in such a 
heterotrimeric complex. However, the interaction of PRK and US11 is not disrupted by 
RNase treatment of the lysates, which suggests that this interaction may be, at least in 
part, independent of a common dsRNA ligand. It has also been suggested that US 11 
may act as a pseudosubstrate for PKR, becoming phosphorylated in favour of eIF-2a or 
can block the active site of PKR by protein-protein interactions (Cassady et al, 1998b; 
Poppers et al., 2000). By binding to a dsRNA activator, US 11 may be able to increase 
the likelihood of interacting with PKR by bringing it in to close proximity, by 
interacting with the same RNA molecule so that it may either block the active site of 
PKR or act as substrate for phosphorylation via protein-protein interactions.
The second point to be considered is whether US11 is acting at the RNA level to down- 
regulate the accumulation of the UL13 protein kinase. The UL13 protein kinase is a 
57kDa nuclear kinase which is packaged into the virion as a tegument protein
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(Cunningham et al., 1992; Overton et al., 1992). The UL13 gene is non-essential with 
mutants in this gene displaying reduced plaque size and a decrease in viral yield of 
between two- to ten-fold (Purves & Roizman, 1992; Coulter et al., 1993; Overton et al., 
1994). UL13 has been shown to be involved in the phosphorylation of ICP22 (US1), 
US 1.5, ICPO (RL2), gE, gl, and VP22 (UL49) and two cellular proteins, RNAP II and 
EF-18. UL13 mutants display impaired ability to induce host shut-off mediated by vhs. 
The substrates and pathways that UL13 influences are described in Table 7.1. The 
down-regulation of UL13 by US 11 early in infection may serve as a modulatory 
function, delaying the full activity of UL13 until later in infection. Any of the pathways 
down-stream of UL13 may therefore be potentially influenced. Subsequent examination 
of the phosphorylation status of these proteins in the absence of US 11 may indicate 
which pathways could be effected.
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Pathway/protein targeted Effect o f UL13 Reference
ICP22 (US1): Required for the 
expression of a subset of late 
genes and ICPO mRNA
Phosphorylated by UL13. UL13 mutants 
show a decrease in four phosphorylated 
forms and an increase in one. ICP22 and 
UL13 mutants show a decrease in the 
expression of ICPO, US11 and ICP35.
Sears et al., 1985; 
Purves & Roizman, 
1992; Purves et al., 
1993; Prod’hon et 
al., 1996.
ICP22 localization to sites of 
transcription containing EAP, 
ICP4 and RNAP II
In UL13 mutants ICP22 does not localize to 
these sub-nuclear structures.
Leopardi et al., 1997
RNAP II: Hypophosphorylated 
form (Ho) binds promoter, 
hyperphosphorylated (Ha) form 
proceeds to elongation.
In HSV-1 infected cells Ila and Ho are 
decreased, and intermediate phosphorylated 
form present (Hi). May help to re-direct 
transcription to viral genes. UL13 and 
ICP22 mutants: No decrease in Ila and IIo 
and Hi does not accumulate.
Rice et al, 1995; 
Long et al., 1999.
Cyclins A/B & cdc-25 
phosphatase: G2/M transition
Decrease in cyclins A and B and increase in 
cdc-25 phosphatse activity require UL13 
and ICP22 HSV-1 infected cells
Advini et al., 2000.
EF-18: GDP-GTP exchange in 
translation
Hyperphosphorylated in HSV-1 infected 
cells. Dependent on UL13.
Kawaguchi et al., 
1998
ICPO Cell type dependent phosphorylated forms 
dependent on the presence of UL13.
Ogle et al., 1997
gE and gl UL13 interacts with gE. Phosphorylation of 
gl and gE decreased in UL13 mutant virus.
Ng et al., 1998
VP22 (UL49): Decreased phosphorylation in UL13 mutant 
virus.
Coulter et al., 1993
Vhs UL13 mutant does not induce host shut off 
of protein synthesis.
Fenwick & Everett, 
1990; Overton et a l,  
1994
Tegument dissociation Phosphorylation o f VP13/14 and VP22 
required for dissociation form virion. 
Release of VP22 impaired in UL13 mutant
Morrison et al., 
1998
Table 7.1: Proteins and pathways influenced by the UL13 protein kinase.
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7.5 Future work
For subsequent work on the interaction between US 11 and RNA there several avenues
of work that could be explored:
(1) The determination of the pathway by which US 11 down-regulates UL13 and A34 
RNAs and whether this shares any similarities to the RRE/XRE interaction. The 
examination of cytosolic and nuclear RNA turnover and the study of proteins which 
US11 interacts with may provide a valuable insight into the mechanism of its action.
(2) Identification of further US11-RNA interactions. The use of SELEX to generate 
high affinity RNA partners for US 11 may allow the secondary structure-dependent 
binding of US 11 to be examined or identify key RNA motifs which are not yet 
apparent. The identification of other RNAs by modification of SI RT-PCR. A 
protocol which utilises 6-mer instead of 9-mer random primers has generated more 
amplified sequences including the known binder, A34. Subsequent identification and 
study of these species may elucidate other RNAs which interact with US11.
(3) The influence of US 11 on the UL13 kinase activity. The use of phosphorylation 
assays to assess the impact of the US 11-dependent down-regulation of UL13 mRNA 
in infected cells.
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Sequence alignment of the DNA amplified in SI RT-PCR
B l a s t n :  h t t p : / / w w w . n c b i . n l m . n i h . g o v / B L A S T /
Sequences producing significant alignments: (bits)
Value
a t
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a t
a t
a t
a t
a t
a t
a t
a t
a t
a t
a t
a t
a t
at.
at.
a t
a t
at.
a t
a t
a t
a t
a t
962937 8|ref INC 001806.11 Human herpesvirus 1, complete g, 
194 4 536|emb1X14112.1[HEICG Herpes simplex virus (HSV) ty, 
59841|emb1X03839.1IHEHSV1EX HSV-1 (strain 17) gene for e.
2217211dbjID10879.ilHS1ULR Herpes simplex virus type 1 1 
33007 5 |gbIK02022.1 IHS1EXO HSV1 (KOS) alkaline exonucleas 
5832548 IdbjIAB009268.1IAB009268 Human herpesvirus 1 UL13
592 67 67|dbj|AB009266.2|AB009266
592 67 65 1dbj|AB0092 65.2 |Ab00 92 65
58 3254 0|dbj[AB0092 64.1|AB0092 64
14 701992|gblAC018 4 91.8IAC0184 91
96292671 ref 1NC 001798.11 Human herpesvirus 2, complete g 
6572414|emb1Z86099.2|HSV2HG52 Herpes simplex virus type 
330249|gb|M11854.11HS2EXO HSV-2 (HG-52) alkaline exonucl
Human herpesvirus 1 UL12 
Human herpesvirus 1 UL12 
Human herpesvirus 1 UL12 
Drosophila melanogaster, 
Drosophila melanogaster c 
Drosophila melanogaster c 
Drosophila melanogaster c 
Drosophila melanogaster c 
Drosophila melanogaster c 
Drosophila melanogaster c 
Drosophila melanogaster c 
Drosophila melanogaster c. 
Drosophila melanogaster c, 
Drosophila melanogaster c, 
Drosophila melanogaster c 
Drosophila melanogaster a, 
Drosophila melanogaster c, 
Drosophila melanogaster c, 
Drosophila melanogaster 
4097498|gb[U62907.1|MMU62 907 Mus musculus zinc finger pr,
qi 3834442 1 qb |AF070699.1 AF070699
qi 3834440 1 gb |AF070698.1 AF070698
q1 3834438 I qb iAF070697.1 AF070697
qi 3834436 i qb iAF070696.1 AF070696
qi 3834434 1 qb IAF070695.1 AF070695
qi 3834432 Igb|AF070694.1 AF070694
qi 3834430 1 gb iAF070 693.1 AF070693
qi 3834428 1qb|AF07 0692.1 AF070692
qi 3834426 Igb|AF07 0691.1 AF070691
qi 3834424 i qb iAF070690.1 AF070690
qi 3834422 1qbIAF07 068 9.1 AF070689
qi 3834420 1 qb IAF070688.1 AF070688
qi 3892192|gb| AF070687.1 AF070687
qi 8118592 1 gb |AF263371.1 AF263371
10729259|gb|AE002611.2IAE002 611
15163618|gb|AE007939.11AE007 939 Agrobacterium tumefacien
4097500|gb|U62 908.1 IMMU62 908 Mus musculus zinc finger pr 
3834610]gb|AF0932 60.1 IAF0932 60 Mus musculus homer-2b mRN 
3834608|gb|AF093259.1IAF093259 Mus musculus homer-2a (ho 
132746931emb|AL355852.23|AL355852 Human DNA sequence fro
3153171|gb|AF010180.1IAF010180 Agrobacterium tumefaciens 
2 307005|gb|AFO11925.1IAF011925 Bos taurus LN1 mRNA, comp 
18400401gb|U48862.1IPCU48862 Petroselinum crispum pathog
141914 5 Iemb1X98688.1 I PCPRP1 P.crispum mRNA for pathogene 
204 58 1emb1X1257 3.1 IPCPR13 Parsley PcPRl-3 mRNA for patho 
204 56|emb1X12574.1|PCPR12 Parsley PcPRl-2 mRNA for patho
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Al ignments
>giI 9629378|ref INC 001806.11 Human herpesvirus 1, complete genome 
Length = 152261
Score = 559 bits (282), Expect = e-156
Identities = 481/530 (90%), Gaps = 22/530 (4%)
Strand = Plus / Minus
Query: 96 ctggagttngtggttaagcgtgtaggtcgccccgagnntgggcgtacccgtgacccggtt 155 
I I I II I I I I I I I I I I I II I I II II I I I I I I I I I I I I I I I I II I II I I I I I I I I II 
Sbjct: 27332 ctggagttggtggtta-gcgtgtacgtcgccccgagcctgggcgtacccgtgacccggtt 
27274
Query: 156 ttcccgt-accantattttaacaaccagctgtcgccggacttccccctggttnctgctcg 214
I II II I I I I II I I I I I I I I I I II I I I I I I I I I I I I I I I I II I I I I I I I II I I 
Sbjct: 27273 tcccggttaccagtattttaacaaccagctgtcgccggacttcgccctggc-cctgctcg 
27215
Query: 215 cctatcgctgcgtgctgcacccagccntgtttgtcaacccggccgagaccaacacccacg 274 
I I I I II I I I I I I I I I I I I I I I I II II I I I I I I I I I II I I I II I I I I I I I I I I I I I I I 
Sbjct: 27214 cctatcgctgcgtgctgcacccagccctgtttgtcaactcggccgagaccaacacccac- 
27156
Query: 275 ggnntggcgtatgacgncccagagggctcccggcgccacctccgcnntccccaagattcg 334 
II I I II I I I I I I I I I I I I I I II I I I I I I II II I I I I I I I I I I I I II I II I I I 
Sbjct: 27155 ggcctggcgtatgacgtcccagagggcatccggcgccacctccgcaat-cccaagattcg 
27097
Query: 335 gcgcgcgtttaacgg--nggtgtanaaattaccagcaccacaccaaaggcgatactgtcg 392
I I I II I II I I II I I I I I I I I I I I II I I II II I I I I II I I I I I I I I I I I I I I I 
Sbjct: 27096 gcgcgcgttt-acggatcggtgtataaattaccagca-cacacacaaggcgatactgtcg 
27039
Query: 393 tcggtggcgc--gctcccgagcttaagcctctc--ggtgctggtgtncccgcctgtgtca 448 
I I II II I I I I I I II I I I I II II I I I I II II II I II I I I I I I I I I I II I II I I I I 
Sbjct: 27038 tcggtggcgctgcctcccgagcttaagcctctcctggtgctggtgt-cccgcctgtgtca 
26980
Query: 449 caccaaccccgtgcgcg-ggcacgcgctgtcgtgagaatcagcgtncacccggcggcgcg 507 
I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct: 26979 caccaa-cccgtgcgcgcggcacgcgctgtcgtgagaatcagcgttcacccggcggcgcg 
26921
Query: 508 ctcaaccaccgct-ccccnacgtcgtctc-gaaatggagt-cacg--aggccccagcatg 562 
II I II I II I I I I I I II I I I I I I II II I I II I I II II I I I I I I I I  II I I I I I I I 
Sbjct: 26920 ctcaaccaccgctccccccacgtcgtctcggaaatggagtccacggtagg-cccagcatg 
26862
Query: 563 tccgccgggncgcaccgtgactaagcgtccctgggccctggccgaggaca 612
I I I I II I II II I I I I II II I I I I I II I I I I I I II I I I I I I I I II II I I I
Sbjct: 26861 tccgccgggacgcaccgtgactaagcgtccctgggccctggccgaggaca 26812
giI 19445361emb1X14112.1|HE1CG Herpes simplex virus (HSV) type 1 complete 
genome
Length = 152261
Score = 559 bits (282), Expect = e-156
Identities = 481/530 (90%), Gaps = 22/530 (4%)
Strand = Plus / Minus
Query: 96 ctggagttngtggttaagcgtgtaggtcgccccgagnntgggcgtacccgtgacccggtt 155 
I I I I I I I I I II I I I I I I I I I II I I I I I I I II II I I II I I I I I I I I I I I I I I II I I 
Sbjct: 27332 ctggagttggtggtta-gcgtgtacgtcgccccgagcctgggcgtacccgtgacccggtt 
27274
Query: 156 ttcccgt-accantattttaacaaccagctgtcgccggacttccccctggttnctgctcg 214 
I  I I  I I  I  I  I  I  I I  I I  I  I  I  I I  I  I  I I  I  I  I  I I  I  I  I I  I I  I  I  I  I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I  
Sbjct: 27273 tcccggttaccagtattttaacaaccagctgtcgccggacttcgccctggc-cctgctcg 
27215
Query: 215 cctatcgctgcgtgctgcacccagccntgtttgtcaacccggccgagaccaacacccacg 274 
I  I  I  I  I  I I  I I  I  I  I  I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I  I I  I  I  I  
Sbjct: 27214 cctatcgctgcgtgctgcacccagccctgtttgtcaactcggccgagaccaacacccac- 
27156
Query: 275 ggnntggcgtatgacgncccagagggctcccggcgccacctccgcnntccccaagattcg 334 
II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I 
Sbj ct: 27155 ggcctggcgtatgacgtcccagagggcatccggcgccacctccgcaat-cccaagattcg 
27097
Query: 335 gcgcgcgtttaacgg--nggtgtanaaattaccagcaccacaccaaaggcgatactgtcg 392 
I  I  I  I  I  I  I  I  I  I  I  I  I I  I  I  I  I I  I  I I  I  I I  I  I  I  I  I I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I  I  I  I  I I  I  
Sbjct: 27096 gcgcgcgttt-acggatcggtgtataaattaccagca-cacacacaaggcgatactgtcg 
27039
Query: 393 tcggtggcgc--gctcccgagcttaagcctctc--ggtgctggtgtncccgcctgtgtca 448
I I  I  I  I  I  I I  I  I  I  I  I  I  I  I I  I  I  I I  I  I  I  I  I  I  I I  I  I I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  
Sbjct: 27038 tcggtggcgctgcctcccgagcttaagcctctcctggtgctggtgt-cccgcctgtgtca 
26980
Query: 449 caccaaccccgtgcgcg-ggcacgcgctgtcgtgagaatcagcgtncacccggcggcgcg 507 
I  I  I  I  I  I  I I  I  I  I  I  I I  I I  I  I  I  I  I  I I  I I  I  I I  I  I  I I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I  
Sbjct: 26979 caccaa-cccgtgcgcgcggcacgcgctgtcgtgagaatcagcgttcacccggcggcgcg 
26921
Query: 508 ctcaaccaccgct-ccccnacgtcgtctc-gaaatggagt-cacg--aggccccagcatg 562 
I I I I I I I II I I I I II I I II I I I I I I I I I I I I I II II I I I II III I I I I I I I II 
Sbjct: 26920 ctcaaccaccgctccccccacgtcgtctcggaaatggagtccacggtagg-cccagcatg 
26862
Query: 563 tccgccgggncgcaccgtgactaagcgtccctgggccctggccgaggaca 612
I I I II I I II I I I I II II I I I I I II II I I I I I I II I I I I I I I II I I I I I I
Sbjct: 26861 tccgccgggacgcaccgtgactaagcgtccctgggccctggccgaggaca 26812
gi|59841|emb1X03839.1|HEHSV1EX HSV-1 (strain 17) gene for exonuclease (0.16 
to 0.20 genome m.u.)
Length = 7800
Score = 559 bits (282), Expect = e-156
Identities = 481/530 (90%), Gaps = 22/530 (4 
Strand = Plus / Minus
Query: 96 ctggagttngtggttaagcgtgtaggtcgccccgagnntgggcgtacccgtgacccggtt 155 
I I I I I I I I I I I I I I I I II I I I I I I I II II I I II I II I I I I II I I I I I I I I I I I I I 
Sbjct: 4666 ctggagttggtggtta-gcgtgtacgtcgccccgagcctgggcgtacccgtgacccggtt 4608
Query: 156 ttcccgt-accantattttaacaaccagctgtcgccggacttccccctggttnctgctcg 214
I II II I II I I I I I I I I I I II I I I I I I II II I I II I I II I I I I I II I I I I I I I 
Sbjct: 4607 tcccggttaccagtattttaacaaccagctgtcgccggacttcgccctggc-cctgctcg 4549
Query: 215 cctatcgctgcgtgctgcacccagccntgtttgtcaacccggccgagaccaacacccacg 274
I I I I I I I II I I I I I I II I I I I I I I I I I II I I I I II I I I I I I I I I I I I II I I I I I I I I 
Sbjct: 4548 cctatcgctgcgtgctgcacccagccctgtttgtcaactcggccgagaccaacacccac- 4490
Query: 275 ggnntggcgtatgacgncccagagggctcccggcgccacctccgcnntccccaagattcg 334
I I  I  I  I  I  I  I I  I  I  I  I  I  I  I I  I  I  I  I I  I  I  I  I I  I  I  I  I  I  I I  I  I  I  I  I  I  I  I  I  I  I  I  I I  I I  I  I  
Sbjct: 4489 ggcctggcgtatgacgtcccagagggcatccggcgccacctccgcaat-cccaagattcg 4431
Query: 335 gcgcgcgtttaacgg--nggtgtanaaattaccagcaccacaccaaaggcgatactgtcg 392 
I I I I I I  II I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I  
Sbjct: 4430 gcgcgcgttt-acggatcggtgtataaattaccagca-cacacacaaggcgatactgtcg 4373
Query: 393 tcggtggcgc--gctcccgagcttaagcctctc--ggtgctggtgtncccgcctgtgtca 448 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I II I I I I I 
Sbjct: 4372 tcggtggcgctgcctcccgagcttaagcctctcctggtgctggtgt-cccgcctgtgtca 4314
Query: 449 caccaaccccgtgcgcg-ggcacgcgctgtcgtgagaatcagcgtncacccggcggcgcg 507 
I  I  I  I I I  I  I  I  I  I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I  
Sbjct: 4313 caccaa-cccgtgcgcgcggcacgcgctgtcgtgagaatcagcgttcacccggcggcgcg 4255
Query: 508 ctcaaccaccgct-ccccnacgtcgtctc-gaaatggagt-cacg--aggccccagcatg 562 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I III I I I I I I I I I 
Sbjct: 4254 ctcaaccaccgctccccccacgtcgtctcggaaatggagtccacggtagg-cccagcatg 4196
Query: 563 tccgccgggncgcaccgtgactaagcgtccctgggccctggccgaggaca 612 
I I I I I I I I I I I I I I I I I I I I I I I I  I I I I I I I I I I I I I I II I I I I I I I I I 
Sbjct: 4195 tccgccgggacgcaccgtgactaagcgtccctgggccctggccgaggaca 4146
>gi1221721|dbj|D10879.1|HS1ULR Herpes simplex virus type 1 long unique region 
UL
Length = 108360
Score = 559 bits (282), Expect = e-156
Identities = 481/530 (90%), Gaps = 22/530 (4%)
Strand = Plus / Minus
Query: 96 ctggagttngtggttaagcgtgtaggtcgccccgagnntgggcgtacccgtgacccggtt 155 
I I I I II I I I I II I II I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct: 18334 ctggagttggtggtta-gcgtgtacgtcgccccgagcctgggcgtacccgtgacccggtt 
18276
Query: 156 ttcccgt-accantattttaacaaccagctgtcgccggacttccccctggttnctgctcg 214
I II II I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I II II I I 
Sbjct: 18275 tcccggttaccagtattttaacaaccagctgtcgccggacttcgccctggc-cctgcteg 
18217
Query: 215 cctatcgctgcgtgctgcacccagccntgtttgtcaacccggccgagaccaacacccacg 274 
II I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I II I I I I I I II I I I 
Sbjct: 18216 cctatcgctgcgtgctgcacccagccctgtttgtcaactcggccgagaccaacacccac- 
18158
Query: 275 ggnntggcgtatgacgncccagagggctcccggcgccacctccgcnntccccaagatteg 334
i I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I 
Sbjct: 18157 ggcctggegtatgacgtcccagagggcatccggcgccacctccgcaat-cccaagattcg 
18099
Query: 335 gegegegtttaacgg--nggtgtanaaattaccagcaccacaccaaaggcgatactgteg 392
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I II I I 
Sbjct: 18098 gcgcgcgttt-acggatcggtgtataaattaccagca-cacacacaaggcgatactgtcg 
18041
Query: 393 tcggtggcgc--gctcccgagcttaagcctctc--ggtgctggtgtncccgcctgtgtca 448 
I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I II I I I 
Sbjct: 18040 tcggtggcgctgcctcccgagcttaagcctctcctggtgctggtgt-cccgcctgtgtca 
17982
Query: 449 caccaaccccgtgcgcg-ggcacgcgctgtcgtgagaatcagcgtncacccggcggcgcg 507 
II I I I I I I I I I I I I I I I I I I I I I II I II I I I I II I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct: 17981 caccaa-cccgtgcgcgcggcacgcgctgtcgtgagaatcagcgttcacccggcggcgcg 
17923
Query: 508 ctcaaccaccgct-ccccnacgtcgtctc-gaaatggagt-cacg--aggccccagcatg 562 
I I I I I II I I I I I I I I II I I I I I I I I I I I I I II I I I I I I I I I I I I  I II I I I I I I 
Sbjct: 17922 ctcaaccaccgctccccccacgtcgtctcggaaatggagtccacggtagg-cccagcatg 
17864
Query: 563 tccgccgggncgcaccgtgactaagcgtccctgggccctggccgaggaca 612
I I I I II I I I I I I II I II I I I II I II I II I I I I I I II I I I I I I I I I I I I I
Sbjct: 17863 tccgccgggacgcaccgtgactaagcgtccctgggccctggccgaggaca 17814
>giI 330075 IgbIK02022.1 IHS1EXO HSV1 (KOS) alkaline exonuclease gene, 0.175- 
0.160 map units
Length = 2579
Score = 529 bits (267), Expect = e-148
Identities = 463/513 (90%), Gaps = 19/513 (3% 
Strand = Plus / Plus
Query: 112 agcgtgtaggtcgccccgagnntgggcgtacccgtgacccggttttcccgt-accantat 170 
I  I  I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I  I I  I  I  I  I  I I  I I  I  I  I  I  I I I  
Sbjct: 4 agcgtgtacgtcgccccgagcctgggcgtacccgtgacccggtttcccggttaccagtat 63
Query: 171 tttaacaaccagctgtcgccggacttccccctggttnctgctcgcctatcgctgcgtgct 230 
I I  I  I  I  I I  I  I I  I  I  I I  I  I I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I I  I  I  I I  I  I  I  I  I I  I  I  I I  I  I  I  I  I  I I  
Sbjct: 64 ttcaacaaccagctgtcgccggacttcgccctggc-cctgctcgcctatcgctgcgtgct 122
Query: 231 gcacccagccntgtttgtcaacccggccgagaccaacacccacgggnntggcgtatgacg 290 
I II I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II II I I I I I I I II I 
Sbjct: 123 gcacccagccctgtttgtcaactcggccgagaccaacacccac-ggcctggcgtatgacg 181
Query: 291 ncccagagggctcccggcgccacctccgcnntccccaagattcggcgcgcgtttaacgg- 349 
I  I  I  I I  I  I  I  I I  I  I  I I  I  I  I  I  I  I I  I  I  I I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I  I  I  
Sbjct: 182 tcccagagggcatccggcgccacctccgcaat-cccaagattcggcgcgcgttt-acgga 239
Query: 350 -nggtgtanaaattaccagcaccacaccaaaggcgatactgtcgtcggtggcgc--gctc 406 
I  I  I  I I  I  I  I  I  I  I  I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I  I  I  I  I I  I  I  I  I  I  I I  I  I  I I  I  I  I  I  I  I I I  
Sbjct: 240 tcggtgtataaattaccagca-cacacacaaggcgatactgtcgtcggtggcgctgcctc 298
Query: 407 ccgagcttaagcctctc--ggtgctggtgtncccgcctgtgtcacaccaaccccgtgcgc 464 
I  I  I I  I I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I I  I I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I  I  I  I I  I  I  I  
Sbjct: 299 ccgagcttaagcctctcctggtgctggtgt-cccgcctgtgtcacaccaa-cccgtgcgc 356
Query: 465 g-ggcacgcgctgtcgtgagaatcagcgtncacccggcggcgcgctcaaccaccgct-cc 522
I  I  I  I  I  I  I I  I  I  I  I  I I  I  I  I  I  I  I  I  I I  I  I  I I  I  I  I  I  I  I  I I  I  I  I  I I  I  I  I  I  I  I  I  I  I  I I  I  I  I I  I I  
Sbjct: 357 gcggcacgcgctgtcgtgagaatcagcgttcacccggcggcgcgctcaaccaccgctccc 416
Query: 523 ccnacgtcgtctc-gaaatggagt-cacgag-gccccagcatgtccgccgggncgcaccg 579
I I  I  I  I  I  I I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I I  I  I  I  I I  I  I  I  I  I  I  I  I  I  I  I  I  I I  I  I I  
Sbjct: 417 cccacgtcgtctcggaaatggagtccacgggaggcccagcatgtcctccgggacgcaccg 476
Query: 580 tgactaagcgtccctgggccctggccgaggaca 612 
I  I  I  I  I  I  I  I I  I I  I  I I  I I  I  I  I  I  I  I  I I  I  I  I  I I  I  I I  
Sbjct: 477 tgactaagcgttcctgggccctggccgaggaca 509
>qi|5832548 IdbjI ABO0 9268.1IAB009268 Human herpesvirus 1 UL13 gene for protein 
kinase, complete cds,
strain:VR-3 
Length = 1557
Score = 387 bits (195), Expect = e-105
Identities = 354/395 (89%), Gaps = 16/395 (4%)
Strand = Plus / Plus
Query: 96 ctggagttngtggttaagcgtgtaggtcgccccgagnntgggcgtacccgtgacccggtt 155
I I II I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II 
Sbjct: 1171 ctggagttggtggtta-gcgtgtacgtcgccccgagcctgggcgtacccgtgacccggtt 1229
Query: 156 ttcccgt-accantattttaacaaccagctgtcgccggacttccccctggttnctgctcg 214 
I II II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I II I 
Sbjct: 1230 tcccggttaccagtatttcaacaaccagctgtcgccggacttcgccctggc-cctgctcg 1288
Query: 215 cctatcgctgcgtgctgcacccagccntgtttgtcaacccggccgagaccaacacccacg 274
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I II I I I I I 
Sbjct: 1289 cctatcgctgcgtgctgcacccagccctgtttgtcaactcggccgagaccaacacccac- 1347
Query: 275 ggnntggcgtatgacgncccagagggctcccggcgccacctccgcnntccccaagatteg 334
II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I II I I II I I I 
Sbjct: 1348 ggcctggcgtatgacgtcccagagggcatccggcgccacctccgcaat-cccaagattcg 1406
Query: 335 gegegegtttaacgg--nggtgtanaaattaccagcaccacaccaaaggcgatactgtcg 392 
I I I I I I I I I I I I I I II I I I I I I I I I I I I I II I I I I I I I I I II I I II I I I I I I 
Sbjct: 1407 gegegegttt-aeggateggtgtataaattaccagca-cacacacaaggcgatactgtcg 1464
Query: 393 tcggtggcgc--gctcccgagcttaagcctctc--ggtgctggtgtncccgcctgtgtca 448 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II II I I 
Sbjct: 1465 tcggtggcgctgcctcccgagcttaagcctctcctggtgctggtgt-cccgcctgtgtca 1523
Query: 449 caccaaccccgtgcgcg-ggcacgcgctgtcgtga 482 
I I I I I I I I I I I I II I I I II I I I I I I I I I I I I II 
Sbjct: 1524 caccaa-cccgtgcgcgcggcacgcgctgtcgtga 1557 
>
giI 9629267|ref|NC 001798.11 Human herpesvirus 2, complete genome 
Length = 154746
Score = 143 bits (72), Expect = 2e-31
Identities = 196/235 (83%), Gaps = 8/235 (3%)
Strand = Plus / Minus
Query: 112 agegtgtaggtcgccccgagnntgggcgtacccgtgacccggttttcccg--taccant 168
I II I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
Sbjct: 27290 agcgtgtacgtggccccgagcctgggcgtccccgtgacccgcgt--cccgggctaccagt
27233
Query: 169 attttaacaaccagctgtcgccggacttccccctggttnctgctcgcctatcgctgcgtg 228
I I I I I I I I I I I I I II I I I I I I I I I I I II III II I I I I I I I I II I I I I I II 
Sbjct: 27232 actttaacaaccagctctcgccggactttgccgtggc-cctcctcgcctatcgctgcgtt 
27174
Query: 229 ctgcacccagccntgtttgtcaacccggccgagaccaacacccacgggnntggcgtatga 288 
I I I I I I II III I I II I I I I I I I I I I I I I II I I I II I I I I I I II I I I I I I I II I 
Sbjct: 27173 ctgcaccccgccctctttgtcaactcggccgagaccaacacccac-ggcctggcgtatga 
27115
Query: 289 cgncccagagggctcccggcgccacctccgcnntccccaagattcggcgcgcgtt 343 
II II I I I I I I I I I I I I I I I I I I III I I I I II I I I I I I I I I II I II I 
Sbjct: 27114 cgtgccggagggcatccggcgccaccttcgcaat-cccaagattcggcgcgcgtt 27061
>gi|6572414|embIZ8 6099.2 |HSV2HG52 Herpes simplex virus type 2 (strain HG52), 
complete genome
Length = 154746
Score = 143 bits (72), Expect = 2e-31
Identities = 196/235 (83%), Gaps = 8/235 (3%) 
Strand = Plus / Minus
Query: 112 agcgtgtaggtcgccccgagnntgggcgtacccgtgacccggttttcccg--taccant 168
I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
Sbjct: 27290 agcgtgtacgtggccccgagcctgggcgtccccgtgacccgcgt--cccgggctaccagt 
27233
Query: 169 attttaacaaccagctgtcgccggacttccccctggttnctgctcgcctatcgctgcgtg 228
I I I I I II I I I I II I I I I I I I I I I I I I II III II I I I I I I I I I I I I I I I I I 
Sbjct: 27232 actttaacaaccagctctcgccggactttgccgtggc-cctcctcgcctatcgctgcgtt 
27174
Query: 229 ctgcacccagccntgtttgtcaacccggccgagaccaacacccacgggnntggcgtatga 281
I I I I I I I I III I I I I I I II I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I 
Sbjct: 27173 ctgcaccccgccctctttgtcaactcggccgagaccaacacccac-ggcctggcgtatga 
27115
Query: 289 cgncccagagggctcccggcgccacctccgcnntccccaagattcggcgcgcgtt 343 
II II I I I II I I I I I I I I I I II I I I I  I I I I I II I I I I I I I I I I I I I I 
Sbjct: 27114 cgtgccggagggcatccggcgccaccttcgcaat-cccaagattcggcgcgcgtt 27061
>giI 3302491gb|M11854.1|HS2EXQ HSV-2 (HG-52) alkaline exonuclease gene, 0.177- 
0.160 map units
Length = 2474
Score = 117 bits (59), Expect = le-23
Identities = 115/133 (86%), Gaps = 2/133 (1%)
Strand = Plus / Plus
Query: 211 ctcgcctatcgctgcgtgctgcacccagccntgtttgtcaacccggccgagaccaacacc 270
11II11II1111 1111 11II11II III I 11II11111 11111111111111111 
Sbjct: 31 ctcgcctatcgccgcgttctgcaccccgccctctttgtcaactcggccgagaccaacacc 90
Query: 271 cacgggnntggcgtatgacgncccagagggctcccggcgccacctccgcnntccccaaga 330 
I I I  II I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I  I I I I I II I 
Sbjct: 91 cac-ggcctggcgtatgacgtgccggagggcatccggcgccaccttcgcaat-cccaaga 148
Query: 331 ttcggcgcgcgtt 343 
I I I I I I I I I I I I I 
Sbjct: 149 ttcggcgcgcgtt 161
>giI 5 92 6767|dbj|ABO09266.2|ABO09266 Human herpesvirus 1 UL12 gene for 
alkaline deoxyribonuclease,
complete cds, strain:KH169 
Length = 1881
Score = 111 bits (56), Expect = l e - 2 2
Identities = 58/59 (98%)
Strand = Plus / Plus
Query: 554 cccagcatgtccgccgggncgcaccgtgactaagcgtccctgggccctggccgaggaca 612 
I I I I I I I I II I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct: 18 cccagcatgtccgccgggacgcaccgtgactaagcgtccctgggccctggccgaggaca 76
>gi|5926765 Idbj |AB009265.2IAB009265 Human herpesvirus 1 UL12 gene for 
alkaline deoxyribonuclease,
complete cds, strain:WT51 
Length = 1881
Score = 111 bits (56), Expect = l e - 2 2
Identities = 58/59 (98%)
Strand = Plus / Plus
Query: 554 cccagcatgtccgccgggncgcaccgtgactaagcgtccctgggccctggccgaggaca 612 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct: 18 cccagcatgtccgccgggacgcaccgtgactaagcgtccctgggccctggccgaggaca 76
>gi|5832540|dbjIAB009264.1IAB009264 Human herpesvirus 1 UL12 gene for 
alkaline deoxyribonuclease,
complete cds, strain:VR-3 
Length = 1881
Score = 111 bits (56), Expect = l e - 2 2
Identities = 58/59 (98%)
Strand = Plus / Plus
Query: 554 cccagcatgtccgccgggncgcaccgtgactaagcgtccctgggccctggccgaggaca 612
I I II I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I
Sbjct: 18 cccagcatgtccgccgggacgcaccgtgactaagcgtccctgggccctggccgaggaca 76
>giI 14701992 IgbI AC0184 91.8|AC018491 Drosophila melanogaster, chromosome X, 
region 19A-19B, BAC clone
BACR11H15, complete sequence 
Length = 177953
Score = 44.1 bits (22), Expect = 0.15 
Identities = 22/22 (100%)
Strand = Plus / Plus
Query: 175 acaaccagctgtcgccggactt 196 
I I I I I I I I I I I I I I I I I I II II 
Sbjct: 930 acaaccagctgtcgccggactt 951
>gi|3834442|gb|AF07 0699.1|AF07 0699 Drosophila melanogaster cytoplasmic dynein 
intermediate chain isoform
DIC5b (Cdic) mRNA, complete cds 
Length = 1962
Score = 44.1 bits (22), Expect = 0.15 
Identities = 22/22 (100%)
Strand = Plus / Plus
Query: 175 acaaccagctgtcgccggactt 196 
I I I I I I I I I I I I I I I I I I I I I I 
Sbjct: 1529 acaaccagctgtcgccggactt 1550
>gi|3834440|gb|AF07 0 698.1|AF07 0698 Drosophila melanogaster cytoplasmic dynein 
intermediate chain isoform
DIC5a (Cdic) mRNA, complete cds 
Length = 1993
Score = 44.1 bits (22), Expect = 0.15 
Identities = 22/22 (100%)
Strand = Plus / Plus
Query: 175 acaaccagctgtcgccggactt 196 
I I I I I I I II I I I I I I I I I I I I I 
Sbjct: 1560 acaaccagctgtcgccggactt 1581
>gi|3834438 Igb|AF07 0697.1|AF07 0697 Drosophila melanogaster cytoplasmic dynein 
intermediate chain isoform
DIC4 (Cdic) mRNA, complete cds 
Length = 1884
Score = 44.1 bits (22), Expect = 0.15 
Identities = 22/22 (100%)
Strand = Plus / Plus
Query: 175 acaaccagctgtcgccggactt 196
I I I I I I I I I I I I I I I I I I I I I I
Sbjct: 1451 acaaccagctgtcgccggactt 1472
>giI 38 34 4 36|gb|AF07 0696.1IAF070696 Drosophila melanogaster cytoplasmic dynein 
intermediate chain isoform
DIC3b (Cdic) mRNA, complete cds 
Length = 1908
Score = 44.1 bits (22), Expect = 0.15 
Identities = 22/22 (100%)
Strand = Plus / Plus
Query: 175 acaaccagctgtcgccggactt 196 
I I I I I I II I I I I I I I I I I I I II 
Sbjct: 1475 acaaccagctgtcgccggactt 1496
>gi|3834434 Igb|AF07 0695.1 IAF07 0 695 Drosophila melanogaster cytoplasmic dynein 
intermediate chain isoform
DIC3a (Cdic) mRNA, complete cds 
Length = 1911
Score = 44.1 bits (22), Expect = 0.15 
Identities = 22/22 (100%)
Strand = Plus / Plus
Query: 175 acaaccagctgtcgccggactt 196 
I I I I I I I I I I I I I I I I I I I I I I 
Sbjct: 1478 acaaccagctgtcgccggactt 1499
>giI 3834432|gb|AF070694.1|AF07 0 694 Drosophila melanogaster cytoplasmic dynein 
intermediate chain isoform
DIC2c (Cdic) mRNA, complete cds 
Length = 1953
Score = 44.1 bits (22), Expect = 0.15 
Identities = 22/22 (100%)
Strand = Plus / Plus
Query: 175 acaaccagctgtcgccggactt 196 
I I I I I I I I I I I I I II I I I I I I I 
Sbjct: 1520 acaaccagctgtcgccggactt 1541
> ji|3834430 IgbIAF07 0 693.1 IAF07 0 693 Drosophila melanogaster cytoplasmic dynein 
intermediate chain isoform
DIC2b (Cdic) mRNA, complete cds 
Length = 1929
Score = 44.1 bits (22), Expect = 0.15 
Identities = 22/22 (100%)
Strand = Plus / Plus
Query: 175 acaaccagctgtcgccggactt 196 
I I I I I I I II I I I I I I I I II I I I 
Sbjct: 1496 acaaccagctgtcgccggactt 1517
>gi|3834428|gbIAFO70692.1IAF070692 Drosophila melanogaster cytoplasmic dynein 
intermediate chain isoform
DIC2a (Cdic) mRNA, complete cds 
Length = 2704
Score = 44.1 bits (22), Expect = 0.15 
Identities = 22/22 (100%)
Strand = Plus / Plus
Query: 175 acaaccagctgtcgccggactt 196 
II I II I I I I I I II I I I I II I I I 
Sbjct: 1665 acaaccagctgtcgccggactt 1686
>gi|3834426|gbIAF070691.1 IAFO70691 Drosophila melanogaster cytoplasmic dynein 
intermediate chain isoform
DIClc (Cdic) mRNA, complete cds 
Length = 1881
Score = 44.1 bits (22), Expect = 0.15 
Identities = 22/22 (100%)
Strand = Plus / Plus
Query: 175 acaaccagctgtcgccggactt 196 
I I I I I II I I I I I I I I I I I I I II 
Sbjct: 1448 acaaccagctgtcgccggactt 1469
gi|3834424|gb|AF07 0 690.1 IAF07 0 690 Drosophila melanogaster cytoplasmic dynein 
intermediate chain isoform
DIClb (Cdic) mRNA, complete cds 
Length = 1884
Score = 44.1 bits (22), Expect = 0.15 
Identities = 22/22 (100%)
Strand = Plus / Plus
Query: 175 acaaccagctgtcgccggactt 196
I I I I I I I I I I I I I I I I I I I I I I
Sbjct: 1451 acaaccagctgtcgccggactt 1472
gi[3834422|gb|AFO70689.1 IAF07 0 68 9 Drosophila melanogaster cytoplasmic dynein 
intermediate chain isoform
DICIa (Cdic) mRNA, complete cds 
Length = 2670
Score = 44.1 bits (22), Expect = 0.15 
Identities = 22/22 (100%)
Strand = Plus / Plus
Query: 175 acaaccagctgtcgccggactt 196 
I I I I I I I I I II I I I II I I I II I 
Sbjct: 1632 acaaccagctgtcgccggactt 1653
>g i |3834420|gb|AF070688.1|AF07 0 68 8 Drosophila melanogaster axonemal dynein 
intermediate chain Sdic
(Sdic) mRNA, complete cds 
Length = 2029
Score = 44.1 bits (22), Expect = 0.15 
Identities = 22/22 (100%)
Strand = Plus / Plus
Query: 175 acaaccagctgtcgccggactt 196 
I I I I I II I I I I I I I I I I I I I I I 
Sbjct: 1288 acaaccagctgtcgccggactt 1309
>gi|3892192|gb|AFO7 0687.1|AFO70687 Drosophila melanogaster cytoplasmic dynein 
intermediate chain isoform
(Cdic) gene, complete cds; and axonemal dynein 
intermediate chain (Sdic) gene, partial cds 
Length = 13833
Score = 44.1 bits (22), Expect = 0.15 
Identities = 22/22 (100%)
Strand = Plus / Plus
Query: 175 acaaccagctgtcgccggactt 196 
I I I I I I I I I I I I I I I I I I I I I I 
Sbjct: 7209 acaaccagctgtcgccggactt 7230
gi I  8118592|g b | AF2 63371.1 |AF2 63371 Drosophila melanogaster cytoplasmic dynein 
intermediate chain subunit
(Dicl9B) mRNA, complete cds 
Length = 2859
Score = 44.1 bits (22), Expect = 0.15 
Identities = 22/22 (100%)
Strand = Plus / Plus
Query: 175 acaaccagctgtcgccggactt 196
I I I I I I I I I I I I I I I I I I I I I I
Sbjct: 1663 acaaccagctgtcgccggactt 1684
>gi|1072 92 59|gb|AE002611.2|AE002611 Drosophila melanogaster genomic scaffold 
142000013385548, complete 
sequence 
Length = 216981
Score = 44.1 bits (22), Expect = 0.15 
Identities = 22/22 (100%)
Strand = Plus / Minus
Query: 175 acaaccagctgtcgccggactt 196 
I I I I I I I I I I II I I II I I I I II 
Sbjct: 216585 acaaccagctgtcgccggactt 216564
gi|4097498lgb|U62907.1|MMU62 907 Mus musculus zinc finger protein 95 (Zfp95) 
mRNA, complete cds
Length = 3175
Score = 42.1 bits (21), Expect = 0.58 
Identities = 21/21 (100%)
Strand = Plus / Minus
Query: 58 gattggccacgcgtcgactag 78 
I I I I I I I I I I I I II II I I I I I 
Sbjct: 3175 gattggccacgcgtcgactag 3155
>gi|15163618 Igb1AE007 939.1 IAE007 939 Agrobacterium tumefaciens strain C58 
plasmid Ti, section 17 of 20 of
the complete sequence 
Length = 11441
Score = 38.2 bits (19), Expect = 9.0 
Identities = 19/19 (100%)
Strand = Plus / Plus
Query: 388 tgtcgtcggtggcgcgctc 406 
I I I I I I I I I I I I I I I I I I I 
Sbjct: 1466 tgtcgtcggtggcgcgctc 1484
>gi|4097500|gb|U62908.1|MMU62 908 Mus musculus zinc finger protein 96 (Zfp96) 
mRNA, complete cds
Length = 2307
Score = 38.2 bits (19), Expect = 9.0 
Identities = 19/19 (100%)
Strand = Plus / Minus
Query: 60 ttggccacgcgtcgactag 78
I I I I I I I II I I I II I I I I I 
Sbjct: 2298 ttggccacgcgtcgactag 2280
> g i I 38 34 6 1 0  I g b I A F O 9 3 2 6 0 . 1 IAFO9 3 2 6 0  Mus musculus homer-2b mRNA, complete cds
Length = 1673
Score = 38.2 bits (19), Expect = 9.0 
Identities = 19/19 (100%)
Strand = Plus / Plus
Query: 60 ttggccacgcgtcgactag 78 
I I I I I I I I I I I I I II I I II 
Sbjct: 4 ttggccacgcgtcgactag 22
>gi|3834608|gb|AF093259.1|AFO93259 Mus musculus homer-2a (homer-2a) mRNA, 
complete cds
Length = 1640
Score = 38.2 bits (19), Expect = 9.0 
Identities = 19/19 (100%)
Strand = Plus / Plus
Query: 60 ttggccacgcgtcgactag 78 
I I I I I I I I I I I I I I I I I I I 
Sbjct: 4 ttggccacgcgtcgactag 22
>giI 132746931emb|AL355852.23|AL355852 Human DNA sequence from clone RP11- 
403E24 on chromosome X, complete
sequence [Homo sapiens]
Length = 128765
Score = 38.2 bits (19), Expect = 9.0 
Identities = 19/19 (100%)
Strand = Plus / Minus
Query: 169 attttaacaaccagctgtc 187
I II I I I I I I I I I I I I I I I I 
Sbjct: 66763 attttaacaaccagctgtc 66745
>gi|3153171|gb|AFO10180.1|AFO1018 0 Agrobacterium tumefaciens plasmid pTiC58 
Tral region, Trail region
and acc operon, complete sequence; and unknown genes 
Length = 24708
Score = 38.2 bits (19), Expect = 9.0 
Identities = 19/19 (100%)
Strand = Plus / Plus
Query: 388 tgtcgtcggtggcgcgctc 406
I I I I I I I I I I I I I I I I I I I
Sbjct: 4522 tgtcgtcggtggcgcgctc 4540
> q i I 2 3 0 7  0 0 5 | g b | A F 0 1 1 9 2 5 . 1 IAFO1 1 9 2 5  Bos taurus LN1 mRNA, complete cds
Length = 1500
Score = 38.2 bits (19), Expect = 9.0 
Identities = 19/19 (100%)
Strand = Plus / Plus
Query: 60 ttggccacgcgtcgactag 78 
I I I I I I I I I I I I I I I I II I 
Sbjct: 68 ttggccacgcgtcgactag 86
>gi118400401gbIU4 8 862.1|PCU4 88 62 Petroselinum crispum pathogenesis-related 
protein (prl-1) gene,
complete cds 
Length = 2011
Score = 38.2 bits (19), Expect = 9.0 
Identities = 22/23 (95%)
Strand = Plus / Plus
Query: 372 acaccaaaggcgatactgtcgtc 394 
I I I I I I I I I I I I I I I I I I I II I 
Sbjct: 1459 acaccaaaggcgatgctgtcgtc 1481
>gi1141914 5 1emb1X98688.1 IPCPRP1 P.crispum mRNA for pathogenesis-related 
protein 1
Length = 468
Score = 38.2 bits (19), Expect = 9.0 
Identities = 22/23 (95%)
Strand = Plus / Plus
Query: 372 acaccaaaggcgatactgtcgtc 394 
I I I II I II I I I I I I I I I I I I I I 
Sbjct: 365 acaccaaaggcgatgctgtcgtc 387
>gi|20458 Iemb1X12573.1|PCPR13 Parsley PcPRl-3 mRNA for pathogenesis-related 
protein type B
Length = 689
Score = 38.2 bits (19), Expect = 9.0 
Identities = 22/23 (95%)
Strand = Plus / Plus
Query: 372 acaccaaaggcgatactgtcgtc 394 
I I I I I I I I I I I I I I I I I I I I I I 
Sbjct: 452 acaccaaaggcgatgctgtcgtc 474
> g i|204 56 Iemb1X12574.1|PCPR12 Parsley PcPRl-2 mRNA for pathogenesis-related 
protein type A
Length = 807
Score = 38.2 bits (19), Expect = 9.0 
Identities = 22/23 (95%)
Strand = Plus / Plus
Query: 372 acaccaaaggcgatactgtcgtc 394 
I I I II II I I I II I I I I I I I I I I 
Sbjct: 426 acaccaaaggcgatgctgtcgtc 448
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